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1.1 The burden of depression-related symptoms: state of the art 
Depression is the leading cause of disability worldwide and is a major contributor to the overall 
global burden of diseases, with high levels of suicide incidence (www.who.int, World Health 
Organisation website). According to the World Health Organization, it is estimated that 10% to 
15% of the general population will experience clinical depression during their lifetime (Tsuang, 
Taylor, & Faraone, 2004). Currently, more than 350 million of people of all ages suffer from 
depression (www.who.int). Indeed, depressive disorders often start at young age, affecting 
lifestyle and usually becoming recurrent. The prevalence of depression is approximately doubled 
in females compared to males, and several studies suggest that the heritability of the disorder is 
significantly higher in women (Mill & Petronis, 2007). Depression core symptoms include 
depressed mood, anhedonia (reduced ability to experience pleasure from natural rewards), 
irritability, difficulties in concentrating, social withdrawal (withdrawal from social contact that 
derives from indifference or lack of desire to have social contact) and abnormalities in appetite 
and sleep, the so called “neurovegetative symptoms” (Krishnan & Nestler, 2008).  
Depression has shown to be comorbid with several neuropsychiatric diseases, such as 
schizophrenia, bipolar disorders, Alzheimer’s diseases, anxiety disorders, autism spectrum 
disorders (ASD) and stress-related diseases. In particular, anxiety-related disorders, such as 
obsessive-compulsive disorders and social anxiety disorder, are highly comorbid with depression, 
with up to 90% of patients experiencing clinical depression at some point in their lifetime (Ressler 
& Mayberg, 2007). Moreover, depression often occurs during the prodromic phase of Alzheimer’s 
disease, schizophrenia and bipolar disorders.  
 
1.2 The impact of dietary factors on depressive-like symptoms 
Lifestyle, particularly environmental and dietary factors, have a great influence on the 
pathogenesis of depression. In this regard, dietary Polyunsaturated Fatty Acids (PUFA) have 
received great attention during the last decades. PUFAs are a family of lipids that are identified by 
the position of the last double bond in their structure. Among them, n-3 and n-6 PUFAs are 
biologically important molecules that mediate several processes, such as signal pathways, 
membrane fluidity, neurotransmission, neuroinflammation and cell survival. N-3 and n-6 PUFA can 
be supplied either directly from diet or by metabolic conversion of their essential precursors, α-
linolenic acid (18:3n-3) and linoleic acid (18:2n-6), respectively (Morgese & Trabace, 2016; 
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Morgese, Tucci, et al., 2017; Zuliani et al., 2009). N-3 PUFA include alpha linolenic acid (ALA), 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), while n-6 PUFA include linoleic acid 
(LA) and arachidonic acid (AA). N-3 PUFA, in particular DHA, are crucial for the brain development 
and to maintain correct central nervous system (CNS) functionality. Experimental evidence in 
animals has demonstrated that DHA deficiency during early brain development is deleterious and 
permanent (Lo Van et al., 2016; Lozada, Desai, Kevala, Lee, & Kim, 2017; Maekawa et al., 2017). 
During embryonal life and lactation, PUFA intake exclusively depends on maternal diet (Lafourcade 
et al., 2011). Indeed, it has been reported that maternal malnutrition plays a crucial role in 
development of psychiatric complications in later adulthood. In particular, evidence from human 
studies indicate that maternal metabolic state and diet influence dramatically the risk for 
behavioural disorders in progeny (Sullivan, Riper, Lockard, & Valleau, 2015). Unfortunately, it is 
quite appropriate to assume that this nutritional-poor diet will be later perpetuated, considering 
that represents part of a lifestyle acquired during early childhood.  
Modern western diets are characterized by deficiency in content of n-3 PUFA, in particular low 
consumption of fish in favour of baked and junk food has determined a dramatic increase of the n-
6/n- 3 PUFA ratio. Indeed, such ratio moved from 1, typical of early 20th century, up to 15 in 
industrialized countries (Simopoulos, 2009, 2011). Epidemiological evidences have established a 
negative correlation between n-3 PUFA consumption and development of anxiety and depressive 
symptoms as well as physiological distress (U. E. Lang, Beglinger, Schweinfurth, Walter, & 
Borgwardt, 2015; Larrieu, Madore, Joffre, & Laye, 2012; Ross, 2009). These findings were 
supported by clinical studies, indicating that the lack of n-3 PUFA in diet is linked to an increased 
susceptibility to neuropsychiatric disorders (Beydoun et al., 2015; Lucas, Kirmayer, Dery, & 
Dewailly, 2010; Murakami, Miyake, Sasaki, Tanaka, & Arakawa, 2010; Panagiotakos et al., 2010), 
while beneficial results with n-3 PUFA supplementation alone or in adjunctive therapies have been 
described in treatment of depressive-like disorders (Grosso, Pajak, et al., 2014; P. Y. Lin & Su, 
2007). 
Moreover, Evans and colleagues demonstrated that n-6 PUFA and their biosynthetic enzymes are 
useful biomarkers for measurements of depressive disorders and burden of diseases, suggesting 
that they should also be taken into consideration when n-3 PUFA role is investigated (Evans et al., 
2015). However, studies involving humans are often polluted by uncontrollable variables and 
biases and some contrasting results and inconsistencies in clinical evaluations have also been 
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denounced (Grosso, Galvano, et al., 2014; Grosso, Pajak, et al., 2014). In this context, the use of 
animal model can be very useful, especially when diet-influenced outcomes need to be measured 
in offspring, since dosing, age of first assumption, along with duration of assumption are strictly 
monitored and are quite reliable. 
Along with dietary deficiency, chronic stress is another environmental risk factor for the 
development of depressive symptoms and dysregulation of hypothalamic–pituitary adrenal (HPA) 
axis in response to chronic or repeated stressful events is a reported important mechanism 
(McEwen, Eiland, Hunter, & Miller, 2012). In this regard, low cerebral DHA content, secondary to 
poor diet, has been associated to increased anxiety-like behaviour induced by chronic mild stress 
paradigm in animals (Harauma & Moriguchi, 2011). Indeed, it has been reported that a diet poor in 
n-3 PUFA increased aggressive behaviour in rodents, while high n-3 PUFA diet was able to reduce 
the stress response (Fedorova & Salem, 2006; Ikemoto et al., 2001), indicating that n-3 PUFA 
deficiency plays a central role in the chronic stress modulation.  
In this context, in chapter 2 and 3 of the present thesis, effects of n-3 PUFA deficient and n-3 PUFA 
enriched diets on female rat offspring have been investigated, in terms of depressive-like 
behaviours and alterations of neurochemical parameters related to chronic stress, anxiety and 
depression.    
 
1.3 From neurobiology to neuropsychiatric symptoms: searching for new 
biomarkers 
However, current nosology for the diagnosis of neuropsychiatric disorders classify each disorder 
into non-overlapping diagnostic categories. This separation is not based on their underlying 
etiology, but on convention-based clustering of qualitative symptoms of the disorder (Kas et al., 
Neuroscience & Biobehavioral reviews, submitted). Although these diagnostic categories are 
sufficient to provide the basis for general clinical treatments, they do not describe the underlying 
neurobiology that gives rise to individual symptoms. The ability to precisely link these symptoms 
to the underlying neurobiology would not only facilitate the development of better treatments, it 
would also allow physicians to help patients with a better understanding of the complexities and 
management of their illnesses (Kas et al., Neuroscience & Biobehavioral reviews, submitted). To 
realize this ambition, a paradigm shift is needed to raise awareness and to build an understanding 
of how neuropsychiatric diagnoses can be based on quantitative biological parameters. In this 
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regard, the main limit in the construction of biologically valid diagnoses is the lack of objective 
biomarkers. Moreover, the uncertain relationship between diagnosis and underlying etiology has 
created difficulties for the development of appropriate disease models and targeted treatments. 
Currently, there has been a rethinking of these diagnostic boundaries in regard to their usefulness 
in treatment and classification of neuropsychiatric disorders (Kas et al., Neuroscience & 
Biobehavioral reviews, submitted). This is partly based on the notion that there is more 
pathogenetic overlap between psychiatric and neurodegenerative disorders than previously 
thought, and that they might better be described as domains of cross-disorder-related traits 
rather than be classified into separate categories (Insel & Cuthbert, 2015; Kas et al., 2011; 
Krishnan & Nestler, 2008). To reach this purpose, animal models can be really helpful to 
longitudinally study behavioural alterations resembling human symptoms in a translational way, 
and ultimately investigate underlying neurobiology in order to deeper understand the etiology.  
 
1.4 Revisiting behavioural paradigms and rodent models for a translational 
approach 
In this thesis, we focused on depressive-like symptoms that occur in several neuropsychiatric and 
neurodegenerative diseases, and, using different animal paradigms and models, we tried to 
disentangle the heterogeneous neurobiology behind these symptoms. 
In particular, the most used test to assess depressive-like behaviour is the Forced Swimming Test 
(FST). The FST is a reliable test widely used to evaluate depressive-like state and screen 
antidepressants activity in rodents (Li, Jiang, Song, Quan, & Yu, 2017). This test is based on learned 
helplessness that results in depressive-like symptoms, such as immobility increase and swimming 
and struggling decrease. 
Disrupted sociability is an important behavioural aspect that needs to be taken into account to 
fully delineate a translational picture of symptoms related to depression. 
The currently available behavioural tests to assess sociability are the social interaction test and the 
three chamber or social preference test. In the social interaction test, interaction between two 
animals is evaluated, while, in the three chamber test, the animal can choose between one empty 
chamber and one chamber with a stimulus animal. Thus, in these tests only dyadic interactions can 
be analyzed. Hence, these behavioural tests are not able to investigate social dynamics in a 
translational way, due to the interactions with no more than two animals at the same time. For 
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this purpose, semi-natural habitats have been developed. In nature, rodents live in large groups 
with organized social structures and dominance hierarchies (So, Franks, Lim, & Curley, 2015). One 
of the most interesting systems for the behavioural analyses of social group dynamics is the Visible 
Burrow System (VBS), developed by the Blanchard group (D. C. Blanchard et al., 2012; D. C. 
Blanchard et al., 1995; R. J. Blanchard, Yudko, Dulloog, & Blanchard, 2001; Pobbe et al., 2010). The 
VBS is a semi-natural environment resembling rodent ecological appropriate environment. It 
consists of an open-arena that is connected to continuously dark tunnels with multiple nests in 
order to mimic the natural burrows. Research using the VBS has been primarily focused on 
aggression, dominance and hierarchies in rats (R. J. Blanchard, Dulloog, et al., 2001; R. J. 
Blanchard, Yudko, et al., 2001; Buwalda, Koolhaas, & de Boer, 2017). However, during the last 
decade, attention has shifted towards the use of mice, thus encouraging the study of transgenic 
and mutant mice lines, resembling humane neuropsychiatric phenotypes. Among these lines, an 
interesting mutant strain is the BTBR T+tf/J (BTBR) inbred strain. The BTBR mice show deficits in 
social interaction, impaired communication, and repetitive behaviours, thus resembling the 
autism-like phenotype in humans (McFarlane et al., 2008). The BTBR behavioural deficits have 
been investigated in the VBS and subsequently validated using the Three Chamber test, by Pobbe 
et al. (Pobbe et al., 2010). In their VBS colonies, composed of four males, BTBR mice showed an 
impairment in all social behavioural domains, such as approach, aggressive behaviour and allo-
grooming (Pobbe et al., 2010). Therefore, the BTBR strain appears to be a useful model to study 
social behavioural dysfunctions in a translational perspective.  
In this regard, our group implemented a modified version of the VBS, adding two additional 
chamber in the burrows in order to have more nests. Moreover, to reproduce behaviours that 
naturally occur in colonies, we used mixed-sex colonies, using 2 females and 6 males for each VBS 
experiment. In chapter 4, we used the VBS to identify and validate behavioural readouts to assess 
sociability and social withdrawal features in BTBR and C57BL/6J control strain. In particular, 
C57BL/6J mouse strain has normal sociability and has been used as control strain in numerous 
preclinical studies (Cai et al., 2017; Hsieh, Wen, Miyares, Lombroso, & Bordey, 2017). 
Furthermore, transgenic Knock-Out (KO) mice models for candidate genes involved in social 
pathways are becoming a growing field of research. In this context, cadherin superfamily, 
originally characterized as calcium-dependent cell-adhesion molecules, is now known to be 
involved in many biological processes, including cell recognition, cell signaling during 
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embryogenesis and formation of neural circuits (Bruining et al., 2015; Morishita & Yagi, 2007). In 
particular, protocadherin family, the largest subgroup within the cadherin superfamily, are 
predominantly expressed in the nervous system. Interestingly, recent evidence suggested that 
Protocadherin 9 (Pcdh9) might be involved in schizophrenia and ASD pathogenesis (Hirabayashi & 
Yagi, 2014). Moreover, a recent study reported that the gene encoding Pcdh9 might be considered 
as a novel risk factor for Major Depressive Disorder (MDD) (Xiao, Zheng, et al., 2017). In this 
regard, in chapter 5 of this thesis, we investigated VBS colonies composed of 2 Homozygous 
(HOM) KO Pcdh9, 2 Heterozygous (HET) KO Pcdh9 and 2 Wild Type (WT) Pcdh9 males, together 
with 2 WT Pcdh9 females, in order to evaluate sociability and social withdrawal features in relation 
to genotype differences.  
 
1.5 Unravelling neurobiological alterations underlying depressive-like symptoms 
Disentangle the etiology of depressive-like symptoms is a hard challenge. Indeed, available 
techniques to analyze the aberrant function of brain circuits is based on either post-mortem 
studies, which have numerous limitations, or neuroimaging techniques, which rely on detecting 
changes in neuronal activity by using indirect markers of activation (Krishnan). Although these 
approaches have provided important insights into candidate brain regions, simple increases or 
decreases in regional brain activity are probably insufficient to explain the complex array of 
symptoms related to depression (Krishnan & Nestler, 2008). Therefore, neuropsychiatric 
symptomatology raises from heterogeneous neurobiology (Cummings, 2015), as a result of 
pathophysiological and biochemical alterations within several brain regions (Schiavone, Tucci, et 
al., 2017). This hypothesis is supported by several levels of evidence, in which neuropsychiatric 
symptoms are associated with underlying neurotransmitter system imbalances, including NA, DA, 
5-HT, glutamate and gamma-aminobutyric acid (GABA), but also HPA axis dysfunctions, 
neurotrophins impairments and, recently, soluble beta amyloid involvement (Panza et al., 2010; 
Sweet et al., 2004; Wegener et al., 2004). 
The monoamine hypothesis of depression  
Depression has been associated with impaired neurotransmission of serotonergic, noradrenergic 
and dopaminergic pathways. This concept is now over fifty years old and arose from the empirical 
observation that depressive symptoms were influenced by the pharmacological manipulation of 
the monoaminergic system (Lanni, Govoni, Lucchelli, & Boselli, 2009; Sanacora, 2010). For 
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instance, reserpine, an antihypertensive first introduced in 1954, was found to deplete presynaptic 
stores of serotonin and noradrenaline and induce depression in some individuals (Lopez-Munoz, 
Bhatara, Alamo, & Cuenca, 2004). Moreover, iproniazid and imipramine had potent antidepressant 
effects in humans and were later shown to enhance central serotonin and noradrenaline 
transmission (Krishnan & Nestler, 2008). Since the catecholamine hypothesis of depression was 
first described, most antidepressant drug development has targeted the enhancement of 
monoamine neurotransmissions. For decades tricyclic antidepressants, that inhibit the reuptake of 
norepinephrine and serotonin, were the principal treatment choice for physicians. Therefore, 
monoamine hypothesis has been accepted as the most common hypothesis of major depression 
for a long period because of its simplicity and understandability (Boku, Nakagawa, Toda, & 
Hishimoto, 2017). Indeed, several evidence links depression to deficiencies in the 
neurotransmission of the monoamines 5-HT, NA and DA (D'Aquila, Collu, Gessa, & Serra, 2000; 
Popik et al., 2006). In this context, it has been suggested that a triple re-uptake inhibitor, resulting 
in an additive effect of enhancing neurotransmission in all three monoamine systems, might lead 
to improved efficacy and quicker onset of the antidepressant response (Marks, Pae, & Patkar, 
2008). Although receiving considerable support, the monoamine hypothesis is considered 
restricted by several researchers (Joyce, 2007), as it does not provide a comprehensive 
explanation for the mechanism of actions of antidepressants and fails to explain why less than 
50% of patients achieve full remission despite the numerous drugs available (Trivedi et al., 2006). 
For this reason, identification of new effective and safe treatment for depression is still a 
significant task and drugs targeting monoamine neurotransmissions alone are not able to fully 
cure all the behavioural symptoms and the different aspects and subtypes of depression.  
GABAergic and glutamatergic neurotransmissions in depressive-like symptoms affecting the 
social sphere 
During last decades, a number of evidence suggested that altered function of the amino acid 
neurotransmitter systems, especially GABA and glutamate systems, might contribute significantly 
to the etiology of neuropsychiatric disorders (Sanacora, 2010). 
In this regard, glutamate is the major mediator of excitatory synaptic transmission in the 
mammalian brain (Maletic et al., 2007). Abnormal function of the glutamergic system has been 
implicated in the pathophysiology of several neuropsychiatric disorders, such as Huntington's 
chorea, epilepsy, Alzheimer's disease, schizophrenia and anxiety disorders (Hashimoto, Malchow, 
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Falkai, & Schmitt, 2013; Siegel & Sanacora, 2012). Increasing evidence indicated that abnormal 
activity of the glutamatergic system observed in patients affected by mood disorders is likely to 
contribute to impairments in synaptic and neural plasticity found in these patients (Lanni et al., 
2009). Moreover, preclinical studies demonstrated a negative correlation between glutamatergic 
tone and sociability, reporting an increase in social interactions following suppression of glutamate 
neurotransmission, while activation of prefrontal cortex led to reduced social interactions 
(Kendell, Krystal, & Sanacora, 2005), suggesting that attenuation of glutamatergic tone might 
ameliorate depressive-like symptoms affecting sociability, such as social withdrawal. 
Conversely, GABA is the most widely distributed inhibitory neurotransmitter in the mammalian 
central nervous system (Celio, 1986). GABAergic tone is involved in the synaptic transmission of 5-
HT, NA and DA, and has been shown to act as a modulator of several behavioural processes, such 
as sleep, appetite, aggression, sexual behaviour, pain, thermoregulation and mood. In this regard, 
reduced GABA concentrations have been observed in plasma and cerebrospinal fluid of depressed 
patients (Bhagwagar & Cowen, 2008). Accordingly, neuroimaging data has shown lowered levels of 
GABA in the occipital cortex of depressed subjects (Price, Lee, Garvey, & Gibson, 2010) and 
patients suffering from schizophrenia, depression, ASD and bipolar disorders appear to have 
lowered central and peripheral GABA levels when compared to healthy controls (Lewis, 2014; 
Romeo, Choucha, Fossati, & Rotge, 2017). In particular, this lowered functionality is visible during 
the prodromal stage of the diseases, concomitantly with behavioural dysfunctions, such as 
disrupted sociability (Minzenberg et al., 2010). In this view, recent studies showed that decreasing 
GABA neurotransmission in prefrontal cortex and amygdala led to decreased sociability (Paine, 
Swedlow, & Swetschinski, 2017). Thus, changes in GABA signaling might mediate sociability 
dysfunctions, such as social withdrawal, which is an important early symptom of several 
neuropsychiatric diseases. 
In conclusion, drugs aim to potentiate GABAergic and attenuate glutamatergic neurotrasmissions 
might be helpful to treat depressive-like symptoms, particularly in relation to the social sphere. 
Nerve Growth Factor in depressive-like symptoms 
Nerve growth factor (NGF), a key neurotrophin for the development of the nervous system, was 
initially discovered by Cohen and Levi-Montalcini, who won the Nobel Prize for this amazing 
discovery (Cohen, Levi-Montalcini, & Hamburger, 1954). Since first being discovered in 1979, NGF 
has been studied in different areas, such as neurology, angiogenesis, immunology, urology, and 
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others (Y. W. Chen et al., 2015). In the searching for neurobiological substrate involved in 
depressive-like states, NGF also play a significant role. NGF is an important member of the 
neurotrophins groups and is produced mainly in the cortex, hippocampus and hypothalamus, but 
also in the peripheral nervous system and immune system (Martino et al., 2013; Xiong et al., 
2011). Evidence from animal studies reported decreased levels of NGF in specific brain areas of 
different mouse models, such as anxiety-related models, stress-induced diseases, learned 
helplessness and threatening treatment. All those mouse models are believed to represent forms 
of depressive-like models (Y. W. Chen et al., 2015). Accordingly, clinical studies have detected 
reduced levels of NGF in patients with major depression when compared with healthy individual 
controls (Diniz et al., 2014; Xiong et al., 2011). In addition, treatment with certain antidepressants 
has increased NGF levels in both clinical and experimental studies (Hassanzadeh & Rahimpour, 
2011; Wiener et al., 2015). Furthermore, a significant decrease in serum NGF has been observed in 
patients with mild cognitive impairment, suggesting that the availability of NGF might be reduced 
at the onset of several neurodegenerative process (Schaub, Anders, Golz, Gohringer, & Hellweg, 
2002). Since the identification of peripheral biomarkers to help in the diagnosis or to monitor the 
progression of mental diseases is still a field open to future research, NGF might be further 
investigated as a putative biomarker related to neurodegenerative disorders. 
In addition, NGF and 5-HT are close and reciprocally regulated signals, thus the changes in NGF 
levels, acting through modifications of the 5-HT system, might help to disentangle the 
neurobiological mechanisms that give rise to depressive-like symptoms (Colaianna et al., 2010; 
Garcia-Alloza et al., 2004; Tapia-Arancibia, Aliaga, Silhol, & Arancibia, 2008). 
HPA axis parameters related to depressive-like states 
Chronic stress is generally known to exacerbate the development of a wide variety of 
neuropsychiatric diseases, such as depression, fear and anxiety disorders (Z. P. Liu et al., 2014). In 
this regard, HPA axis hyperactivation is a crucial response to chronic stress. HPA axis 
hyperactivation is featured by increased hypothalamic corticotropin-releasing factor (CRF) 
expression and consequently elevated plasmatic glucocorticoid concentrations (T. Chen, Li, & 
Chen, 2009; Wang et al., 2010; Zhang et al., 2017). In regard to depressive-like symptoms, it has 
long been hypothesized that cortisol secretion is an important neurobiological characteristic of 
depressive disorders (Lee & Rhee, 2017). Moreover, a number of studies supported the hypothesis 
of HPA axis involvement in depression, reporting an increase in hypothalamic CRF in depressed 
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patients (Raadsheer, Hoogendijk, Stam, Tilders, & Swaab, 1994; Raadsheer et al., 1995), or a 
decrease of CRF receptors in the frontal cortex (Nemeroff, Owens, Bissette, Andorn, & Stanley, 
1988), or a decreased sensitivity to negative feedback (Halbreich, Asnis, Shindledecker, Zumoff, & 
Nathan, 1985; Pfohl, Sherman, Schlechte, & Winokur, 1985; Young et al., 2004).  
However, HPA axis dysfunctions have been found only in a subset of depressed patients (Varghese 
& Brown, 2001), suggesting that not all the depressive disorders share the same pathogenic 
pathways. Interestingly, HPA axis hyperactivity is highly related to anxiety disorders (Herman & 
Tasker, 2016; Y. T. Lin et al., 2017). In this regard, recent studies indicated that optogenetic 
inhibition of parvalbumin CRF neurons reduces anxiety-like behaviour, while stimulation induces 
anxiety-like behaviour (Fuzesi, Daviu, Wamsteeker Cusulin, Bonin, & Bains, 2016; Herman & 
Tasker, 2016). 
Hence, future medications, pointing towards the modulation of HPA axis parameters, should be 
considered for the treatment of depressive-like disorders comorbid with anxiety states.  
Soluble Amyloid Beta (Aβ1-42) peptide in depressive-like states 
During the last decade the soluble Aβ1-42 peptide has gained great attention in the study of 
depression insurgence, also considering that such neuropsychiatric disease is highly comorbid with 
Alzheimer’s Disease (AD) and other neurodegenerative illnesses (Colaianna et al., 2010; Morgese, 
Schiavone, & Trabace, 2017; Pomara & Sidtis, 2007; Schiavone, Tucci, et al., 2017; Sun et al., 
2008). More recently, depressive signs have been potentially linked, in part, to the presence of 
soluble Aβ in the brain. Aβ peptides are physiologically produced from the Aβ protein precursor 
through beta and gamma secretase cleavage (Zetterberg, Mattsson, Shaw, & Blennow, 2010). 
They possess different brain area-selective neuromodulatory actions (Morgese, Schiavone, et al., 
2017; Morgese et al., 2014; Mura et al., 2010; Trabace et al., 2007). Although the relationship 
among soluble Aβ, brain neurochemistry and depression remains complex, several studies have 
demonstrated an increased risk for the development of AD in individuals with late-life depression, 
indicating a prodromal state of AD (Dal Forno et al., 2005; Steffens et al., 1997; Sun et al., 2008). 
Similarly, it has been reported that depressed individuals are nearly twice as likely to develop 
dementia, often in the form of AD, compared with non-depressed individuals (Jorm, 2001). Aβ 
might have an effect on mood not limited to AD patients, indeed depressive-like states might 
precede or accompany dementia (Starkstein, Mizrahi, & Power, 2008). In this regard, our group 
has previously shown that central Aβ 1-42 administration in male rats was able to evoke a 
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depressive-like phenotype (Colaianna et al., 2010), characterized by increased immobility 
frequency in the Forced Swimming test and reduced cortical 5-HT and neurotrophins, such as NGF 
and Brain-Derived Neurotrophic Factor (BDNF). Since behavioural and neurochemical alterations 
were observed at a time at which amyloid plaques were not visible in the rat brain (Trabace et al., 
2007), we could hypothesize that cerebral injection of soluble Aβ induced long-lasting neuronal 
circuits disruption ultimately responsible of depressive-like symptomatology (Schiavone, Tucci, et 
al., 2017).  
 
1.6 Thesis aims and outline 
The knowledge of the pathophysiology of depressive-like symptoms has evolved substantially 
from Galen’s speculations in antiquity about an excess of black bile (“melancholia”) to current 
evidence that incorporate lifestyle factors, genetic, endocrine, neurochemical and metabolic 
mediators, and cellular, molecular and epigenetic alterations. In this regard, considering the 
polysyndromic nature of depression, a multifactorial approach to better explore the 
etiopathogenesis of different depressive-like symptoms is warranted (Krishnan & Nestler, 2008).  
Hence, the overall aim of this thesis was to investigate neurobiological determinants related to 
depressive-like symptoms. More specifically, by using different animal models and behavioural 
paradigms resembling human depressive-like symptoms, we evaluated the underlying 
neurobiological pathways, including monoamine system impairments, alterations in amino acids 
neurotransmissions, neurotrophin changes and HPA axis dysfunctions. 
In particular, in chapter 2 and 3, we assessed the effect of n-3 PUFA in adult female offspring fed 
from conception with a diet poor in n-3 PUFA, or rich in n-3 PUFA, or a control diet. From a 
behavioural point of view, we performed Forced Swimming test to assess depressive-like 
behaviour and Open Field test to evaluate locomotor activity and anxiety-like behaviour. 
Moreover, we analyzed monoamine contents, in particular NA, DA, 5-HT and 5-HT turnover, HPA 
axis parameters, in particular hypothalamic CRF and plasmatic corticosterone, cortical NGF levels, 
plasmatic soluble Aβ levels, and, the last but not the least, GABA and glutamate levels.  
Furthermore, we evaluated the effects of n-3 PUFA supplementation on a model of Aβ-induced 
depressive-like phenotype in adult female rats, performing the behavioural tests and 
neurochemical analyses listed above. 
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Moreover, in chapter 4 and 5 of this thesis, we implemented a modified version of the Visible 
Burrow System to study group-housed social dynamics and ultimately identify and validate 
behavioural readouts to assess sociability and social withdrawal features in mutant BTBR strain, 
transgenic Pcdh9 line and C57BL/6J control strain. In addition, we investigated the neurobiological 
alterations underlying social behaviours, particularly focusing on GABA and glutamate 
neurotransmission. 
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Abstract  
Depression is one of the most common psychiatric diseases and the prevalence of depressive 
symptoms in women is almost twice compared to men, although the reasons of this gender 
difference are not fully understood yet. Recently, soluble Aβ1-42 peptide has been receiving great 
importance in the development of depression, also since depression is highly comorbid with 
Alzheimer’s disease and other neurodegenerative illnesses. Accordingly, we have previously 
shown that central Aβ injection is able to elicit depressive-like phenotype in male rats. In the 
present study, we reproduced for the first time the Aβ-induced depressive-like model in female 
rats, evaluating behavioural and neurochemical outcomes. Moreover, we studied the effect of 
lifelong exposure to either n-3 PUFA enriched or n-3 PUFA deficient diet, in female rats, both 
intact and after central Aβ administration. Our results confirmed the Aβ-induced depressive-like 
profile also in female rats. Moreover, chronic exposure to n-3 PUFA deficient diet led to highly 
negative alterations in behavioural and neurochemical parameters, while lifelong exposure to n-3 
PUFA enriched diet was able to restore the Aβ-induced depressive-like profile in female rats. In 
conclusion, the Aβ-induced depressive-like profile was reversed by n-3 PUFA supplementation, 
indicating a possible therapeutic role of n-3 PUFA in the treatment of the burden of depressive 
disorders.  
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2.1 Introduction 
Depression is one of the most common psychiatric diseases and the prevalence of depressive 
symptoms has reached epidemic proportions during the last few decades (Gorman, 2006). In this 
regard, several studies reported that depression is more prevalent in women compared to men 
(Gorman, 2006; Kokras et al., 2015; Marcus et al., 2005). Although the reasons of this gender 
difference are not fully understood yet, women show different response to sex hormones, that 
might ultimately influence behaviour and brain functions (Marrocco & McEwen, 2016).In 
particular, estrogens modulate several neural and behavioural functions, including mood, 
cognitive function, blood pressure regulation, motor coordination, pain, and opioid sensitivity 
(McEwen & Milner, 2017).  In addition, it has been shown that estrogens also affect neurotrophic 
functions and monoamine neurotransmission in several brain areas, thus they might ultimately be 
involved in the pathogenesis of depressive-like disorders (Borrow & Cameron, 2014). These 
evidence suggest that the antidepressant therapy should be personalized, taking into account also 
gender differences (Sloan & Kornstein, 2003; Thiels, Linden, Grieger, & Leonard, 2005). In addition, 
a series of studies indicated that estrogens modulate the metabolic production of different 
endogenous and exogenous molecules (M. Barton et al., 2017; Laredo, Villalon Landeros, & 
Trainor, 2014; Migliaccio, Davis, Gibson, Gray, & Korach, 1992). Among these molecules, it has 
been reported that estrogens stimulate the conversion of essential fatty acids into their longer 
chain metabolites, such as α-linolenic acid conversion into docosahexanoic acid (DHA) (Burdge & 
Wootton, 2002; Giltay, Gooren, Toorians, Katan, & Zock, 2004). DHA is a key n-3 polyunsaturated 
fatty acid (PUFA) involved in the Central Nervous System (CNS) development (Colangelo et al., 
2017) and, thus, fundamental during pregnancy and early stage of childhood (Echeverria, 
Valenzuela, Catalina Hernandez-Rodas, & Valenzuela, 2017). DHA and arachidonic acid (AA, 20:4n-
6) are biologically important PUFAs, and can be supplied either directly from diet or by metabolic 
conversion of their essential precursors α-linolenic acid (18:3n-3) and linoleic acid (18:2n-6), 
respectively (Morgese, Tucci, et al., 2017). DHA, AA and their mediators modulate several 
processes, such as signal pathways, membrane fluidity, neurotransmission, neuroinflammation 
and cell survival (Echeverria et al., 2017). During embryonic life and lactation, PUFAs intake 
exclusively depends on maternal diet, as the metabolic conversion of essential precursors cannot 
be accomplished (Lafourcade et al., 2011). Indeed, in utero exposure to unbalanced diet can be an 
important risk factor for mental disorders in later adulthood. Modern western diets are 
26 
 
characterized by low fish consumption and more junk food, resulting in n-3 PUFA deficiency and 
abnormal n-6 PUFA increase, respectively (Simopoulos, 2011). This unbalanced n-6/n-3 ratio is 
considered to be detrimental for the CNS functioning. Indeed, recent research suggests an 
etiological role for n-3 PUFAs deficiency in mood disorders, such as Major Depressive Disorder 
(MDD) (Grosso et al., 2016; McNamara & Welge, 2016). Accordingly, different epidemiological 
studies reported an inverse correlation between n-3 PUFA intake and depressive symptoms 
among United States women (Beydoun et al., 2013; Beydoun et al., 2015). In this regard, we have 
previously shown that lifelong deficiency of n-3 PUFA leads to a depressive-like phenotype 
associated with reduced serotonin (5-HT) levels and increased soluble amyloid beta (Aβ)1-42 
concentrations (Morgese, Tucci, et al., 2017) in male rats. The Aβ1-42 peptide, produced through 
proteolytic cleavage of the amyloid precursor protein (APP), has been demonstrated to have 
powerful neurotoxic effects (Pomara & Sidtis, 2007). Recently, soluble Aβ1-42 peptide has been 
received great importance in the development of depression, also since depression is highly 
comorbid with Alzheimer’s disease and other neurodegenerative illnesses (Schiavone, Tucci, et al., 
2017; Sun et al., 2008).  In our previous studies, we injected soluble Aβ1-42 in the ventricular area 
of male rats, provoking a depressive-like phenotype (Colaianna et al., 2010), accompanied by 
reduced cortical 5-HT and neurotrophins, such as Nerve Grow Factor (NGF) and Brain-Derived 
Neurotrophic Factor (BDNF).  
Although the majority of animal studies on depression use males in order to avoid the variability 
that hormonal cycle could induce (Altemus, 2006), the US National Institute of Health is strongly 
encouraging preclinical research on females (Kokras et al., 2015). For this reason, considering also 
the higher incidence of depressive disorders in women, the development of preclinical models of 
depressive-like profile in females is becoming necessary (D'Souza & Sadananda, 2017). 
In the present study, we reproduced for the first time the Aβ-induced depressive-like model in 
female rats, evaluating behavioural and neurochemical outcomes. Moreover, we studied the 
effect of lifelong exposure to either n-3 PUFA enriched or n-3 PUFA deficient diet, in female rats, 
both intact and after Aβ central administration. 
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2.2 Materials and Methods 
Animals 
Adult (250-300g) Wistar rats (Harlan, S. Pietro al Natisone, Udine) were used in this study. They 
were housed at constant room temperature (22±1°C) and relative humidity (55±5%) under a 12 h 
light/dark cycle (lights on at the 7 A.M.) with ad libitum access to food and water.  
Procedures involving animals and their care were conducted in conformity with the institutional 
guidelines of the Italian Ministry of Health (D.L. 26/2014), the Guide for the Care and Use of 
Mammals in Neuroscience and Behavioral Research (National Research Council 2004), the 
Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the 
protection of animals used for scientific purposes. All procedures involving animals were 
conducted in accordance to ARRIVE guidelines. Animal welfare was daily monitored through the 
entire period of experimental procedures. No signs of distress were evidenced, anyway all efforts 
were made to minimize the number of animals used and their suffering. 
Diets 
One male and two female rats were housed together for mating. Animals were exposed to specific 
diets mimicking lifelong n-3 PUFA deficiency or supplementation, as previously described (Aid et 
al., 2003; Lafourcade et al., 2011; Morgese et al., 2016). In particular, after mating dams were 
randomly assigned to the group fed with either a diet containing 6% total fat in the form of only 
rapeseed oil (n-3 enriched, rich in -linolenic acid 18:3n-3) or peanut oil (n-3 deficient, rich in 
linoleic acid 18:2n-6) throughout gestation and lactation. As control group, dams were fed with a 
diet containing 6% total fat in the form of 3% of peanut oil plus 3% of rapeseed oil, called control 
diet. After weaning, offspring continued to be subjected to the same diet throughout life. All 
experiments were carried out in female eight-week-old rats. 
Effects on experiments carried out may be influenced by the time of their estrous cycle (Jans, 
Lieben, & Blokland, 2007). Pro-estrous/estrus events tend to be dictated by lighting times, but 
under normal lighting schedules (as in the present study) tend to occur during the late afternoon 
to early hours of the morning (Witcher & Freeman, 1985). Hence, all animal procedures were 
performed in the morning (usually (09.00–12.00 h) to reduce estrous cycle effects. Serum estradiol 
concentrations were measured to take account of possible differences in the estrous cycle. 
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Aβ administration 
The Aβ1-42 peptide was purchased from Tocris (Bristol, UK) and was dissolved in sterile double-
distilled water (vehicle) at a concentration of 4 μM as previously describe (Colaianna et al., 2010). 
All solutions were freshly prepared. 7-weeks-old rats were anesthetized with 3.6 ml/kg Equithesin 
intraperitoneally (i.p.; composition: 1.2 g sodium pentobarbital; 5.3 g chloral hydrate; 2.7 g 
MgSO4; 49.5 ml propylene glycol; 12.5 ml ethanol and 58 ml distilled water) and secured in a 
stereotaxic frame (David Kopf Instruments, Tujunga, CA, USA). The skin was shaved, disinfected 
and cut with a sterile scalpel to expose the skull and a hole was drilled to insert the infusion needle 
(30-gauge stainless steel tubing; Cooper’s Needles, Birmingham, UK). Coordinates for icv infusions 
were based on the atlas of Paxinos and Watson (1998): AP = - 0.5, ML = + 1.2 and DV = - 3.2 from 
bregma, with the incisor bar set at -3.3 mm. Soluble Aβ (5 μl) was delivered through a 25 μl 
Hamilton microsyringe at 2 μl/min infusion rate over a period of 2.5 min, with an additional 5 min 
allowed to elapse prior to removal of the infusion needle. Control rats were infused with vehicle 
only, because reverse Aβ42-1, used in preliminary experiments, had no effect on the measured 
neurochemical parameters and was indistinguishable from vehicle alone (unpublished 
observations). The injection placement of needle track was verified at the time of dissection. All 
experimental procedures were performed 7 days after icv administration (SHAM or Aβ-treated 
groups). 
Forced swimming test 
The forced swimming test (FST) is a reliable task for discriminating depressive state in animals and 
is widely used for predicting antidepressant properties of drugs (Porsolt, Bertin, & Jalfre, 1977). On 
the first of the two test days, animals were placed individually in inescapable Perspex cylinders 
(diameter 23 cm; height 70 cm) filled with water at constant temperature of 25±1°C at 30 cm of 
height (Cryan, Valentino, & Lucki, 2005). 
During the preconditioning period, animals were videotaped for 15 min. Then, rats were removed 
and dried before to be returned to their home cages. Twenty-four h later, each rat was positioned 
in the water-filled cylinder for 5 min. This session was video-recorded and subsequently scored by 
an observer blind to the treatment groups. During the test sessions, the frequency that rats spent 
performing the following behaviors were measured: struggling (time spent in tentative of 
escaping), swimming (time spent moving around the cylinder) and immobility (time spent 
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remaining afloat making only the necessary movements to keep its head above the water). Data 
were expressed as frequency on 5 sec counts. 
Post-mortem tissue analysis 
Rats were euthanized and brains were immediately removed and cooled on ice for dissection of 
target region, namely PFC, according to the atlas of Paxinos and Watson (1998). Tissues were 
frozen and stored at -80°C until analysis was performed. 
HPLC quantifications 
5-HT, 5-hydroxyindolacetic acid (5-HIAA) and dopamine (DA) concentrations were determined by 
HPLC coupled with an electrochemical detector (Ultimate ECD, Dionex Scientific, Milan, Italy). 
Separation was performed by a LC18 reverse phase column (Kinetex, 150 mm×4.2 mm, ODS 5 μm; 
Phenomenex, Castel Maggiore- Bologna, Italy). The detection was accomplished by a thin-layer 
amperometric cell (Dionex, ThermoScientifics, Milan, Italy) with a 5 mm diameter glassy carbon 
electrode at a working potential of 0.400 V vs. Pd. The mobile phase used was 75 mM NaH2PO4, 
1.7 mM octane sulfonic acid, 0.3 mM EDTA, acetonitrile 10%, in distilled water, buffered at pH 3.0. 
The flow rate was maintained by an isocratic pump (Shimadzu LC-10 AD, Kyoto, Japan) at 0.7 
ml/min. Data were acquired and integrated using Chromeleon software (version 6.80, Thermo 
Scientific Dionex, San Donato Milanese, Italy). 
ELISA quantifications  
PFC samples were analyzed for NGF quantifications by using ELISA kits provided by Cloud-Clone 
Corporation (Houston, Texas, USA). Assays were performed according to the manufacturer’s 
instructions. Briefly, tissues were diluted (10% tissue weight/total volume) with ice-cold medium 
containing phosphate-buffered saline (PBS) and protease inhibitor cocktail (Sigma-Aldrich, Milan, 
Italy). Samples were homogenized and centrifuged at 10.000 x g at 4°C for 20 min. The 
supernatant was collected and assays were performed according to the manufacturer’s 
instructions. To normalize data and negate differences due to sample collection, protein 
concentration was determined by using the BCA assay kit. Each sample analysis was carried out in 
duplicate to avoid intra-assay variations. 
Plasma samples were analyzed for soluble Aβ1-42 by using an ELISA kit provided by Cloud-Clone 
Corporation (Houston, Texas, USA). Assays were performed according to the manufacturer’s 
instructions. Each sample analysis was carried out in duplicate to avoid intra-assay variations. 
Statistical analyses 
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Results were expressed as mean ± S.E.M. Behavioural and neurobiological data were analyzed by 
using one or two-way analysis of variance (ANOVA) followed by Bonferroni post hoc analyses, as 
required. P value was set at 0.05. 
 
2.3 Results 
Effects of n-3 PUFA deficient diet on depressive-like behaviour using FST 
To investigate the influence of lifelong exposure to n-3 PUFA deficient and n-3 PUFA enriched diet 
on depressive-like behaviour, we performed the forced swimming test (FST). Our results show that 
n-3 PUFA deficient diet significantly increased the immobility frequency compared to control diet 
(Figure 1A, One-way ANOVA followed by Bonferroni’s multiple comparison test, F=4.351, P<0.05 
n-3 deficient versus CTRL). Moreover, there were no significant differences in struggling frequency 
(Figure 1B, One-way ANOVA followed by Bonferroni’s multiple comparison test, n.s.), while 
swimming was significantly decreased in n-3 PUFA deficient diet-exposed animals (Figure 1C, One-
way ANOVA followed by Bonferroni’s multiple comparison test, F=4.929, P<0.05 n-3 deficient 
versus CTRL). 
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Figure 1 Effects of control, n-3 PUFA enriched and n-3 PUFA deficient diets on FST. Frequency measure of immobility 
(A), struggling (B), and swimming (C) behaviours in female rats fed from conception until 5 weeks post-weaning with 
control diet (white bar), n-3 PUFA  enriched diet (grey bar), and n-3 PUFA deficient diet (black bar). Data are expressed 
as mean ± SEM (n=12-13 per group). One-way ANOVA followed by Bonferroni’s multiple comparison test, #P < 0.05 vs. 
CTRL. 
Effects of n-3 PUFA deficient diet on plasmatic Aβ levels 
We quantified plasmatic soluble Aβ1-42 peptide in offspring of rats fed with n-3 PUFA enriched and 
n-3 PUFA deficient diets. We found that animals exposed throughout their life to n-3 PUFA 
deficient diet had a significant increase in plasmatic Aβ levels compared to controls (Figure 2, one-
way ANOVA followed by Bonferroni’s multiple comparison test, F=9.164, P<0.01 n-3 deficient 
versus CTRL). 
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Figure 2 Effects of control diet (white bar), n-3 PUFA enriched diet (grey bar), and n-3 PUFA deficient diet (black 
bar).on plasmatic soluble Aβ levels. Data are expressed as mean ± SEM (n=6-7 per group). One-way ANOVA followed 
by Bonferroni’s multiple comparison test **P < 0.01 vs. CTRL  
Effects of n-3 PUFA enriched diet on Aβ-induced depressive-like behaviour using FST 
Our group has previously demonstrated that Aβ soluble peptide is able to evoke a depressive-like 
state (Colaianna et al.), thus we tested whether lifelong exposure to n-3 PUFA enriched diet would 
prevent such Aβ-induced alterations in female offspring rats. As shown in Figure 3A and 3C, n-3 
PUFA enriched diet prevented the depressive effect of Aβ. Indeed, immobility frequency was 
significantly increased and swimming frequency was significantly reduced in Aβ treated rats 
compared to SHAM operated only in control animals (Figure 3A, Two-way ANOVA followed by 
Bonferroni’s multiple comparison test; F(1,32)=6.258 P<0.01, Aβ versus SHAM rats; Figure 3C, Two-
way ANOVA followed by Bonferroni’s multiple comparison test; F(1,32)=13.57, P<0.01, Aβ versus 
SHAM rats), while no differences were evidenced in struggling frequency among groups (Figure 
3B, Two-way ANOVA followed by Bonferroni’s multiple comparison test; n. s.).  
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Figure 3 Effects of control and n-3 PUFA enriched diet on Aβ-induced depressive-like behaviour. Frequency measure 
of immobility (A), struggling (B), and swimming (C) behaviours in female rats SHAM-operated (white bar) and Aβ-
operated (black bar). Data are expressed as mean ± SEM (n=9-12 per group). Two-way ANOVA followed by 
Bonferroni’s multiple comparison test P<0.01, vs. SHAM rats.  
Effects of n-3 PUFA deficient and n-3 PUFA enriched diets on serotonin levels and turnover in 
PFC 
In order to better investigate behavioural results, we performed also neurochemical analyses. In 
particular, we quantified serotonin (5-HT) content and 5-HT turnover (5-HIAA/5-HT ratio) in PFC. 
We found that cortical 5-HT concentrations were significantly lower in animals pre- and post-natal 
fed with n-3 PUFA deficient diet compared to controls (Figure 4A, one-way ANOVA followed by 
Bonferroni’s multiple comparison test, F=3.546, P<0.05 n-3 deficient versus CTRL). Moreover, 5-HT 
turnover was significantly increased in n-3 PUFA deficient rats compared to controls animals 
(Figure 4B, one-way ANOVA followed by Bonferroni’s multiple comparison test, F=6.086, P<0.05 n-
3 PUFA versus n-6/n-3 CTRL). We also quantified 5-HT content in PFC of female rats exposed 
during their entire life to n-3 PUFA enriched or control diet 7 days after Aβ icv injection. In 
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particular, Aβ injection significantly reduced 5-HT content in control rats (Figure 4C, two-way 
ANOVA followed by Bonferroni’s multiple comparison test, F(1,17)=3.431 P<0.05 Aβ-treated vs 
SHAM operated rats), while in n-3 PUFA fed animals no differences were retrieved between 
groups, indicating a protective effect of this diet towards Aβ-induced impairment (Figure 4C, two-
way ANOVA followed by Bonferroni’s multiple comparison test, n.s., Aβ-treated vs SHAM operated 
rats). In regard to 5-HT turnover, no differences were found among experimental groups (Figure 
4D, two-way ANOVA followed by Bonferroni’s multiple comparison test, n.s.). 
 
Figure 4 Effects of control (white bar), n-3 PUFA enriched (grey bar) and n-3 PUFA deficient (dark bar) diets on cortical 
5-HT levels (A) and 5-HIAA/5-HT ratio (B) in naïve animal.  Data are expressed as mean ± SEM. One-way ANOVA 
followed by Bonferroni’s multiple comparison test, #P<0.05 vs. CTRL Effects of control and n-3 PUFA enriched diet on 
cortical 5-HT levels (C) and 5-HIAA/5-HT ratio (D) in SHAM- (white bar) and Aβ-operated (dark bar) females. Data are 
expressed as mean ± SEM (n=5-7 per group). Two-way ANOVA followed by Bonferroni’s multiple comparison test, 
*P<0.05 vs. SHAM-operated. 
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Effects of n-3 PUFA deficient and n-3 PUFA enriched diets on dopamine levels in PFC 
We quantified cortical dopamine in female offspring fed with n-3 PUFA enriched; n-3 PUFA 
deficient or control diets and no significant differences were found (Figure 5A, One-way ANOVA 
followed by Bonferroni’s multiple comparison test, n.s.). We also analyzed dopamine content in 
PFC of female rats exposed during their entire life to n-3 PUFA enriched or control diets 7 days 
after Aβ icv injection; we found a significant increase in dopamine content of Aβ-treated animals 
compared to SHAM operated only in n-3 PUFA fed animals, suggesting a specific interaction with 
dopaminergic system only in presence of Aβ (Figure 5B, two-way ANOVA followed by Bonferroni’s 
multiple comparison test, F(1,20)=5.873, P<0.05, Aβ-treated vs SHAM operated rats).  
 
Figure 5 Effects of control (white bar), n-3 PUFA enriched (grey bar) and n-3 PUFA deficient (dark bar) diets on cortical 
DA levels in naïve (A), SHAM- (white bar) and Aβ-operated (dark bar) females (B). Data are expressed as mean ± SEM 
(n=6 per group). One- and Two-way ANOVA followed by Bonferroni’s multiple comparison test *P<0.05 vs. SHAM-
operated. 
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Effects of n-3 PUFA deficient and n-3 PUFA enriched diets on cortical NGF protein content  
To endorse our results on behavioral analyses, we measured NGF protein levels in PFC of our 
experimental groups. We found that NGF was significantly reduced in n-3 PUFA deficient animals 
compared to animal exposed to n-3 PUFA enriched and control diets (Figure 6A, One-way ANOVA 
followed by Bonferroni’s multiple comparison test, F=7,514, P<0.001 n-3 deficient versus n-3 
enriched, P<0.05 n-3 deficient vs CTRL diet).  
Interestingly, cortical NGF concentrations significantly increased after Aβ administration in n-3 
PUFA fed animals compared to controls, still confirming a protective role of this diet towards Aβ-
induced impairments (Figure 6B, Two-way ANOVA followed by Bonferroni’s multiple comparison 
test, F(1,16)=4.835 ,P<0.05 n-3 enriched vs CTRL diet).  
 
Figure 6 Effects of control (white bar), n-3 PUFA enriched (grey bar) and n-3 PUFA deficient (dark bar) diets on cortical 
NGF levels in naïve (A), SHAM- (white bar) and Aβ-operated (dark bar) females (B). Data are expressed as mean ± SEM 
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(n=5-6 per group). One- and Two-way ANOVA followed by Bonferroni’s multiple comparison test #P<0.05 vs. CTRL, 
**P<0.01 vs. n-3 enriched, #P<0.05 vs. Aβ-operated CTRL diet.  
 
2.4 Discussion 
In the present study, we showed that chronic exposure to n-3 PUFA deficient diet leads to highly 
negative alterations in behavioural and neurochemical parameters, while lifelong exposure to n-3 
PUFA enriched diet is able to restore the Aβ-induced depressive-like profile in female rats.  
From a behavioural point of view, our results showed an increase in immobility frequency and a 
decrease in swimming frequency in FST in female adult offspring fed during their entire life with n-
3 PUFA deficient diet. FST is a reliable test widely used to assess depressive-like state and screen 
antidepressants activity in rodents (Li et al., 2017). This test is based on learned helplessness that 
results in depressive-like symptoms, such as immobility increase and swimming and struggling 
decrease. These results are in line with our previous study, in which we reported a significant 
increase in immobility and decrease in swimming and struggling frequency in male rats fed with a 
diet poor in n-3 PUFA, confirming the positive effect of n-3 PUFA supplementation (Morgese, 
Tucci, et al., 2017). In order to rule out whether the increased immobility frequency and the 
decreased swimming frequency could be due to locomotor impairments, we performed OF test, 
whose results indicated no differences in vertical or horizontal activity in all experimental groups. 
Thus, the impairment retrieved in the FST could not be attributed to alteration in locomotion, but 
it might be related instead to neurobiological alterations induced by low n-3 PUFA consumption.  
In addition, we quantified plasmatic concentrations of Aβ in female animals receiving a diet either 
rich or poor in n-3 PUFA. Our results showed that plasmatic Aβ levels were significantly increased 
in female rats fed with poor n-3 PUFA diet compared to controls. In good agreement, our previous 
study in male rats showed that a diet poor in n-3 PUFA increased plasmatic Aβ levels compared to 
controls, while high n-3 PUFA diet significantly decreased such levels (Morgese et al., 2016). 
Recently, the Aβ peptide, particularly in its soluble forms, is gaining more and more attention in 
the study of depressive disorders (Colaianna et al., 2010; Pomara & Sidtis, 2007; Schiavone, Tucci, 
et al., 2017; Sun et al., 2008). In this regard, our group has previously demonstrated that central 
Aβ administration can evoke a depressive like-phenotype in rats characterized by increased 
immobility frequency in the FST and by reduced cortical 5-HT and neurotrophin levels (Colaianna 
et al., 2010). Regarding Aβ and n-3 PUFA interaction, recent studies suggest a crucial role played 
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by n-3 PUFA in the production/clearance of the Aβ peptide (Hopperton, Trepanier, Giuliano, & 
Bazinet, 2016; Lim et al., 2005). Indeed, it has been shown that n-3 PUFA, by increasing membrane 
fluidity, promote the Aβ interaction with membrane lipid bilayers, influencing the peptide 
aggregation process (Emendato et al., 2016). Thus, we can speculate that in our model the 
decrease availability of n-3 PUFA in plasmalemma, secondary to deficiency in n-3-PUFA 
consumption, may lead to less interaction of Aβ species to the membrane, ultimately resulting in 
higher soluble Aβ levels.  
To better understand the link between Aβ and PUFA and to investigate possible gender 
differences, we administered the soluble Aβ peptide in female offspring fed with n-3 PUFA 
enriched or control diet. 7 days after Aβ icv, we performed the FST and we found that in control 
animals immobility frequency was significantly increased and swimming frequency was 
significantly decreased in Aβ-treated females compared to SHAM operated animals, confirming 
the efficacy of the Aβ-depressive-like model also in females. Conversely, in n-3 PUFA fed animals, 
there were no differences between Aβ injected and SHAM operated animals, indicating a 
protective role of n-3 PUFA diet on the depressive-like phenotype induced by soluble Aβ injection. 
From a neurochemical point of view, we focused on 5-HT, 5-HT metabolism and DA in PFC. In this 
regard, we found that cortical 5-HT was significantly decreased in n-3 PUFA deficient females and 
5-HIAA/5-HT ratio was significantly increased, confirming  the deleterious effects of a diet poor in 
n-3 PUFA. Furthermore, cortical 5-HT was significantly reduced in Aβ-treated animals compared to 
SHAM operated animals, both fed with control diet, consolidating the Aβ-induced depressive-like 
profile. As widely known, 5-HT and its metabolism impairment are strongly involved in the 
pathogenesis of depression and Selective Serotonin Reuptake Inhibitors (SSRI) are the most used 
pharmacological treatment for major depressive disorder (Salaminios et al., 2017). Moreover, in 
an interesting clinical study, Barton and Colleagues found an elevated brain 5-HT turnover in 
unmedicated patients with depression (D. A. Barton et al., 2008) and several studies also reported 
a decrease in brain 5-HT turnover after classical or natural antidepressant treatments (Ahmed & 
Azmat, 2017; S. H. Lin et al., 2015). Interestingly, we found that n-3 PUFA enriched diet was able to 
restore 5-HT levels in Aβ treated animals. Among the several mechanisms that have been 
proposed to explain the influence of n-3 PUFA on the 5-HT synthesis, release and function in the 
brain, one of the most important might be the DHA modulation of 5-HT receptors accessibility 
(Patrick & Ames, 2015). In particular, DHA increases cell membrane fluidity in postsynaptic 
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neurons, thus, in low DHA conditions, the membrane becomes less fluid and the binding of 
serotonin to its receptor decreases significantly, due to the lower accessibility of serotonin 
receptors (Jones, Arai, & Rapoport, 1997; Paila, Ganguly, & Chattopadhyay, 2010). This effect is 
not limited to the serotonin receptors, but also affects the dopamine receptors and other 
neurotransmitter receptors (Paila et al., 2010). Furthermore, n-3 PUFA might influence serotonin 
neurotransmission acting through the inflammatory pathways. Interestingly, McNamara and 
colleagues showed that n-3 PUFA deficiency was positively correlated with pro-inflammatory 
cytokine production, lead to an increase in central 5-HT turnover, while n-3 PUFA supplementation 
prevented this negative effect (McNamara, Able, Rider, Tso, & Jandacek, 2010).  
As regard other monoaminergic neurotransmissions, several evidence pointed out to an important 
role of dopaminergic system in the pathogenesis of depression (Finan & Smith, 2013; Hori & 
Kunugi, 2013; Tye et al., 2013). In our model, we found no differences in cortical DA in naïve 
animals fed with n-3 PUFA enriched or n-3 PUFA deficient diet, but after Aβ injection, DA was 
significantly increased in animals exposed to n-3 PUFA enriched diet compared to SHAM operated 
animals. 
Recent preclinical studies have indicated the involvement of dopaminergic receptors, either D1, 
D2 or D3, in the antidepressant effects (Pytka et al., 2016). In addition, it was shown that lesion of 
dopamine neurons in ventral tegmental area lead to dopamine depletion in the nucleus 
accumbens, producing depressive-like phenotype in the animals (Furlanetti, Coenen, & Dobrossy, 
2016). 
 In this regard, very little is known about relationships between PUFA status and dopaminergic 
functioning in major depression. In a clinical study, DHA was inversely correlated with homovanillic 
acid, the main DA metabolite, in cerebrospinal fluid, indicating a possible link between n-3 PUFA 
status and dopaminergic tone in the brain (Sublette et al., 2014). Moreover, Zimmer and 
Colleagues demonstrated that in n-3 PUFA deficient rats, dopamine vesicles are specifically 
decreased in frontal cortex, inducing modification in dopamine metabolism (Zimmer et al., 2002). 
The mechanism leading to this modification might involve different pathways, such as vesicle 
turnover and membrane fluidity. Hence, even if drugs acting on dopaminergic system play a 
marginal role in the treatment of depression, this still remains a field open for future 
investigations.  
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In the searching for biological substrate involved in depressive state, neurotrophins also play a 
significant role. In this regard, we found a decrease of cortical NGF in female rats exposed to n-3 
PUFA deficient diet, further confirming the putative pro-depressive effect of a diet poor in n-3 
PUFA. Moreover, in Aβ treated animals, NGF was significantly increased in n-3 PUFA fed animals 
compared to controls, supporting the hypothesis of a possible therapeutic effect of n-3 PUFA in 
pathological conditions. Accordingly, it has been demonstrated that neurotrophic factors are 
relevant in neurodegenerative diseases, such as Parkinson’s and Alzheimer’s disease (Iulita et al., 
2017; Triaca & Calissano, 2016).  Since neurodegenerative symptoms also occur in depression, a 
neurotrophin hypothesis of depression has been raised. In particular, it has been shown that NGF 
decrease contributes to the etiology of depression (Song, Zhang, & Manku, 2009). Interestingly, it 
has been reported that dopamine agonists, such as bromocriptine, bergolide, cabergolide, may 
promote the synthesis and secretion of NGF (Ohta et al., 2010; Ohta et al., 2003). These data are 
in line with our results, in which Aβ treated females exposed to n-3 PUFA enriched diet showed an 
increase in cortical dopamine and also in cortical NGF.  These results suggest a beneficial effect of 
n-3 PUFA supplementation in Aβ- induced depressive-like symptoms, acting also through 
dopamine neurotransmission. Our hypothesis is supported by previous clinical studies in 
randomized placebo-controlled trials in which the antidepressant efficacy of n-3 PUFA 
supplementation is equivalent to and also additive to the effects of classical antidepressants 
(Gertsik, Poland, Bresee, & Rapaport, 2012; Jazayeri et al., 2008; J. J. Liu et al., 2013).  
Although our group is a pioneer on the depressive-like model induced by soluble Aβ icv injection 
(Colaianna et al., 2010; Morgese et al., 2015; Morgese, Schiavone, et al., 2017; Morgese et al., 
2014; Morgese, Tucci, et al., 2017; Schiavone, Tucci, et al., 2017; Trabace, 2014; Trabace et al., 
2007; Tucci et al., 2014), this is the first study using female rats. In particular, female trends 
confirm male results regarding Aβ-induced depressive-like profile. Literature about estrogens 
involvement in the pathogenesis of depression is controversial. In this regard, there are several 
studies supporting the influence of hormonal fluctuations in the development of mental illnesses, 
in particular pointing toward the importance of sex hormones as neuro-endocrine modulators 
(Fink, Sumner, McQueen, Wilson, & Rosie, 1998; Kudielka & Kirschbaum, 2005; Soares, Castro, 
Reis-Henriques, Monteiro, & Santos, 2012). Nevertheless different studies reported the influence 
of social factors, such as marital and employment status, as a trigger in the development of 
depression in women (Bulloch, Williams, Lavorato, & Patten, 2009; Diaz, Guendelman, & 
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Kuppermann, 2014). From our point of view, females did not show differences compared to males, 
revealing the same Aβ-induced phenotype.   
Furthermore, n-3 PUFA supplementation showed differences in naïve females compared to Aβ 
treated animals, indicating a positive effect only in presence of Aβ-induced dysfunctions. These 
results endorse the hypothesis of a possible therapeutic use of n-3 PUFA supplementation, acting 
in synergy with antidepressants or even alone. In support to our findings, several studies 
supported the benefits of n-3 PUFA supplementation in the treatment of post partum depressive 
symptoms (Chong et al., 2015; Sparling, Henschke, Nesbitt, & Gabrysch, 2017), while a recent 
study reported no efficacy of daily n-3 PUFA supplementation in the prevention of maternal 
depressive symptoms (Vaz, Farias, Adegboye, Nardi, & Kac, 2017). 
Conversely, the deleterious effects of n-3 PUFA deficiency are widely shown and the inverse 
correlation between low n-3 PUFA intake and increase of depressive-like symptoms is extensively 
reported (Beydoun et al., 2013; Beydoun et al., 2015; Grosso et al., 2016).  
Although the underlying mechanisms of action are still unclear and different hypotheses have 
been raised, mainly based on up or down regulation of physiological n-3 PUFA pathways. Among 
these pathways, we focused on the modulation of n-3 PUFA supplementation or deficiency on 
monoamine neurotransmission, especially 5-HT, DA and their metabolism. In particular, the highly 
unsaturated nature of EPA and DHA results in the influence of membrane fluidity and signal 
transduction. Thus, n-3 PUFA supplementation provokes changes that may affect different 
neurotransmitter systems, particularly altering the regulation of dopaminergic and serotonergic 
neurotransmission, which are dysfunctional in depressed patients (Grosso, Galvano, et al., 2014). 
Furthermore, DHA is important in brain development and plays a critical role in neuronal signaling 
pathways regulated by neurotrophins. In particular, high cortical accretion of DHA upregulates 
mRNA expressions of key neurotrophins, such as NGF. Consistent with the health benefits of n-3 
PUFA intake, NGF increase has been shown to ameliorate the symptoms of neurodegenerative 
disorders, such as Alzheimer’s depressive disorder (Wiener et al., 2015).    
To the best of our knowledge, this is the first study that evaluates the effect of Aβ icv injection in 
female rats, reporting depressive-like behaviour and neurochemical impairments. In conclusion, 
the Aβ-induced depressive-like profile was reversed by n-3 PUFA supplementation, indicating a 
possible therapeutic role of n-3 PUFA in the treatment of the burden of depressive disorders.  
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Abstract 
Chronic stress is generally known to exacerbate the development of a wide variety of 
neuropsychiatric diseases, such as depression and anxiety disorders. The prevalence of these 
stress-related psychiatric disorders is about twice as high in women compared to men. Diets, 
genetics and lifestyle contribute to the onset and progression of mental illnesses. As regarding 
dietary factors, Polyunsaturated Fatty Acids (PUFA) have received great attention during the last 
decades, particularly due to the trend towards a poor n-3 PUFA intake of modern Western diets. In 
this regard, we have previously demonstrated that female offsprings receiving from conception a 
diet poor in n-3 PUFA showed a depressive-like behaviour, accompanied by decreased cortical 
serotonin and nerve growth factor. In the present study we investigated behavioural and 
neurochemical consequences of lifelong n-3 PUFA deficiency and n-3 PUFA enrichment on stress- 
and anxiety-related parameters in female offspring. Our results showed that female rats exposed 
to n-3 PUFA deficient diet spent more time performing self-grooming and staying in the periphery 
of the arena in the open field test, both indexes of anxiety-like behaviour. Moreover, we found a 
hyperactivation of the HPA axis pathway in n-3 PUFA deficient female rats, accompanied by a 
significant increase in serotonin and noradrenaline content in amygdala. In addition, we found a 
significant decrease of GABA and increase in glutamate in both amygdala and prefrontal cortex of 
female rats fed with n-3 PUFA deficient diet compared to females fed with n-3 PUFA enriched diet. 
In conclusion, modern Western diets, lacking in n-3 PUFA, might elicit significant neurochemical 
alterations that can ultimately lead to stress-related disorders, such as depression and anxiety.  
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3.1 Introduction 
Stress-related psychiatric disorders, such as depressive diseases, are about twice as high in women 
compared to men (Donner & Lowry, 2013; Kendler, Thornton, & Gardner, 2000; Weissman et al., 
1993). Likewise, the US National Institute of Mental Health reports that the lifetime prevalence of 
an anxiety disorder is 60 % higher in women than in men (Donner & Lowry, 2013; Kessler, Chiu, 
Demler, Merikangas, & Walters, 2005; Leach, Christensen, Mackinnon, Windsor, & Butterworth, 
2008; McLean & Anderson, 2009) and that the onset, severity, clinical course, and treatment 
response of anxiety disorders differ significantly in women (Pinna, Costa, & Guidotti, 2009).  
Although this gender difference is well defined in literature, the biological bases underlying such 
dissimilarity are not fully yet unraveled (Bangasser et al., 2010). The increase in prevalence of 
these neuropsychiatric disorders made mandatory the search of novel strategic approaches 
destined at their prevention. 
Genetics and environmental factors have been shown to crucially endow to the onset and 
progression of mental illnesses (Alam, Abdolmaleky, & Zhou, 2017; Barrenger, Draine, Angell, & 
Herman, 2017; Papadimitriou, 2017; Xiao, Chang, & Li, 2017). In particular, among environmental 
factors, dietary factors gained great attention in the last decade. In this regard, the right 
consumption of Polyunsaturated Fatty Acids (PUFA) with diet has been in the spotlight. PUFAs are 
a family of lipids identified by the position of the last double bond in their structure. Among them, 
n-3 and n-6 PUFAs are biologically important molecules that mediate several processes, such as 
signal pathways, membrane fluidity, neurotransmission, neuroinflammation and cell survival 
(Echeverria et al., 2017). N-3 and n-6 PUFA can be supplied either directly from diet or by 
metabolic conversion of their essential precursors, α-linolenic acid (18:3n-3) and linoleic acid 
(18:2n-6), respectively (Morgese & Trabace, 2016; Zuliani et al., 2009). N-3 PUFA include alpha 
linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), while n-6 PUFA 
include linoleic acid (LA) and arachidonic acid (AA). N-3 PUFA, in particular DHA, are crucial for 
brain development and for proper central nervous system (CNS) functionality (Echeverria et al., 
2017; Maekawa et al., 2017). Experimental evidence in animals has demonstrated that DHA 
deficiency during early brain development is deleterious with permanent consequences 
(Lafourcade et al., 2011; Lo Van et al., 2016; Lozada et al., 2017; Maekawa et al., 2017). 
Accordingly, we have previously demonstrated that female and male offspring receiving for their 
entire life a diet poor in n-3 PUFA showed a depressive-like behaviour in the forced swimming test, 
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accompanied by decreased cortical serotonin (5-HT) and nerve grow factor (NGF) content 
(Morgese, Tucci, et al., 2017). In addition, we have reported that, in male rats, lifelong n-3 
deficiency lead to increased vulnerability to stress (Morgese et al., 2016). Indeed, chronic stress is 
generally known to exacerbate the development of a wide variety of neuropsychiatric diseases, 
such as depression, fear and anxiety disorders (Z. P. Liu et al., 2014). In this regard, Hypothalamic-
Pituitary-Adrenal (HPA) axis hyperactivation is a well-known hormonal response to chronic stress.  
Activation of the HPA axis, starting with hypothalamic increase in corticotropin-releasing-Factor 
(CRF) , acting through Adeno-Cortico-Tropic Hormone (ACTH) and ultimately  leading to an 
increase in plasmatic corticosterone (in animals) or cortisol (in humans), is modulated by several 
brain signaling systems (Stephens & Wand, 2012). Among these systems, monoamines and amino 
acids neurotransmissions need to be taken into account. In this context, a number of evidence has 
indicated alterations in both noradrenaline and HPA axis parameters in anxiety and affective 
disorders (Dunn & Berridge, 1990; Heinrichs & Koob, 2004; Owens & Nemeroff, 1991; Smagin, 
Heinrichs, & Dunn, 2001). In particular, it has been widely reported that noradrenaline can excite 
CRF-containing cells in the hypothalamic paraventricular nucleus to activate the HPA axis (Dunn & 
Swiergiel, 2008). Moreover, the amygdala plays a critical role in emotional disorders (Hakamata et 
al., 2017) and it has been shown that the amygdala regulates the HPA axis response, probably 
involving serotonin and noradrenaline neurotrasmissions (Weidenfeld, Newman, Itzik, Gur, & 
Feldman, 2002). However, also GABA and glutamate neurotransmissions play an important role in 
the stress-induced HPA axis hyperactivation. Interestingly, it has been reported that glutamate, a 
well-known excitatory neurotransmitter, can activate the HPA axis inducing ACTH elevation 
(Zelena, Mergl, & Makara, 2005), while depression of the GABAergic tone has been shown to 
contribute the HPA axis activation (Cullinan, Ziegler, & Herman, 2008; Herman, Mueller, & 
Figueiredo, 2004; Mikkelsen, Bundzikova, Larsen, Hansen, & Kiss, 2008). On the other hand, it has 
been proposed that CRF signaling is positively regulated by estrogens and that, after certain 
stressors, the hypothalamic CRF expression is greater in female, both in humans and rodents 
(Bangasser et al., 2010). Thus, in the present study we deeply investigated behavioural and 
neurochemical consequences of lifelong n-3 PUFA deficiency and n-3 PUFA enrichment on stress- 
and anxiety-related parameters in female offsprings. In particular, we performed Open Field test 
and analyzed HPA axis parameters, catecholamines and amino acids involved in stress- and 
anxiety-related mechanisms.  
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3.2 Materials and Methods 
Animals 
Adult (250-300g) Wistar rats (Harlan, S. Pietro al Natisone, Udine) were used in this study. They 
were housed at constant room temperature (22±1°C) and relative humidity (55±5%) under a 12 h 
light/dark cycle (lights on at the 7 A.M.) with ad libitum access to food and water.  
Procedures involving animals and their care were conducted in conformity with the institutional 
guidelines of the Italian Ministry of Health (D.L. 26/2014), the Guide for the Care and Use of 
Mammals in Neuroscience and Behavioral Research (National Research Council 2004), the 
Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the 
protection of animals used for scientific purposes. All procedures involving animals were 
conducted in accordance to ARRIVE guidelines. Animal welfare was daily monitored through the 
entire period of experimental procedures. No signs of distress were evidenced, anyway all efforts 
were made to minimize the number of animals used and their suffering. 
Diets 
One male and two female rats were housed together for mating. Animals were exposed to specific 
diets mimicking lifelong n-3 PUFA deficiency or supplementation, as previously described (Aid et 
al., 2003; Lafourcade et al., 2011; Morgese et al., 2016). In particular, after mating dams were 
randomly assigned to the group fed with either a diet containing 6% total fat in the form of only 
rapeseed oil (n-3 enriched, rich in -linolenic acid 18:3n-3) or peanut oil (n-3 deficient, rich in 
linoleic acid 18:2n-6) throughout gestation and lactation. As control group, dams were fed with a 
diet containing 6% total fat in the form of 3% of peanut oil plus 3% of rapeseed oil, called control 
diet. After weaning, offspring continued to be subjected to the same diet throughout life. All 
experiments were carried out in female eight-week-old rats. 
Effects on experiments carried out may be influenced by the time of their estrous cycle (Jans et al., 
2007). Pro-estrous/estrus events tend to be dictated by lighting times, but under normal lighting 
schedules (as in the present study) tend to occur during the late afternoon to early hours of the 
morning (Witcher & Freeman, 1985). Hence, all animal procedures were performed in the morning 
(usually (09.00–12.00 h) to reduce estrous cycle effects. Serum estradiol concentrations were 
measured to take account of possible differences in the estrous cycle. 
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Open Field Spontaneous Locomotor Activity 
The open field apparatus consisted of a circular arena, 75 cm diameter, made of dark plastic under 
dim lighting, as previously described by Monteggia et al. (Monteggia et al., 2007). The 
experimental sessions were videotaped by a camera fixed above the arena. Animals were 
acclimatized to the test room for 1 h before each test. Motor activity was measured by placing the 
rat into the center of the arena before a 20-min session. The scoring was performed using a video-
tracking motion analysis system (ANY-MAZE, San Diego Instrument, San Diego, CA). To assess 
general locomotor activity, the following behavioral parameters (expressed as frequency on 5 min 
counts) were scored: number of square limit crossings with both forepaws, rearing (standing with 
the body inclined vertically, forequarters raised), and wall rearing (standing on the hind limbs and 
touching the walls of the apparatus with the forelimbs). To investigate anxiety-related behaviour, 
we measured time spent performing general grooming activity consisting of the following: face 
grooming (strokes along the snout), head washing (semicircular movements over the top of the 
head and behind the ears), and body grooming (body fur licking) (Choleris, Thomas, Kavaliers, & 
Prato, 2001). Time spent in center and periphery was quantified as measure of anxiety-like 
behaviour. 
Post-mortem tissue analysis 
Rats were euthanized and brains were immediately removed and cooled on ice for dissection of 
target region, namely PFC, according to the atlas of Paxinos and Watson (1998). Tissues were 
frozen and stored at -80°C until analysis was performed. 
HPLC quantifications 
Serotonin (5-HT) and noradrenaline (NA) concentrations in amygdala and NA concentrations in 
hypothalamus were determined by HPLC coupled with an electrochemical detector (Ultimate ECD, 
Dionex Scientific, Milan, Italy). Separation was performed by a LC18 reverse phase column 
(Kinetex, 150 mm×4.2 mm, ODS 5 μm; Phenomenex, Castel Maggiore- Bologna, Italy). The 
detection was accomplished by a thin-layer amperometric cell (Dionex, ThermoScientifics, Milan, 
Italy) with a 5 mm diameter glassy carbon electrode at a working potential of 0.400 V vs. Pd. The 
mobile phase used was 75 mM NaH2PO4, 1.7 mM octane sulfonic acid, 0.3 mM EDTA, acetonitrile 
10%, in distilled water, buffered at pH 3.0. The flow rate was maintained by an isocratic pump 
(Shimadzu LC-10 AD, Kyoto, Japan) at 0.7 ml/min. Data were acquired and integrated using 
Chromeleon software (version 6.80, Dionex, San Donato Milanese, Italy). 
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GABA and glutamate concentrations in prefrontal cortex were determined by HPLC using ODS-3 
column (150 × 4.6 mm, 3 µm; INERTSIL) with fluorescence detection after derivatization with 
ophthalaldehyde/mercaptopropionic acid (emission length, 460 nm; excitation length, 340 nm). 
The mobile phase gradient consisted of 50 mM sodium acetate buffer, pH 6.95, with methanol 
increasing linearly from 2 to 30% (v/v) over 40 min. The flow rate was maintained by a pump 
(JASCO, Tokyo, Japan) at 0.5 ml/min. Results were analyzed by Borwin software (version 1.50; 
Jasco) and substrate concentration was expressed as µM. 
ELISA quantifications  
Hypothalamus samples were analyzed for CRF quantifications by using ELISA kits provided by 
Tebu-Bio (Magenta, Milan, Italy). Assays were performed according to the manufacturer’s 
instructions. Briefly, tissues were diluted (10% tissue weight/total volume) with ice-cold medium 
containing phosphate-buffered saline (PBS) and protease inhibitor cocktail (Sigma-Aldrich, Milan, 
Italy). Samples were homogenized and centrifuged at 10.000 x g at 4°C for 20 min. The 
supernatant was collected and assays were performed according to the manufacturer’s 
instructions. To normalize data and negate differences due to sample collection, protein 
concentration was determined by using the BCA assay kit. Each sample analysis was carried out in 
duplicate to avoid intra-assay variations.  
Plasma samples were analyzed for corticosterone by using an ELISA kit provided by Cloud-Clone 
Corporation (Houston, Texas, USA). Assays were performed according to the manufacturer’s 
instructions. Each sample analysis was carried out in duplicate to avoid intra-assay variations. 
Statistical analyses 
Results were expressed as mean ± S.E.M. Statistical analyses were performed using Graph Pad 5.0 
(GraphPad Software, San Diego, CA) for Windows. Behavioral and neurochemical data were tested 
for normality and then analyzed by using two-way analysis of variance (ANOVA) for repeated 
measures or one-way ANOVA followed by Bonferroni’s or Tukey’s multiple comparisons test, as 
required. Differences were considered statistically significant when P value was less than 0.05. 
 
3.3 Results 
Effects of n-3 PUFA deficient diet on anxiety-related behaviour using the Open Field Test 
To investigate the effects of lifelong n-3 PUFA deficiency and lifelong n-3 PUFA supplementation 
on anxiety-related behaviour in adult female rats, we performed the Open Field Test (OF). Time 
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spent performing self-grooming is commonly considered as an index of anxiety-like state; in 
addition, anxiety-like behavior is usually positively correlated with time spent in periphery and 
inversely correlated with time spent in the center of the arena (ref). Our results showed that n-3 
PUFA deficient diet significantly increased self-grooming compared to n-3 PUFA enriched and 
balanced diet (Figure 1A, One-way ANOVA followed by Tukey’s multiple comparison test, F=7.839, 
P<0.01 n-3 deficient versus CTRL, P<0.05 n-3 deficient vs. n-3 enriched). Moreover, in regard to 
time spent in the center, there were no differences among experimental groups (Figure 1B, One-
way ANOVA followed by Tukey’s multiple comparison test, n.s.), while in n-3 PUFA deficient 
animals, the time spent in periphery was significantly increased compared to control animals 
(Figure 1C, One-way ANOVA followed by Tukey’s multiple comparison test, F=5.245, P< 0.01, n-3 
deficient vs. CTRL). 
 
 
Figure 1 Effects of control, n-3 PUFA enriched and n-3 PUFA deficient diets on anxiety-like behaviours in the OF test. 
Time spent preforming self-grooming (A), time spent at the center of the arena (B), and time spent at the periphery of 
the arena (C) in female rats fed from conception until 5 weeks post-weaning with control diet (white bar), n-3 PUFA  
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enriched diet (grey bar), and n-3 PUFA deficient diet (black bar). Data are expressed as mean ± SEM (n=6-10 per 
group). One-way ANOVA followed by Bonferroni’s multiple comparison test *P < 0.05 vs. n-3 enriched, ##P<0.01, 
###P<0.001 vs. CTRL. 
Effects of n-3 PUFA deficient or n-3 PUFA enriched diet on locomotor activity  
In order to evaluate whether different diet exposure could impair locomotor activity, rearing, wall-
rearing and crossing frequency were scored during the OF test. We did not find any dysfunctions 
associated to diets exposure, in either vertical or horizontal activity, as revealed by crossing, 
rearing, and wall rearing frequency measurements (Figure 2A–C, Two-way ANOVA for repeated 
measures followed by Bonferroni’s multiple comparison test, n.s.). 
 
Figure 2 Effects of control, n-3 PUFA enriched and n-3 PUFA deficient diets on locomotor activity in the OF test. 
Frequency measure of crossing (A), rearing (B), and wall rearing (C) behaviours in female rats fed from conception 
until 5 weeks post-weaning with control diet (blue line), n-3 PUFA  enriched diet (red line), and n-3 PUFA deficient diet 
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(black line). Data are expressed as mean ± SEM. Two-way ANOVA RM followed by Bonferroni’s multiple comparison 
test, n.s. 
Effects of n-3 PUFA deficient diet on HPA axis parameters 
To corroborate behavioural with neurochemical data, we analyzed HPA axis parameters, 
quantifying NA and CRF in hypothalamus and corticosterone in plasma samples. We found that n-3 
PUFA deficient diet leads to HPA axis dysfunctions. In particular, NA was significantly increased in 
n-3 PUFA deficient females compared to controls (Figure 3A, One-way ANOVA followed by Tukey’s 
multiple comparison test, F=8.232, P< 0.05, n-3 deficient vs. CTRL). Furthermore, hypothalamic 
CRF was significantly increased in n-3 PUFA deficient animals compared to n-3 PUFA enriched and 
controls (Figure 3B, One-way ANOVA followed by Tukey’s multiple comparison test, F=5.898,P< 
0.05, n-3 deficient vs. n-3 enriched and CTRL). Finally, plasmatic corticosterone was significantly 
increased in animals fed with n-3 PUFA deficient diet compared to both n-3 PUFA enriched and 
control diets, while n-3 PUFA enriched diet significantly decreased corticosterone levels compared 
to control diet. (Figure 3C, One-way ANOVA followed by Tukey’s multiple comparison test, 
F=77.08,P<0.001, n-3 deficient vs. n-3 enriched; P< 0.05, n-3 deficient vs. CTRL; P<0.001 n-3 
enriched vs. CTRL).  
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Figure 3 Effects of control, n-3 PUFA enriched and n-3 PUFA deficient diets on HPA axis parameters. Levels of 
hypothalamic NA (A), hypothalamic CRF (B), and plasmatic corticosterone (C) in female rats fed from conception until 
5 weeks post-weaning with control diet (white bar), n-3 PUFA  enriched diet (grey bar), and n-3 PUFA deficient diet 
(black bar). Data are expressed as mean ± SEM (n=4-6 per group). One-way ANOVA followed by Bonferroni’s multiple 
comparison test *P < 0.05, ***P<0.001 vs. n-3 enriched; #P<0.05 vs. CTRL; §§§P<0.001 vs. CTRL. 
Effects of n-3 PUFA deficient diet on monoamine neurotransmission in amygdala 
To further explore the impairments in stress response due to lifelong n-3 PUFA deficient diet, we 
quantified NA and 5-HT levels in the amygdala. Interestingly, we found a significantly increase in 
female rats fed with n-3 PUFA deficient diet in both 5-HT and NA levels, suggesting an 
enhancement in the amygdaloidal neurotransmission induced by stress and anxiety (Figure 4A, 
One-way ANOVA followed by Tukey’s multiple comparison test, F=5.403, P<0.05 n-3 deficient diet 
vs. CTRL; Figure 4B, One-way ANOVA followed by Tukey’s multiple comparison test, F=4.789, 
P<0.05 n-3 deficient diet vs. CTRL).  
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Figure 4 Effects of control (white bar), n-3 PUFA enriched (grey bar) and n-3 PUFA deficient (dark bar) diets on 
amygdaloidal 5-HT (A) and NA (B) levels. Data are expressed as mean ± SEM (n=4-6 per group). One-way ANOVA 
followed by Bonferroni’s multiple comparison test, #P<0.05 vs. CTRL. 
Effect of n-3 PUFA deficient diet on GABA and glutamate neurotransmission in amygdala and 
PFC 
Ultimately, we analyzed GABA and glutamate content in amygdala and PFC of female rats fed with 
n-3 PUFA enriched and n-3 PUFA deficient diets. Our results showed a significant decrease in 
amygdaloidal GABA levels in n-3 PUFA deficient compared to n-3 PUFA enriched diet (Figure 5A, 
One-way ANOVA followed by Tukey’s multiple comparison test, F=7.001, P<0.01, n-3 deficient vs. 
n-3 enriched). Such a decrease was paralleled by a significant reduction in GABA levels in PFC 
(Figure 5B, One-way ANOVA followed by Tukey’s multiple comparison test, F=4.040, P<0.05, n-3 
deficient vs. n-3 enriched). Moreover, n-3 PUFA deficient females showed a significant increase in 
glutamate content compared to females fed with n-3 PUFA enriched diet in both amygdala (Figure 
5C, One-way ANOVA followed by Tukey’s multiple comparison test, F=6.209, P<0.05, n-3 deficient 
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vs. n-3 enriched) and PFC areas (Figure 5D, One-way ANOVA followed by Tukey’s multiple 
comparison test, F=6.073, P<0.01, n-3 deficient vs. n-3 enriched). 
 
 
Figure 5 Effects of control (white bar), n-3 PUFA enriched (grey bar) and n-3 PUFA deficient (dark bar) diets on 
amygdaloidal GABA (A) and cortical GABA (B) levels, and on amygdaloidal glutamate (C) and cortical glutamate (D) 
levels. Data are expressed as mean ± SEM (n=5 per group). One-way ANOVA followed by Bonferroni’s multiple 
comparison test, *P<0.05, **P<0.01 vs. n-3 enriched. 
 
3.4 Discussion 
In this study, the lifelong effects of diets enriched and deficient in n-3 PUFA on anxiety-like state 
and stress-induced dysfunctions in female rats have been evaluated, using behavioural and 
neurochemical tools. From a behavioural point of view, we performed the OF test. Besides the 
scoring of vertical and horizontal activity, to evaluate locomotor activity, the OF test is a valid tool 
for the evaluation of anxiety-like behaviours. In particular, when rodents are exposed to a new 
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environment, they are naturally inclined to move from the center towards the peripheral zone of 
the open field and closer to the limiting walls. This behaviour is considered as an index of timidity 
(Walsh & Cummins, 1976), and it is assumed to be an indicator of animal fear/anxiety state 
(Varela, Acanda de la Rocha, Diaz, & Lopez-Gimenez, 2017). Conversely, the animals that spent 
more time in the center of the arena are considered less fearful or anxious than those ones that 
prefer the peripheral area (Stanford, 2007). In addition, increased time spent performing self-
grooming is also considered as an index of anxiety, since self-grooming in animals is an innate 
programmed behaviour that is controlled by a complex neural circuitry, and abnormal self-
grooming behaviours are observed in many animal models of different anxiety disorders (Kalueff 
et al., 2016).  In our experimental conditions, we found that n-3 PUFA deficient fed rats spent 
more time performing self-grooming and staying in the periphery of the arena, both indexes of 
anxiety-like behaviour. These findings cannot be related to impaired locomotion considering that 
no differences in vertical or horizontal activity among experimental groups were found.  
Emotional disorders include both anxiety and depression and these two pathologies are highly 
comorbid. In this regard, we have previously shown that n-3 PUFA deficient diet has detrimental 
effects in both female and male rats, eliciting depressive-like alterations, such as increased 
immobility and decreased swimming frequency in FST, accompanied by reduced cortical 5-HT and 
increase in plasmatic soluble Aβ peptide (Morgese, Tucci, et al., 2017). Although lower levels of n-
3 PUFA have been extensively correlated with major depressive disorder, less is known about 
PUFA status and anxiety disorders (J. J. Liu et al., 2013).  
Recent evidence leads to hypothesize that n-3 PUFA may possess an anxiolytic effect, in addition 
to their antidepressant properties. Interestingly, Vinot and colleagues showed a reduction in 
anxiety in non-human primates following n-3 PUFA supplementation (Vinot et al., 2011). One 
mechanism involved in the beneficial effects of n-3 PUFA supplementation might be the PUFA 
regulation of immune responses to stress. In particular, it has been showed that n-3 PUFA 
supplementation reduces oxidative stress and pro-inflammatory cytokines, which are elevated in 
anxiety- and depressive-like states (Calder, 2006; Skouroliakou et al., 2010). In addition, a number 
of preclinical studies suggest that n-3 PUFA deficiency and additional stressors might converge in a 
pathologic synergism, resulting in the development and progression of anxiety disorders (Kiecolt-
Glaser et al., 2007; J. J. Liu et al., 2013; Skouroliakou et al., 2010).  In this context, a series of 
studies reported a strong correlation between anxiety disorders and chronic stress (Buffalari & 
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Grace, 2009; Hill & Patel, 2013; McEwen, 2007). In particular, the hyperactivity of HPA axis 
induced by chronic stress is highly related to depressive- and anxiety-like behaviours (Y. T. Lin et 
al., 2017). Interestingly, we found a deep alteration of the HPA axis pathway in n-3 PUFA deficient 
female rats, with a significant increase in hypothalamic NA and CRF and in plasmatic 
corticosterone. Indeed, it has been widely demonstrated that the HPA axis becomes active in 
response to stress and recent studies found that higher cortisol concentrations during stressful 
conditions are associated with high levels of anxiety in children and adolescents (Kallen, 
Ferdinand, & Tulen, 2007). Accordingly with our results, Larrieu et al. showed that n-3 PUFA 
supplementation prevents HPA axis hyperactivity and neuronal atrophy in PFC, inducing resilience 
to stress-induced emotional and neuronal impairments (Larrieu et al., 2014). In conclusion, n-3 
PUFA enriched diet might be helpful for the treatment of stress-induced disorders and anxiety-like 
states. Here we also corroborated behavioral data with neurochemical quantification in brain 
areas crucially involved in stress response and anxiety-like disorders such as amygdala and PFC. In 
particular, we found a significant increase in 5-HT and NA content in amygdala of female rats 
treated with n-3 PUFA deficient diet. The amygdala has a pivotal role in emotional disorders and 
its functions are strongly modulated from stressful conditions and events (Hill et al., 2013). 
Hyperactivation of the amygdala following chronic stress is believed to be one of the primary 
mechanisms underlying the increased propensity for anxiety-like behaviours and pathological 
states (Hill et al., 2013). In particular, it has been demonstrated that stressors increase NA release 
in amygdala and an excessive increase could desensitize the α1-adrenergic receptors and 
contribute to the hyperexcitability of the amygdala, leading to anxiety disorders induced by stress 
(Hakamata et al., 2017; Weidenfeld et al., 2002). In addition, also amygdaloidal 5-HT content is 
involved in anxiety mechanisms. In a recent study, Johnson and colleagues pharmacologically 
depleted 5-HT in the basolateral amygdala nuclei complex and their results showed a decrease in 
anxiety-like behaviour in social interaction and open field tests (Johnson et al., 2015). Moreover, 
the amygdala is known to modulate the function of the HPA axis, but the mechanisms of this 
effect are still not clear (Weidenfeld et al., 2002). In this regard, Feldman and colleagues suggested 
that amygdaloidal 5-HT has an excitatory effect on the HPA axis (Feldman, Newman, Gur, & 
Weidenfeld, 1998), while Ma and colleagues reported that NA release in medial amygdala 
facilitates activation of HPA axis after acute stress (Ma & Morilak, 2005). Hence, the amygdaloidal 
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increase in noradrenaline and serotonin levels might contribute to the increase in anxiety indexes 
found in the OF test and to the HPA axis hyperactivation in n-3 PUFA deficient females. 
Furthermore, we found a significant decrease of GABA in both amygdala and PFC of female rats 
fed with n-3 PUFA deficient diet compared to females fed with n-3 PUFA enriched diet. On the 
other hand, amygdaloidal and cortical glutamate levels were significantly increased in n-3 PUFA 
deficient female rats compared to females fed with n-3 PUFA enriched diet.  In this regard, 
dysfunctions of the central GABA system have been associated with anxiety disorders (Lydiard, 
2003; Nemeroff, 2003; Nutt & Malizia, 2001) and it has been largely reported that an 
enhancement of GABAergic tone exerts anxiolytic effects (Kalueff, Kaluyeva, & Maillet, 2017; A. P. 
Lang & de Angelis, 2003; Nemeroff, 2003; Rosenthal, 2003; Stahl, 2004). In line with our results, 
Manzanares and colleagues sustained the hypothesis that the behavioural and neurophysiological 
consequences of chronic stress might be partially explained by the attenuation of GABAergic 
inhibition in the basolateral amygdala, ultimately leading to neuronal hyperexcitability (Rodriguez 
Manzanares, Isoardi, Carrer, & Molina, 2005). Interestingly, recent studies have suggested a 
possible involvement of DHA in the potentiation of GABA activity. In particular, it has been 
reported that DHA enhances the binding of diazepam to the GABA receptor in the cortical cell 
membrane (Takeuchi, Iwanaga, & Harada, 2003), while bicuculline, a GABA A antagonist, 
dramatically increased the negative effects of DHA deficiency (van Elst et al., 2014). In this regard, 
GABA A receptor functions might be influenced by PUFAs modulation of the membrane fluidity. 
Moreover, it has been suggested that n-6 PUFA increase, secondary to n-3 PUFA deficiency, might 
inhibit GABAergic neurotransmission and consequently cause neuronal excitability acting through 
phospholipase A2 or phospholipase C activation (Schwartz & Yu, 1992; van Elst et al., 2014). These 
results suggest that DHA might modulate neuronal excitability partially via a GABA-dependent 
mechanism (Sogaard et al., 2006) and that n-3 PUFA deficiency might ultimately lead to chronic 
stress and anxiety-related impairments acting also through GABAergic alterations. 
As regard glutamatergic neurotransmission, it has been widely demonstrated the role of 
glutamate excitotoxicity in the pathogenesis of different mental illnesses, including schizophrenia, 
bipolar disorders, Alzheimer’s disease, anxiety-related disorders and major depressive disease 
(Frisardi, Panza, & Farooqui, 2011; Hashimoto, Sawa, & Iyo, 2007; Ogawa et al., 2017; Schiavone, 
Mhillaj, et al., 2017). In this regard, our group has previously demonstrated a significant increase 
of cortical glutamate in a rat model of Aβ-induced depressive-like disorders (Tucci et al., 2014), 
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unpublished data). Moreover, a recent study showed a key role of glutamate pathways 
abnormalities within the cortico-striatal-thalamo-cortical circuitry and temporal lobes in 
obsessive-compulsive disorder pathogenesis, one of the most common anxiety disorder (Vlcek, 
Polak, Brunovsky, & Horacek, 2017). Furthermore, increasing preclinical evidence suggests that 
glutamate plays an important role in the activation of the HPA axis, by inducing the 
adrenocorticotropin hormone (Zelena et al., 2005). Indeed, activation of glutamatergic projections 
to the amygdala and to the nucleus tractus solitarius is implicated in the stress response (Mathew 
et al., 2001). Interestingly, it has been reported that DHA is a physiological inhibitor of glutamate 
uptake (Berry et al., 2005; Grintal et al., 2009).  Thus, the reduced amount of DHA released at the 
synapses of n-3 PUFA deficient animals would lead to less inhibition of glutamate uptake, and 
ultimately to a reduced efficacy at some glutamatergic synapses involved in memory formation, 
providing an explanation for the cognitive deficits associated with n-3 PUFA deficiency (Grintal et 
al., 2009). These results are in line with our data, in which we reported an increase of glutamate in 
PFC and amygdala of n-3 PUFA deficient females, accompanied by an increase of HPA axis 
parameters, pointing towards an involvement of glutamatergic neurotransmission on the HPA axis 
hyperactivation. Hence, HPA axis modulators and glutamate antagonists might converge in the 
same pathways to treat chronic stress and anxiety-related disorders, and ultimately n-3 PUFA 
might be beneficial to protect glutamatergic neurotransmission from damage induced by stress, 
possibly preventing the development of stress-related disorders, such as depression or anxiety. 
To the best of our knowledge, this is the first study that deeply investigated the negative 
consequences of a diet deficient in n-3 PUFA on stress- and anxiety-related neurochemical 
parameters in female rats. Our results, indicate that modern Western diets, characterized by such 
a low n-3 PUFA content, might elicit significant neurochemical alterations that can ultimately lead 
to stress-related disorders, such as depression and anxiety and particular attention should be paid 
in female population that is already more susceptible to these disorders. 
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Abstract 
Disrupted sociability and consequent social withdrawal are (early) symptoms of a wide variety of 
neuropsychiatric diseases, such as schizophrenia, autism spectrum disorders, depressive disorders 
and Alzheimer’s disease. The paucity of objective measures to translationally assess social 
withdrawal characteristics has been an important limitation to study this behavioural alteration, 
both in human and rodents. The aim of the present study was to investigate sociability and social 
withdrawal in rodents using a behavioural paradigm, the Visible Burrow System (VBS). The VBS 
mimics a natural environment, with male and female rodents housed together in an enclosure 
where an open arena is connected to a continuously dark burrow system that includes 4 boxes 
connected by corridors. In this study, mixed-sex colonies of C57BL/6J and of BTBR mice have been 
investigated (n=8 mice per colony).  Results showed marked differences between the two strains, 
in terms of sociability as well as social withdrawal behaviours. In particular, BTBR mice performed 
less social behaviours and have a preference for non-social behaviours compared to C57BL/6J 
mice. The lack of sociability in BTBR was further accompanied by reduced GABA and increased 
glutamate concentrations in PFC and amygdala. In conclusion, our study validated the use of the 
VBS as a behavioural paradigm to investigate sociability and social withdrawal features and their 
underlying neurobiology, to further develop new therapeutic treatments for behavioural 
dysfunctions that may be relevant across neuropsychiatric diseases. 
 
 
 
 
 
 
 
 
 
 
 
63 
 
4.1 Introduction 
Several neuropsychiatric diseases share the same behavioural dysfunctions, such as anxiety, 
delusion, apathy and impaired social functioning (Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition, DSM-5). Among these behavioural alterations, social withdrawal, defined 
as “withdrawal from social contact that derives from indifference or lack of desire to have social 
contact”, appears to be an early manifestation of a wide variety of neuropsychiatric diseases, such 
as schizophrenia, major depressive disorders (MDD), Alzheimer’s disease and autism spectrum 
disorders (ASD) (Green, 2016; Wilson & Koenig, 2014). Indeed, a deep analysis of social withdrawal 
behaviours and their underlying neurobiology has become necessary in order to find new 
therapeutic strategies to treat this important neuropsychiatric symptom. In this regard, mice can 
provide a good opportunity to study social behaviours, as they are highly social species and show 
distinct and robust social behaviours (Ricceri, Moles, & Crawley, 2007). However, to investigate 
sociability and social withdrawal dynamics in a translational way, novel approaches that take into 
account natural behavioural variation into account. In this context, the Visible Burrow System 
(VBS) has been developed to reproduce group-housed rodent behaviours in semi-natural settings 
(Arakawa, Blanchard, & Blanchard, 2007; Herman & Tamashiro, 2017; Melhorn, Elfers, Scott, & 
Sakai, 2017). The VBS mimics a natural environment, where male and female animals are housed 
together in an enclosure where an open arena, with an imposed diurnal photoperiod, is connected 
to a continuously dark burrow system, consisting of tunnels and small chambers as the 
underground burrows and nests of colonies into the wild (D. C. Blanchard et al., 2012; D. C. 
Blanchard et al., 1995; Buwalda et al., 2017; Pobbe et al., 2010). Although it has been used mainly 
to study dominance and hierarchy, this social housing model appears to be a useful tool to analyze 
social group behaviour dynamics that naturally occur in a mixed-sex colony (McEwen, McKittrick, 
Tamashiro, & Sakai, 2015). To validate the suitability of the VBS to study sociability and social 
withdrawal behaviours, mouse models with behavioural phenotypes affecting the social sphere 
need to be used. In particular, BTBR T+tf/J (BTBR) inbred mouse strain shows robust behavioural 
phenotypes with analogies to the core symptoms of ASD, such as deficits in social interaction, 
impaired communication, and repetitive behaviours (McFarlane et al., 2008; Molenhuis, de Visser, 
Bruining, & Kas, 2014; Pobbe et al., 2010). The BTBR strain shows lower social approach and 
abnormalities in reciprocal social interaction in comparison to the control C57BL/6J mice strain 
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when tested in standard behavioural assays, such as social interaction and social preference tests 
(Moy et al., 2007; Yang et al., 2007).  
Furthermore, recent studies are focusing on the neural circuits underlying social behavioural 
alterations. A number of evidence suggest a key role played by corticolimbic circuitry, including 
the medial prefrontal cortex (PFC) and basolateral amygdala. Indeed, it has been reported that 
activation of PFC and amygdala leads to a reduced social preference in the three chamber 
preference test and reduced social interaction in the social interaction test (Sanders & Shekhar, 
1995), while NMDA and AMPA receptors blockade, with consequent glutamatergic 
neurotransmission suppression, ultimately leads to an increase in social interaction in the social 
interaction test (Sajdyk & Shekhar, 1997). Accordingly, in an elegant study, Paine et colleagues 
showed that a decrease in GABA functioning in either medial PFC or basolateral amygdala, due to 
a bilateral injection of a GABA A antagonist, decreased social preference in the three chamber 
preference test and social interaction in the social interaction test (Paine et al., 2017).  
Interestingly, the GABAergic system has also been investigated in clinical research focused on 
schizophrenia, depression and bipolar disorders (Lewis, 2014; Romeo et al., 2017). Patients 
suffering from these diseases appear to have lowered central and peripheral GABA levels when 
compared to healthy controls (Lewis, 2014; Romeo et al., 2017). Moreover, this lowered 
functionality is visible during the prodromal stage of the diseases (Minzenberg et al., 2010), and 
might ultimately represent a biomarker of symptomatic states in these patients (Romeo et al., 
2017). 
In the present study, the VBS has been validated as a behavioural paradigm to study sociability 
and social withdrawal behaviours in mice colonies. Hence, we studied BTBR and C57BL/6J mixed-
sex colonies housed in VBS continuously for 5 days, evaluating all the kind of social and non-social 
behaviours. To further investigate the mechanisms underlying sociability and social withdrawal, 
we quantified GABA and glutamate in PFC and amygdala of each mouse in our colonies.  
 
4.2 Materials and Methods 
Animals 
Adult C57BL/6J and BTBR male and female mice aged 14-22 weeks were used in this study. C57BL/6J mice 
were offspring of breeding pairs obtained from Janvier Labs (Le Genest-Saint-Isle, France) and BTBR mice 
were offspring of breeding pairs obtained from Jackson Laboratory (Bar Harbor, Maine, U. S.). Animals were 
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bred in the animal facilities of the University of Groningen. Animals were housed in standard polypropylene 
cages, 34 cm x 18 cm x 14 cm, in a group of two mice in a temperature-controlled room (temperature 21 ± 
2 °C). All subjects were maintained on a 12-h light/dark cycle, with access to water and standard chow ad 
libitum in their home cages. All procedures were conducted in accordance with protocols approved by the 
University of Groningen. 
Apparatus 
The VBS’ were built in-house at the University of Groningen, based on the design by Blanchard et 
al. (1995). Extra chambers (nests) were added to better study the social dynamics. The system 
consisted of two parts: an open arena (50cm x 50cm) with two stations where animals had access 
to food and water ad libitum, and a burrow (50cm x 25cm) with 4 chambers and a corridor. The 
open arena was subjected to a 12:12 L/D cycle (ZT0 at 08:00, see figure 3) and was open to the 
outside. The burrow of the VBS was closed using a polycarbonate lid that functioned as an 
infrared-pass filter. Thus the burrow was in complete darkness at all time, resembling the natural 
environment. Within the burrow 2 big chambers (7,5cm x 12,5cm) and 2 small chambers (7,5cm x 
7,5cm) were placed with a tunnel connecting them to each other and to the open arena (see 
Figure 1). Behaviour in the VBS was recorded using a Bassler Cam GigE monochrome infrared 
sensitive camera (acA1300-60gm). Thus, due to its infrared sensitivity, the camera not only 
recorded behaviour in the open arena, but also could capture behaviour in the burrow through 
the polycarbonate lid. 
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Figure 1 The modified Visible Burrow System (VBS) 
Experimental procedures 
Animals were placed in the experimental room two weeks before the start of the experiments. 
Each colony consisted of 6 male mice and 2 female mice of the same strain. Every colony 
contained no more than 2 littermates. Females were used to mimic the natural group-housed 
conditions in rodents. Females were previous sterilized by legating the oviducts and leaving the 
ovaries intact in order to maintain the estrous cycle. Estrous cycle was monitored every day before 
the start of the experiments. Two days before the start of the experiment males were marked with 
a commercial crème-based hair dye (Garnier Olia B++ Super blonde) to facilitate individual 
recognition of the animals. Animals were housed in the system for 8 days. During the experiment, 
the animals were recorded continuously. The animals were weighted at the beginning and at the 
end of the experiment in order to leave them undisturbed in the system. 
Behavioural ethogram 
Social and non-social behaviours scored are described in Table 1. 
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Table 1 
Behavioural ethogram describing all the different behaviour scored. 
 
Behavioural analyses 
Behaviour was analyzed using The Observed 13 XT (Noldus Information Technology, Wageningen, 
The Netherlands). Each colony was observed for 10 minutes of six hours divided over the day. The 
six hours were previously tested and then selected for their representation of the full day and to 
cover most of the activity phase of the animals. The first 10 minutes of these hours were tested for 
their accuracy in representing the full hour. A total of 3 C57BL/6J and 2 BTBR colonies were scored 
manually for 5 days. Frequency and duration in seconds of every behaviour were scored for every 
10 minutes of each of the chosen six hours and data were showed as frequency per day and time 
spent per day. The data of the 5 days scored were summed and showed in the overall behaviour in 
order to analyze strain differences.  
BEHAVIOURS DESCRIPTION 
Social Exploration Sniffing another animal, following another animal, playing with another animal 
Approach Moving towards another animal 
Aggression When the subject is biting, chasing, fighting other animals 
Avoidance 
submissive and avoidance behaviour. Submissive 
reactions to aggressive behaviour (i.e. not fighting 
back/surrendering). Also moving/running away from 
aggressive encounters and social 
contact/approaches 
Huddling 
Resting/huddling while in contact with conspecifics. 
When the subject resumes activity for more than 5 
seconds, behaviour is not considered part of 
resting/huddling 
Sexual activity Mounting Female  
Passive/Receiving social contact 
Receiving social contact is scored when an animal 
does not react to social exploration of another 
animal (i.e. passive social interaction) 
Allogrooming When an animal is grooming another animal 
Autogrooming When an animal is grooming itself 
Feeding/Drinking Feeding/drinking from the feeding station 
Environmental Exploration 
Animal explores the surrounding environment, 
behaviour is not aimed towards another animal. 
(e.g. digging, locomotion, sniffing the walls) 
Alone Inactivity  
Resting whilst not being in bodily contact with 
another animal. When the subject resumes activity 
for more than 5 seconds, behaviour is not 
considered part of resting 
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Post mortem analyses 
After 5 days of VBS colony housing, male mice were immediately euthanized by cervical 
dislocation and brains were collected, frozen in isopentane and stored at -80⁰C. 
For the standard-housed measurements, 4 adult C57BL/6J and 4 adult BTBR male mice, housed in 
standard cages, two per cage, were euthanized, brains were collected, frozen in isopentane and 
stored at -80⁰C. 
HPLC quantifications 
GABA and glutamate concentrations in prefrontal cortex and amygdala were determined by HPLC 
using ODS-3 column (150 × 4.6 mm, 3 µm; INERTSIL) with fluorescence detection after 
derivatization with ophthalaldehyde/mercaptopropionic acid (emission length, 4.60 nm; excitation 
length, 3.40 nm). The mobile phase gradient consisted of 50 mM sodium acetate buffer, pH 6.95, 
with methanol increasing linearly from 2 to 30% (v/v) over 40 min. The flow rate was maintained 
by a pump (JASCO, Tokyo, Japan) at 0.5 ml/min. Results were analyzed by Borwin software 
(version 1.50; Jasco) and substrate concentration was expressed as µM. 
Statistical analyses 
Frequency and duration of each behaviour were tested for normality and then analyzed per day 
using Two-way ANOVA for repeated measures followed by a Bonferroni’s post-hoc test. 
Differences in the overall behaviour and neurochemical data were tested for normality and then 
analyzed using unpaired t-test. Correlation between social behaviours and GABA tissue levels were 
analyzed by using Pearson correlation. Results were expressed as mean ± S.E.M. Statistical 
analyses were performed using Graph Pad 5.0 (GraphPad Software, San Diego, CA) for Windows. 
Differences were considered statistically significant when P value was less than 0.05. 
 
4.3 Results 
In order to validate the VBS as suitable tool to study social group behaviour dynamics that 
naturally occur in a mixed-sex colony, we analyzed BTBR and C57BL/6J colonies.   
BTBR mice showed reduced social behaviours in VBS colony housing 
We scored social exploration and huddling as social behaviours, for both frequency and duration. 
In particular, we found that the time spent performing social exploration during day 2 was 
significantly decreased in BTBR compared to control (Fig. 2A, Two-way ANOVA RM followed by 
Bonferroni, F(1,28)=10.98, p<0.01 BTBR vs. C57BL/6J). In addition, the overall duration of social 
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exploration was significantly decreased in BTBR compared to controls (Fig. 2B, Unpaired t-test, 
p<0.01 BTBR vs. C57BL/6J). Moreover, the frequency of social exploration during day 2, 3 and 5 
was significantly decreased in BTBR compared to control strain (Fig. 2C, Two-way ANOVA RM 
followed by Bonferroni, F(1,28)=20.72, p<0.001, p<0.05 BTBR vs. C57BL/6J), and also the total 
frequency of social exploration was significantly decreased (Fig. 2D, Unpaired t-test, p<0.001 BTBR 
vs. C57BL/6J). On the other hand, there were no differences in time spent performing huddling in 
BTBR compared to controls (Fig. 2E, Two-way ANOVA RM followed by Bonferroni’s, n. s. BTBR vs. 
C57BL/6J, Fig. 2F Unpaired t-test, n. s. BTBR vs. C57BL/6J), while frequency during day 1 was 
significantly decreased in BTBR compared to controls (Fig. 2G, Two-way ANOVA RM followed by 
Bonferroni, F(1,28)=12.47, p<0.001 BTBR vs. C57BL/6J). Ultimately the total frequency of huddling 
was significantly reduced in BTBR compared to controls (Fig. 2H, Unpaired t-test, p<0.01 BTBR vs. 
C57BL/6J). 
 
 
Figure 2 Duration and frequency of social behaviours in BTBR and C57BL/6J mice. Time spent performing social 
exploration per day (A) in BTBR (red line) and C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, 
**p<0.01 vs. C57BL/6J. Overall time spent performing social exploration (B) in BTBR (white bar) and C57BL/6J (black 
bar) mice. Unpaired t-test, **p<0.01 vs.  C57BL/6J. Frequency of social exploration per day (C) in BTBR (red line) and 
C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, *p<0.05, **p<0.01 vs. C57BL/6J. Overall 
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frequency of social exploration (D) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, ***p<0.001 vs.  
C57BL/6J. Time spent performing huddling per day (E) in BTBR (red line) and C57BL/6J (black line) mice. Two-way 
ANOVA RM followed by Bonferroni, n.s. Overall time spent performing huddling (F) in BTBR (white bar) and C57BL/6J 
(black bar) mice. Unpaired t-test, **p<0.01 vs.  C57BL/6J. Frequency of huddling per day (G) in BTBR (red line) and 
C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, ***p<0.001 vs. C57BL/6J. Overall frequency 
of huddling (H) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, **p<0.01 vs.  C57BL/6J. Data are 
expressed as mean ± SEM (n=12 for BTBR group, n=18 for C57BL/6J group). 
BTBR mice showed increased non-social behaviours in VBS colony housing  
We scored alone inactivity, environmental exploration, avoidance and passive/receiving social 
contact behaviours as non-social behaviours. Our results showed that there were no differences in 
time spent performing alone inactivity per day between the two strains (Fig. 3A, Two-way ANOVA 
RM followed by Bonferroni’s, n. s. BTBR vs. C57BL/6J), while the overall duration of alone inactivity 
was significantly increased in BTBR compared to control strain (Fig. 3B, Unpaired t-test, p<0.05 
BTBR vs. C57BL/6J). Regarding frequency, there were no differences in both daily and overall alone 
inactivity between the two strains (Fig. 3C, Two-way ANOVA RM followed by Bonferroni’s, n. s. 
BTBR vs. C57BL/6J, Fig. 3D Unpaired t-test, n. s. BTBR vs. C57BL/6J). In addition, the time spent 
performing environmental exploration was not significantly different between the two strains (Fig. 
3E, Two-way ANOVA RM followed by Bonferroni’s, n. s. BTBR vs. C57BL/6J, Fig. 3F, Unpaired t-test, 
n. s. BTBR vs. C57BL/6J). Moreover, the frequency of environmental exploration was significantly 
increased in BTBR mice during day 1 (Fig. 3G, Two-way ANOVA RM followed by Bonferroni, 
F(1,28)=0.4863, p<0.001 BTBR vs. C57BL/6J), although no differences were detected in the overall 
frequency of environmental exploration between the two strains (Fig. 3H, Unpaired t-test, n.s. 
BTBR vs. C57BL/6J). Furthermore, we found that BTBR spent significantly more time performing 
avoidance behaviour during day 1 (Fig. 3I, Two-way ANOVA RM followed by Bonferroni, 
F(1,28)=0.01953, p<0.001 BTBR vs. C57BL/6J), while no differences were found in the overall 
avoidance duration (Fig. 3J, Unpaired t-test, n. s. BTBR vs. C57BL/6J). These results were confirmed 
with the avoidance frequency that was significantly increased in BTBR mice compared to controls 
only during day 1 (Fig. 3K, Two-way ANOVA RM followed by Bonferroni, F(1,28)=1.429, p<0.001 
BTBR vs. C57BL/6J), and not in the overall avoidance frequency (Fig. 3L, Unpaired t-test, n. s. BTBR 
vs. C57BL/6J). Ultimately, time spent performing passive/receiving social contact behaviour did 
not differ between the two strains (Fig. 3M, Two-way ANOVA RM followed by Bonferroni’s, n. s. 
BTBR vs. C57BL/6J, Fig. 3N, Unpaired t-test, n. s. BTBR vs. C57BL/6J). Also daily frequency of 
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passive/receiving social contact behaviour was not significantly different between BTBR and 
control animals (Fig. 3O, Two-way ANOVA RM followed by Bonferroni’s, n. s. BTBR vs. C57BL/6J), 
while BTBR showed significantly more passive/receiving social contact frequency compared to 
controls (Fig. 3P, Unpaired t-test, p<0.05 BTBR vs. C57BL/6J). 
 
Figure 3 Duration and frequency of non-social behaviours in BTBR and C57BL/6J mice. Time spent performing alone 
inactivity per day (A) in BTBR (red line) and C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, 
n.s. Overall time spent performing alone inactivity (B) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-
test, *p<0.05 vs.  C57BL/6J. Frequency of alone inactivity per day (C) in BTBR (red line) and C57BL/6J (black line) mice. 
Two-way ANOVA RM followed by Bonferroni, n.s. Overall frequency of alone inactivity (D) in BTBR (white bar) and 
C57BL/6J (black bar) mice. Unpaired t-test, n.s. Time spent performing environmental exploration per day (E) in BTBR 
(red line) and C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. Overall time spent 
performing environmental exploration (F) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, n.s. 
Frequency of environmental exploration per day (G) in BTBR (red line) and C57BL/6J (black line) mice. Two-way 
ANOVA RM followed by Bonferroni, ***p<0.001 vs. C57BL/6J. Overall frequency of environmental exploration (H) in 
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BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, n.s. Time spent performing avoidance per day (I) in 
BTBR (red line) and C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, ***p<0.001 vs. C57BL/6J. 
Overall time spent performing avoidance (J) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, n.s. 
Frequency of avoidance per day (K) in BTBR (red line) and C57BL/6J (black line) mice. Two-way ANOVA RM followed by 
Bonferroni, ***p<0.001 vs. C57BL/6J. Overall frequency of avoidance (L) in BTBR (white bar) and C57BL/6J (black bar) 
mice. Unpaired t-test, n.s. Time spent performing passive/receiving social contact per day (M) in BTBR (red line) and 
C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. Overall time spent performing 
passive/receiving social contact (N) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, n.s. Frequency 
of passive/receiving social contact per day (O) in BTBR (red line) and C57BL/6J (black line) mice. Two-way ANOVA RM 
followed by Bonferroni, n.s. Overall frequency of passive/receiving social contact (P) in BTBR (white bar) and C57BL/6J 
(black bar) mice. Unpaired t-test, *p<0.05 vs. C57BL/6J. Data are expressed as mean ± SEM (n=12 for BTBR group, 
n=18 for C57BL/6J group). 
BTBR mice showed novelty-induced aggressive behaviour in VBS colony housing 
We scored daily aggressive behaviour for both frequency and duration. We found that BTBR 
showed significantly more time spent performing aggression during day 1 (Fig. 4A, Two-way 
ANOVA RM followed by Bonferroni’s, F(1,28)=2.782, p<0.001 BTBR vs. C57BL/6J), while there were 
no differences in the overall aggressive behaviour duration between the two strains (Fig. 4B, 
Unpaired t-test, n. s. BTBR vs. C57BL/6J). In addition, frequency of aggression was increased in 
BTBR during day 1 (Fig.4C, Two-way ANOVA RM followed by Bonferroni’s, F(1,28)=2.907, p<0.001 
BTBR vs. C57BL/6J), while there were no differences detected for the total aggression frequency 
(Fig. 4D, Unpaired t-test, n. s. BTBR vs. C57BL/6J). Since aggressive behaviour could be influenced 
from sexual activity, we scored also sexual activity for both frequency and duration and we did not 
find any differences per day or in the total sexual activity between BTBR and control mice for both 
duration (Fig. 4E, Two-way ANOVA RM followed by Bonferroni’s, n. s. BTBR vs. C57BL/6J, Fig. 4F,  
Unpaired t-test, n. s. BTBR vs. C57BL/6J) and frequency (Fig. 4G, Two-way ANOVA RM followed by 
Bonferroni’s, n. s. Fig. 4H, n. s. BTBR vs. C57BL/6J, Unpaired t-test, n. s. BTBR vs. C57BL/6J). 
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Figure 4 Duration and frequency of aggression and sexual activity in BTBR and C57BL/6J mice. Time spent performing 
aggression per day (A) in BTBR (red line) and C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, 
***p<0.001 vs. C57BL/6J. Overall time spent performing aggression (B) in BTBR (white bar) and C57BL/6J (black bar) 
mice. Unpaired t-test, n.s. Frequency of aggression per day (C) in BTBR (red line) and C57BL/6J (black line) mice. Two-
way ANOVA RM followed by Bonferroni, ***p<0.001 vs. C57BL/6J. Overall frequency of aggression (D) in BTBR (white 
bar) and C57BL/6J (black bar) mice. Unpaired t-test, n.s. Time spent performing sexual activity per day (E) in BTBR (red 
line) and C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. Overall time spent performing 
sexual activity (F) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, n.s. Frequency of sexual activity 
per day (G) in BTBR (red line) and C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. Overall 
frequency of sexual activity (H) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, n.s. Data are 
expressed as mean ± SEM (n=12 for BTBR group, n=18 for C57BL/6J group). 
BTBR mice showed increased grooming behaviour in VBS colony housing 
We scored grooming behaviour, which includes both allogrooming and autogrooming. We found 
that BTBR spent significantly more time performing grooming compared to controls during day 3 
and 5 (Fig.5A, Two-way ANOVA RM followed by Bonferroni’s, F=3.687, p<0.05, p<0.01 BTBR vs. 
C57BL/6J) and in the overall grooming (Fig. 5B, Unpaired t-test, p<0.05 BTBR vs. C57BL/6J). 
Regarding frequency, BTBR showed significant less grooming frequency during day 1 compared to 
control mice (Fig. 5C, Two-way ANOVA RM followed by Bonferroni’s, F=2.043, p<0.05 BTBR vs. 
74 
 
C57BL/6J), while the overall grooming frequency was not significantly different between the two 
strains (Fig. 5D, Unpaired t-test, n. s.  BTBR vs. C57BL/6J).  
To investigate whether the alteration in social activities in BTBR strain were due to alterations in 
general activity, we scored also the total activity of BTBR and C57BL/6J colonies, pooling all the 
active behaviours (social exploration, alone exploration, avoidance, passive, aggressive behaviour, 
sexual activity and grooming). Our results showed that there were no differences in time spent 
performing total activity in BTBR compared to controls during the daily scoring (Fig.5E, Two-way 
ANOVA RM followed by Bonferroni’s, n. s. BTBR vs. C57BL/6J) and in the overall duration of total 
activity (Fig. 5F, Unpaired t-test, n. s. BTBR vs. C57BL/6J). Furthermore, we found an increase in 
total activity frequency during day 1 and a decrease during day 3 in BTBR mice compared to 
controls (Fig. 5G, Two-way ANOVA RM followed by Bonferroni’s, F(1,28)=5.306, p<0.05 BTBR vs. 
C57BL/6J), while there were no differences in the overall frequency of total activity between the 
two strains (Fig. 5H, Unpaired t-test, n. s. BTBR vs. C57BL/6J). 
 
Figure 5 Duration and frequency of grooming and general activity in BTBR and C57BL/6J mice. Time spent performing 
grooming per day (A) in BTBR (red line) and C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, 
*p<0.05, ***p<0.001 vs. C57BL/6J. Overall time spent performing grooming (B) in BTBR (white bar) and C57BL/6J 
(black bar) mice. Unpaired t-test, *p<0.05 vs. C57BL/6J. Frequency of grooming per day (C) in BTBR (red line) and 
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C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, *p<0.05 vs. C57BL/6J. Overall frequency of 
grooming (D) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, n.s. Time spent performing general 
activity per day (E) in BTBR (red line) and C57BL/6J (black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. 
Overall time spent performing general activity (F) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, 
n.s. Frequency of general activity per day (G) in BTBR (red line) and C57BL/6J (black line) mice. Two-way ANOVA RM 
followed by Bonferroni, *p<0.05 vs. C57BL/6J. Overall frequency of general activity (H) in BTBR (white bar) and 
C57BL/6J (black bar) mice. Unpaired t-test, n.s. Data are expressed as mean ± SEM (n=12 for BTBR group, n=18 for 
C57BL/6J group). 
BTBR mice showed decreased GABA and increased glutamate concentrations in PFC and 
amygdala in VBS colony housing 
To corroborate behavioural results with neurochemical analyses, we quantified GABA and 
glutamate levels in PFC and amygdala at the end of the VBS experiments. Our results showed a 
decrease in GABA levels in BTBR compared to control colonies, in both PFC and amygdala (Fig. 6A-
B, Unpaired t-test, p<0.05, BTBR vs. C57BL/6J). Moreover, we found a significant increase in 
cortical and amygdaloidal glutamate levels in BTBR compared to C57BL/6J colonies (Fig. 6C, 
Unpaired t-test, p<0.001, BTBR vs. C57BL/6J, Fig. 6D, Unpaired t-test, p<0.01, BTBR vs. C57BL/6J).  
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Figure 6 Cortical and amygdaloidal GABA and glutamate levels in BTBR and C57BL/6J mice. GABA levels in PFC (A) and 
amygdala (B) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, *p<0.05 vs. C57BL/6J. Glutamate 
levels in PFC (C) and amygdala (D) in BTBR (white bar) and C57BL/6J (black bar) mice. Unpaired t-test, **p<0.01, 
***p<0.001 vs. C57BL/6J. Data are expressed as mean ± SEM (n=12 for BTBR group, n=18 for C57BL/6J group). 
Effect of VBS colony housing on GABA and glutamate concentrations in BTBR and C57BL/6J mice  
In order to investigate the effect of the VBS colony housing on neurochemical outcomes, we 
quantified cortical and amygdaloidal GABA and glutamate levels in standard-housed animals and 
in VBS-housed animals in BTBR and C57BL/6J strains. We found an increase in GABA levels in both 
PFC and amygdala in VBS-housed C57BL/6J compared to the standard-housed C57BL/6J (Fig. 7A, 
Unpaired t-test, p<0.01, VBS-housed vs. standard-housed, Fig. 7B, Unpaired t-test, p<0.05, VBS-
housed vs. standard-housed). Moreover, VBS-housed C57BL/6J showed a decrease in cortical and 
amygdaloidal glutamate levels compared to standard-housed C57BL/6J (Fig. 7C-D, Unpaired t-test, 
p<0.05, VBS-housed vs. standard-housed). As regarding BTBR strain, no differences were detected 
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in GABA and glutamate levels, in both PFC and amygdala, in VBS-housed compared to standard-
housed mice (Fig. 7E-H, Unpaired t-test, n. s., VBS-housed vs. standard-housed). 
 
Figure 7 Effect of VBS colony housing on cortical and amygdaloidal GABA and glutamate levels in BTBR and C57BL/6J 
mice. GABA levels in PFC (A) and amygdala (B) in C57BL/6J mice housed in standard cages (white bar) and C57BL/6J 
VBS-housed (black bar) mice. Unpaired t-test, *p<0.05, **p<0.01 vs. C57BL/6J standard-housed. Glutamate levels in 
PFC (C) and amygdala (D) in C57BL/6J mice housed in standard cages (white bar) and C57BL/6J VBS-housed (black bar) 
mice. Unpaired t-test, *p<0.05 vs. C57BL/6J standard-housed. GABA levels in PFC (D) and amygdala (E) in BTBR mice 
housed in standard cages (white bar) and BTBR VBS-housed (black bar) mice. Unpaired t-test, n.s. Glutamate levels in 
PFC (G) and amygdala (H) in BTBR mice housed in standard cages (white bar) and BTBR VBS-housed (black bar) mice. 
Unpaired t-test, n.s. Data are expressed as mean ± SEM (n=8 for standard-housed C57BL/6J and BTBR groups, n=12 for 
VBS-housed C57BL/6J and BTBR groups). 
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Positive correlation between social exploration and amygdaloidal GABA in C57BL/6J but not 
BTBR mice colonies 
In order to investigate the presence of correlations between social behaviours and GABA tissue 
levels, we performed Pearson correlation for each mouse for 2 C57BL/6J and 2 BTBR colonies. We 
did not found any correlation between social inactivity and cortical and amygdaloidal GABA levels 
for both strains (data not shown). Finally, we found a significant positive correlation between 
social exploration and GABA in amygdala in C57BL/6J mice (Fig. 8A, Pearson correlation, r2=0,6093, 
p<0.01), while the correlation was not significant in BTBR mice (Fig. 8B, Pearson correlation, 
r2=0,2509, n. s.). 
 
Figure 8 Correlation between social exploration and amygdaloidal GABA in C57BL/6J and BTBR colonies. Positive 
correlation between social exploration and amygdaloidal GABA in C57BL/6J mice housed in VBS colonies (A). Pearson 
correlation, r2=0,6093, **p<0.01. Correlation between social exploration and amygdaloidal GABA in BTBR mice housed 
in VBS colonies (B). Pearson correlation, r2=0,2509, n.s. 
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4.4 Discussion 
In the present study, we investigated social dynamics and study social withdrawal features in BTBR 
and C57BL/6J colonies in the VBS paradigm. Our results showed that BTBR mice performed less 
social behaviours and have a preference for non-social behaviours compared to C57BL/6J mice. 
The lack of sociability in BTBR was further accompanied by reduced GABA and increased 
glutamate concentrations in PFC and amygdala.  
In our study, we implemented a modified version of an earlier used VBS paradigm, namely by 
adding two additional chambers in the burrow, enabling animals to have more nests and thus 
mimic the natural environment as much as possible. Moreover, we used mixed-sex colonies to 
better reproduce the group-housed social dynamics that naturally occur in rodents (Buwalda et al., 
2017). To the best of our knowledge, this is the first study using a scoring method that includes 
duration and frequency of the most important behaviours of group-housed animals. Indeed, our 
results showed the total burden of social and non-social behaviours, displaying a clear picture of 
BTBR and C57BL/6J behaviours in colony. In these regards, we found a decrease in time spent 
performing social exploration in BTBR mice compared to controls during day 2 and in the overall 
duration. The decrease in time spent performing social exploration in BTBR was accompanied by a 
decrease also in the frequency during day 2, 3, 5 and in the overall social exploration frequency. As 
widely known, BTBR mice are studied as an ASD model, because of their reduced sociability 
compared to the commonly used as control C57BL/6J strain (Pobbe et al., 2010; Ryan, Fraser-
Thomas, & Weiss, 2017). Indeed, the most important features of ASD phenotype consist in social 
deficits and high levels of repetitive grooming (Pobbe et al., 2010; Silverman, Tolu, Barkan, & 
Crawley, 2010). However, the most used behavioural test to assess sociability is the three chamber 
test, in which social preference is tested towards only one stimulus animal (Moy et al., 2007). 
Hence, in our group-housed environment, we measured time spent and frequency of social 
behaviours for each component of the colony towards the other five males and two females, in 
order to untangle the social dynamics typical of the two studied strains. In this regard, we found a 
decrease of the overall huddling frequency in BTBR mice compared to controls, while no 
differences were detected in terms of duration. Our results are in line with previous studies from 
Blanchard group, in which they found a decrease in huddling frequency in BTBR compared to 
control mice (Pobbe et al., 2010). Although huddling is commonly considered a social inactive 
behaviour, it has also thermoregulatory functions. Factors such as social dominance, gender, 
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ambient temperature and thermogenic needs can all have an influence on the amount of huddling 
(see (Gilbert et al., 2010) for review).  
As regarding non-social behaviours, BTBR showed a general preference compared to C57BL/6J. In 
particular, we found a significant increase in the overall duration of alone inactivity in BTBR mice, 
while no differences were detected in terms of frequency. Conversely, BTBR showed an increase in 
the frequency of environmental exploration during day 1, but no differences in time spent 
performing environmental exploration. In addition, avoidance behaviour was significantly 
increased in BTBR mice during day 1 for both frequency and duration. Ultimately, we found an 
increase of passive/receiving social contact behaviour in BTBR mice only in terms of overall 
frequency, but not overall duration.  
Taken together, our results confirm that the BTBR strain display less sociability and a preference 
for non-social behaviours, also in a semi-natural mixed-sex housing condition.  
Although our results are in line with previous literature regarding BTBR strain and decrease of 
sociability (Meyza et al., 2015), this is the first study showing also an effective increase in non-
social behaviours. In particular, our results reported a trend towards social withdrawal behaviours 
in BTBR mice, opening to a deep investigation of the underlying neurobiology that gives rise to 
these behaviours. 
Furthermore, we found an increase in aggressive behaviour in BTBR compared to C57BL/6J mice 
during day 1, in terms of both frequency and duration. Interestingly, after the first day, the 
aggressive behaviour in BTBR almost disappeared, suggesting a novelty-induced effect due to the 
new group housing condition. In this regard, very little is known about BTBR aggressiveness traits. 
Little aggressive behaviour was observed during social interaction test (Bolivar, Walters, & 
Phoenix, 2007) and resident-intruder paradigm (unpublished observations). Although aggression is 
not one of the core symptoms of ASD, ASD children display high levels of irritability, sometimes 
including aggressiveness towards others (Silverman et al., 2010) and caregiver surveys reported 
some episodes of aggression in ASD patients towards others ASD patients (Kanne & Mazurek, 
2011; Pouw, Rieffe, Oosterveld, Huskens, & Stockmann, 2013). However, to fully evaluate 
aggressive behaviour features, hierarchy should to be taken into account. Dominance hierarchies 
are important aspects of animals living in social groups (Buwalda et al., 2017).  Here, we wanted to 
investigate strain differences and validate the suitability of VBS as a paradigm to study social and 
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non-social behaviours. Future studies will be conducted to analyze individual animal behaviours 
and hierarchy formation within the colonies.  
Since sexual activity is an important trigger for aggressive behaviour, we decided to use mixed-sex 
colonies and analyze their sexual activity. Our results showed that there were no strain differences 
in sexual activity duration and frequency. Accordingly with aggressive behaviour results, sexual 
activity was performed only during day 1 and 2 in BTBR colonies. Considering that females were 
monitored before the beginning of the experiment, avoiding to start the experiment during the 
sexual receptivity phase, these results further confirm the novelty-induced effect due to the new 
housing condition in BTBR mice.  
As regarding grooming behaviour, we found an increase during day 3 and day 5 and in the overall 
duration of grooming in BTBR compared to C57BL/6J mice, while no differences were reported in 
terms of frequency. These data suggest that BTBR performed more grooming for a more 
prolonged time compared to C57BL/6J mice, indicating a less initiation of the behaviour. As widely 
reported, BTBR strain display high levels of repetitive behaviours, such as persistent self-grooming 
and murble-burying (Amodeo, Jones, Sweeney, & Ragozzino, 2012; Jones-Davis et al., 2013; 
McFarlane et al., 2008; Molenhuis et al., 2014; Moller & Raahave, 1974; Pobbe et al., 2010). In line 
with the previous literature, our increase in time spent performing grooming behaviour might be 
interpreted as repetitive behaviour that BTBR mice perform towards themselves (self-grooming) 
and towards others (allo-grooming). For this reason, we decided to pool together self- and allo- 
grooming, due to the their repetitive features and not to consider allo-grooming as a social 
behaviour, as differently reported in other VBS studies (Pobbe et al., 2010).  
Finally, we also checked general activity, to assess whether social and non-social strain differences 
were due to alteration in activity and we did not find any differences between the two strains. In 
support of this findings, Silverman and colleagues demonstrated that BTBR have the same 
response of C57BL/6J in terms of activity and locomotion (Silverman, Babineau, Oliver, Karras, & 
Crawley, 2013). 
From a neurochemical point of view, we found a significant decrease of GABA levels in PFC and 
amygdala in BTBR compared to C57BL/6J animals. The decrease in GABA was accompanied by an 
increase in glutamate levels, respectively in PFC and amygdala of BTBR mice. Recently, GABA 
involvement in sociability pathways is receiving great interest. In this regard, our results are 
consistent with those of Paine et colleagues, who demonstrated that a decrease in GABA functions 
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in PFC and basolateral amygdala lead to a decrease in the social interaction and in the social 
preference tests, without affecting general anxiety, reward or locomotion (Paine et al., 2017). 
However, different social factors contribute to sociability dysfunctions, such as social motivation, 
social anxiety and social cognition (Kennedy & Adolphs, 2012), hence future studies will be 
conducted to assess the involvement of these different social components in the sociability 
impairment.  
Furthermore, it has been widely demonstrated that imbalances in the excitatory and inhibitory 
synaptic transmission might be responsible of severe neuropsychiatric-related symptoms (Gao & 
Penzes, 2015; Nelson & Valakh, 2015; Sorce et al., 2010; Yizhar et al., 2011). In an elegant study, 
Yizhar and colleagues found a reduction in social interactions and social preference when 
activating optogenetically cortical pyramidal neurons (Yizhar et al., 2011). Moreover, it has been 
reported that lesions in the medial PFC increased social behaviour in the social interaction test 
(Shah & Treit, 2003). In conclusion, the decrease in GABA and the corresponding increase in 
glutamate in PFC and amygdala might be responsible of the decrease in social behaviour and 
increase in social withdrawal characteristics in BTBR strain. Thus, enhancing GABA 
neurotransmission could be a possible therapeutic strategy to treat social withdrawal symptoms 
that primarily occur in many neuropsychiatric and neurodegenerative diseases.  
In addition, we evaluated the effect of VBS colony housing condition on GABA and glutamate 
neurotransmission in the two studied strains. Interestingly, we found that GABA was increased 
and glutamate was decreased in both PFC and amygdala in C57BL/6J housed in VBS compared to 
C57BL/6J housed in standard cages. Otherwise, BTBR did not follow the same trend of C57BL/6J, 
indeed no differences were detected in GABA and glutamate levels between the VBS colonies and 
the standard cage housing condition. Thus, C57BL/6J mice showed a neurochemical response to 
the highly social housing conditions, not found in BTBR strain. The BTBR neurochemical non-
response to VBS housing conditions might explain their tendency to perform social withdrawal 
behaviours in the colony. Our findings are consistent with a preclinical study from Crawley group, 
in which they showed that BTBR mice have poor abilities to modulate their responses to different 
social partners, resembling social cognition deficits in ASD patients (Yang et al., 2012).  
To further corroborate neurochemical data with behavioural outcomes, we searched for 
correlations between social exploratory behaviour and GABA levels in amygdala for each individual 
mouse within every colony. We found a significant positive correlation between social exploratory 
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activity and amygdaloidal GABA in C57BL/6J, but not in BTBR colonies. These results endorse the 
hypothesis that GABA neurotransmission deeply affect sociability and that, in physiological 
condition such as in control C57BL/6J mice, GABAergic tone is able to modulate the response to 
different social environments. 
Our study validated the use of the VBS as a behavioural paradigm to deeply analyze sociability and 
social withdrawal behaviours, investigating mixed-sex group-housed dynamics in rodents. In 
conclusion, the VBS can be used as a tool to study behavioural dysfunctions and their underlying 
neurobiology, ultimately helping to design effective treatments for behavioural symptoms 
observed across neuropsychiatric diseases. 
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Abstract 
Genetic deletion of genes related to neuropsychiatric disorders allow us to study gene function in 
relation to disease features. In this regard, genetic ablation of Pcdh9 gene has recently been 
associated to sensory processing deficits and impaired social interactions, that may be relevant for 
symptomatology across the neuropsychiatric spectrum. To study social behavioural phenotypes 
under semi-natural conditions, we have recently implemented the Visible Burrow System (VBS), a 
highly social habitat that may provide useful insights in group-housed social dynamics in a 
translational way. Recently, we have shown the suitability of the VBS to investigate social 
withdrawal features and their underlying neurobiology in a mouse model for ASD-like behavioural 
phenotypes. In this study we investigated for the first time mixed-genotype colonies in the VBS. In 
particular, we evaluated sociability and social withdrawal features in Pcdh9 Wild Type (WT), 
Heterozygous (HET) and Homozygous (HOM) gene knockout (KO) mice, housed together in VBS. In 
light of the known sensory deficits in this genetic mouse model, we also investigated GABAergic 
and glutamatergic alterations in the somatosensory cortex of Pcdh9 WT, KO HET and KO HOM 
mice. In this preliminary study, our results reported no differences in terms of social behaviours 
and non-social behaviours among the three genotypes. Moreover, no genotype differences were 
detected in GABA content in somatosensory cortex, for both standard housing condition and VBS 
colony housing. Interestingly, glutamate levels were significantly increased in Pcdh9 KO HOM mice 
housed in standard cages, while this increase was not found in HOM Pcdh9-deficient mice housed 
in the VBS, suggesting a beneficial effect of this highly social environment on glutamate increase 
induced by Pcdh9 genetic ablation. In conclusion the VBS, beyond its employment as a tool to 
assess sociability in a translational way, might be further used as a behavioural paradigm to test 
pharmacological treatments aiming at restoring social dysfunctions commonly occurring in several 
neuropsychiatric disorders, such as social withdrawal. 
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5.1 Introduction 
Mental disorders are defined and classified in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM–5), edited by the American Psychiatric Association (APA), in order to improve 
diagnoses, treatments and researches (www.apa.org, APA website). The burden of mental 
disorders is continuously growing with significant impacts on health in all countries of the world 
(www.apa.org, APA website). During the last decades, diagnosis in psychiatry only focused on 
subjective symptoms and observable signs (Goodkind et al., 2015). Although symptoms are an 
important starting point, genetics and neurobiology underlying these symptoms need to be deeply 
investigated. Interestingly, genetic and clinical analyses found similarities across a wide variety of 
diagnoses, suggesting that a common neurobiological substrate across mental illnesses might exist 
(Goodkind et al., 2015). In addition, genetic analyses have identified common polymorphisms 
associated with a large range of neuropsychiatric diseases and comorbidity among them is 
considerably higher than expected (Brugger & Howes, 2017). Moreover, several mental diseases, 
such as schizophrenia, Autism Spectrum Disorders (ASD), Alzheimer’s disease, anxiety disorders 
and major depression diseases, share a number of common symptoms, especially regarding the 
social sphere (Goodkind et al., 2015).  
In this context, disrupted sociability and consequent social withdrawal are recently receiving great 
attention as important symptoms that deeply affect the quality of life in neuropsychiatric patients. 
However, the pathophysiology underlying these symptoms still need to be fully elucidated and 
current treatments are not able to improve these relevant behavioural alterations (Wilson & 
Koenig, 2014).  
Furthermore, rodents can be a helpful tool to study behavioural alterations related to 
neuropsychiatric diseases and their underlying neurobiology and genetics. In this regard, to assess 
behavioural alterations in a translational way, habitats mimicking the natural environment in 
which group-housed dynamics can be deeply analyzed might be highly useful. In our study, we 
implemented a modified version of the Visible Burrow System (VBS), a semi-natural habitat 
providing burrows and an open area for mixed-sex rodent colonies, developed by Blanchard group 
(D. C. Blanchard et al., 2012; D. C. Blanchard et al., 1995; R. J. Blanchard, Dulloog, et al., 2001).  
Moreover, considering the important role of genetic factors in the development of mental 
diseases, genetic manipulation in rodents can help to obtain suitable models resembling human 
neuropsychiatric symptoms. In this context, cadherin superfamily, originally characterized as 
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calcium-dependent cell-adhesion molecules, is now known to be involved in many biological 
processes, including cell recognition, cell signaling during embryogenesis and formation of neural 
circuits (Morishita & Yagi, 2007). In particular, protocadherin family, the largest subgroup within 
the cadherin superfamily, are predominantly expressed in the nervous system.  Interestingly, 
recent evidence suggested that Protocadherin 9 (Pcdh9) is involved in sensory processing deficits 
and impaired social interaction (Bruining et al., 2015) that may be relevant in a wide variety of 
neuropsychiatric disorders, such as schizophrenia and ASD pathogenesis (Hirabayashi & Yagi, 
2014; Morishita & Yagi, 2007). Moreover, Xiao and colleagues reported that the gene encoding 
Pcdh9 might be considered as a novel risk factor for Major Depressive Disorder (MDD) (Xiao, 
Zheng, et al., 2017). 
In view of the sensory processing deficits that have been observed in Pcdh9 deficient mice, 
glutamate is the excitatory neurotransmitter of the thalamocortical inputs to the primary visual, 
auditory and somatosensory cortices, thus it is crucial for the cortical hierarchic structure 
controlling the interactions with the environment (Tecchio et al., 2011). Indeed, thalamocortical 
relay neurons receive ascending and descending glutamatergic excitatory inputs and are subjected 
to GABAergic inhibitory input which shapes the sensory information conveyed to the cortex 
(Vahle-Hinz, Detsch, Siemers, & Kochs, 2007).  
In this study we investigated for the first time mixed-genotype colonies in VBS. In particular, we 
evaluated sociability and social withdrawal features in Pcdh9 Wild Type (WT), KO heterozygous 
(HET) and KO homozygous (HOM) mice, housed together in VBS. We also investigated GABAergic 
and glutamatergic alterations in the somatosensory cortex of Pcdh9 WT, KO HET and KO HOM 
mice. 
 
5.2 Materials and Methods 
Animals 
Adult Pcdh9 WT, KO HET and KO HOM male and female mice aged 14-22 weeks were used in this 
study. Animals were bred in the animal facilities of the University of Groningen. Animals were 
housed in standard polypropylene cages, 34 cm x 18 cm x 14 cm, in a group of two mice in a 
temperature-controlled room (temperature 21 ± 2 °C). All subjects were maintained on a 12-h 
light/dark cycle, with access to water and standard chow ad libitum in their home cages. All 
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procedures were conducted in accordance with protocols approved by the University of 
Groningen.  
Generation and Breeding of Pcdh9-Knockout Mice 
Pcdh9-deficient mice were generated using a standard procedure (Bruining et al., 2015). Briefly, a 
targeting vector was designated to delete the second exon of the mouse Pcdh9 gene, which 
encodes extracellular, transmembrane, and part of cytoplasmic domains. The targeting vector was 
constructed by using RPCI-23BAC library (Genetycs, Tsukuba). The 17.2-kb genomic DNA fragment 
was cloned into pBRSDT. The 5’ homology arm was a HindIII/SacI-digested 8.7-kb fragment, and a 
floxed PGK-neo positive selection marker was placed at its downstream. The 3’ homology arm was 
a SacI/NheI-digested 8.8-kb fragment, and a diphtheria toxin A fragment containing a poly-A signal 
was added as a negative selection marker. We obtained homologous recombinants using TT-2 
embryonic stem cells. Mice possessing the neo cassette were produced using standard procedures 
for chimeric mouse production. Successful gene targeting was confirmed by Southern blot 
analysis. The isogenic mice were then used to generate time-mated HET breeding pairs to obtain 
WT and mutant mice from at least three different litters to mimic the background of the parental 
CSS14 and C57BL/6J controls. Chimeric mice were crossed to C57BL/6J females. Initially, F1 hybrids 
from HET matings were generated. Repeated backcrossing with C57BL/6J mice (>10 generations) 
was conducted to ensure an isogenic C57BL/6J background (Bruining et al., 2015). For the Pcdh9 
KO and WT mice all analyses were performed blind for Pcdh9 genotype. 
Genotyping 
Total RNA was isolated from mouse ear clips according to the manufacturer’s instructions using 
the TRIzol procedure (BoomLab, Meppel, The Netherlands). RNA concentrations and purity were 
measured with a NanoDrop® spectrophotometer (Thermo Scientific, Eindhoven, The Netherlands). 
For conversion into cDNA, the cDNA Synthesis Kit (BoomLab, Meppel, The Netherlands) was used 
and the reverse transcription reaction was performed in a thermocycler (PTC-200, MJ Research) 
with a 3-step program: 10 min at 25°C followed by 60 min at 42°C and a final 5 min step at 85°C. 
The machine was set to cool down automatically to 4°C after the end of the final step. cDNA 
samples were then used immediately for Real-Time PCR. Real-Time PCR was performed by using 
DreamTaq polymerase in accordance with the manufacturer’s instructions (Thermo Scientific, 
Eindhoven, The Netherlands). For the target genes the primers used were Pcdh9R1 (5’- 
ACCAGTCTGTAGACAAGGCT -3’), Pcdh9R22 (5’- TACCCGGTAGAATTGACCTGCAG -3’), Pcdh9F1 (5’- 
90 
 
GTGGCTGTCTCCACATAAGA -3’). The mixture was prepared by adding the cDNA sample, followed 
by dNTP mix (Thermo Scientific, Eindhoven, The Netherlands) and 10X primers for the target 
genes. The samples were then placed in thermal cycler machine and run following thermal cycling 
conditions: step 1: 94°C for 2 min, step 2: 94°C for 30 sec, step 3: 60°C for 45 sec, step 4: 72°C for 1 
min, step 5: from step 2, 32x times, step 6: 72°C for 7 min, step 7: 10°C until the end. At the end of 
the reaction, the PCR mixture was loaded with 6x loading dye and run together with a DNA Marker 
on 1.5% agarose gel for electrophoresis (approx. 30 minutes at 90V). The following profiles can be 
expected: 350bp: Pcdh9 WT; 350bp and 500bp: Pcdh9 KO HET; 500bp: Pcdh9 KO HOM.   
Apparatus 
The VBS’ were built in-house at the University of Groningen, based on the design by Blanchard et 
al. (D. C. Blanchard et al., 1995). Extra chambers (nests) were added to better study the social 
dynamics. The system consisted of two parts: an open arena (50cm x 50cm) with two stations 
where animals had access to food and water ad libitum, and a burrow (50cm x 25cm) with 4 
chambers and a corridor. The open arena was subjected to a 12:12 L/D cycle (ZT0 at 08:00, see 
figure 3) and was open to the outside. The burrow of the VBS was closed using a polycarbonate lid 
that functioned as an infrared-pass filter. Thus the burrow was in complete darkness at all time, 
resembling the natural environment. Within the burrow 2 big chambers (7,5cm x 12,5cm) and 2 
small chambers (7,5cm x 7,5cm) were placed with a tunnel connecting them to each other and to 
the open arena (see Figure 1). Behaviour in the VBS was recorded using a Bassler Cam GigE 
monochrome infrared sensitive camera (acA1300-60gm). Thus, due to its infrared sensitivity, the 
camera not only recorded behaviour in the open arena, but also could capture behaviour in the 
burrow through the polycarbonate lid. 
 
 
 
 
 
 
91 
 
 
Figure 1 The modified Visible Burrow System 
 
Experimental procedures 
Animals were placed in the experimental room two weeks before the start of the experiments. 
Each colony consisted of 6 male mice, 2 Pcdh9 WT, 2 Pcdh9 KO HOM and 2 Pcdh9 KO HET, and 2 
Pcdh9 WT female mice. Every colony contained no more than 2 littermates. Females were used to 
mimic the natural group-housed conditions in rodents. Females were previous sterilized by 
legating the oviducts and leaving the ovaries intact in order to maintain the estrous cycle. Estrous 
cycle was monitored every day before the start of the experiments. Two days before the start of 
the experiment males were marked with a commercial crème-based hair dye (Garnier Olia B++ 
Super blonde) to facilitate individual recognition of the animals. Animals were housed in the 
system for 8 days. During the experiment, the animals were recorded continuously. The animals 
were weighted at the beginning and at the end of the experiment in order to leave them 
undisturbed in the system. We performed and analyzed a total of 3 mixed-genotypes colonies. 
Behavioural ethogram 
Social and non-social behaviours scored are described in Table 1. 
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Table 1 
Behavioural ethogram describing all the different behaviour scored. 
 
 
Behavioural analyses 
Behaviour was analyzed using The Observed 13 XT (Noldus Information Technology, Wageningen, 
The Netherlands). Each colony was observed for 10 minutes of six hours divided over the day. The 
six hours were previously tested and then selected for their representation of the full day and to 
cover most of the activity phase of the animals. The first 10 minutes of these hours were tested for 
their accuracy in representing the full hour. A total of 3 mixed-genotype Pcdh9 colonies were 
scored manually for 5 days. Frequency and duration in seconds of every behaviour were scored for 
every 10 minutes of each of the chosen six hours and data were showed as frequency per day and 
BEHAVIOURS DESCRIPTION 
Social Exploration Sniffing another animal, following another animal, playing with another animal 
Approach Moving towards another animal 
Aggression When the subject is biting, chasing, fighting other animals 
Avoidance 
submissive and avoidance behaviour. Submissive 
reactions to aggressive behaviour (i.e. not fighting 
back/surrendering). Also moving/running away from 
aggressive encounters and social 
contact/approaches 
Huddling 
Resting/huddling while in contact with conspecifics. 
When the subject resumes activity for more than 5 
seconds, behaviour is not considered part of 
resting/huddling 
Sexual activity Mounting Female  
Passive/Receiving social contact 
Receiving social contact is scored when an animal 
does not react to social exploration of another 
animal (i.e. passive social interaction) 
Allogrooming When an animal is grooming another animal 
Autogrooming When an animal is grooming itself 
Feeding/Drinking Feeding/drinking from the feeding station 
Environmental Exploration 
Animal explores the surrounding environment, 
behaviour is not aimed towards another animal. 
(e.g. digging, locomotion, sniffing the walls) 
Alone Inactivity  
Resting whilst not being in bodily contact with 
another animal. When the subject resumes activity 
for more than 5 seconds, behaviour is not 
considered part of resting 
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time spent per day. The data of the 5 days scored were summed and showed in the overall 
behaviour in order to analyze strain differences.  
Post mortem analyses 
After 8 days of VBS colony housing, mice were immediately euthanized by cervical dislocation and 
brains were collected, frozen in isopentane and stored at -80⁰C. 
For the standard-housed measurements, 4 adult Pcdh9 KO HET, KO HOM and WT male mice, 
housed in standard cages, two per cage, were euthanized, brains were collected, frozen in 
isopentane and stored at -80⁰C. 
HPLC quantifications 
GABA and glutamate concentrations in somatosensory cortex were determined by HPLC using 
ODS-3 column (150 × 4.6 mm, 3 µm; INERTSIL) with fluorescence detection after derivatization 
with ophthalaldehyde/mercaptopropionic acid (emission length, 4.60 nm; excitation length, 3.40 
nm). The mobile phase gradient consisted of 50 mM sodium acetate buffer, pH 6.95, with 
methanol increasing linearly from 2 to 30% (v/v) over 40 min. The flow rate was maintained by a 
pump (JASCO, Tokyo, Japan) at 0.5 ml/min. Results were analyzed by Borwin software (version 
1.50; Jasco) and substrate concentration was expressed as µM. 
Statistical analyses 
Frequency and duration of each behaviour were tested for normality and then analyzed per day 
using Two-way ANOVA for repeated measures followed by a Bonferroni’s post-hoc test. 
Differences in the overall behaviour and neurochemical data were tested for normality and then 
analyzed using One-way ANOVA followed by Bonferroni’s post-hoc test. Results were expressed as 
mean ± S.E.M. Statistical analyses were performed using Graph Pad 5.0 (GraphPad Software, San 
Diego, CA) for Windows. Differences were considered statistically significant when P value was less 
than 0.05. 
 
5.3 Results 
In order to evaluate Pcdh9 genotype differences, we analyzed mixed-sex colonies formed by 2 
Pcdh9 WT, 2 Pcdh9 KO HET and 2 Pcdh9 KO HOM males, with 2 Pcdh9 WT females, housed 
together in VBS. Moreover, we measured GABA and glutamate content in the somatosensory 
cortex of mice housed in the VBS colonies and mice housed in standard cages, for the three 
different genotypes, respectively. 
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Social behaviours in mixed-genotype VBS colonies  
We scored social exploration, huddling, aggression and sexual activity as social behaviours, for 
both frequency and duration. In particular, we found that duration and frequency of social 
exploration during the daily scoring and the overall were not significantly different among the 
three groups (Fig. 2A, Two-way ANOVA RM followed by Bonferroni, n.s.; Fig. 2B One-way ANOVA 
followed by Bonferroni, n.s.; Fig. 2C, Two-way ANOVA RM followed by Bonferroni, n.s.; Fig. 2D 
One-way ANOVA followed by Bonferroni, n.s.). In addition, our results did not show any difference 
in terms of huddling behaviour among the different genotypes, for both frequency and duration 
(Fig. 2E, Two-way ANOVA RM followed by Bonferroni, n.s.; Fig. 2F One-way ANOVA followed by 
Bonferroni, n.s.; Fig. 2G, Two-way ANOVA RM followed by Bonferroni, n.s.; Fig. 2H One-way 
ANOVA followed by Bonferroni, n.s.). Moreover, there were no differences in time spent 
performing aggression, and also in frequency of aggression, among Pcdh9 KO HOM, KO HET and 
WT (Fig. 2I, Two-way ANOVA RM followed by Bonferroni, n.s.; Fig. 2J One-way ANOVA followed by 
Bonferroni, n.s.; Fig. 2K, Two-way ANOVA RM followed by Bonferroni, n.s.; Fig. 2L One-way ANOVA 
followed by Bonferroni, n.s.). Ultimately, we did not find significant differences in time spent and 
frequency of sexual activity (Fig. 2M, Two-way ANOVA RM followed by Bonferroni, n.s.; Fig. 2N 
One-way ANOVA followed by Bonferroni, n.s.; Fig. 2O, Two-way ANOVA RM followed by 
Bonferroni, n.s.; Fig. 2P One-way ANOVA followed by Bonferroni, n.s.). 
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Figure 2 Duration and frequency of social behaviours in mixed-genotype Pcdh9 colonies. Time spent performing social 
exploration per day (A) in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 WT (black line) mice. Two-way 
ANOVA RM followed by Bonferroni, n.s. Overall time spent performing social exploration (B) in Pcdh9 KO HOM (white 
bar), KO HET (gray bar) and WT (black bar) mice. One-Way ANOVA followed by Bonferroni, n.s. Frequency of social 
exploration per day (C) in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 WT (black line) mice. Two-way 
ANOVA RM followed by Bonferroni, n.s. Overall frequency of social exploration (D) in Pcdh9 KO HOM (white bar), KO 
HET (gray bar) and WT (black bar) mice. One-Way ANOVA followed by Bonferroni, n.s. Time spent performing 
huddling per day (E) in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 WT (black line) mice. Two-way ANOVA 
RM followed by Bonferroni, n.s. Overall time spent performing huddling (F) in Pcdh9 KO HOM (white bar), KO HET 
(gray bar) and WT (black bar) mice. One-Way ANOVA followed by Bonferroni, n.s. Frequency of huddling per day (G) 
in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 WT (black line) mice. Two-way ANOVA RM followed by 
Bonferroni, n.s. Overall frequency of huddling (H) in Pcdh9 KO HOM (white bar), KO HET (gray bar) and WT (black bar) 
mice. One-Way ANOVA followed by Bonferroni, n.s. Time spent performing aggression per day (I) in Pcdh9 KO HET 
(red line), KO HOM (blue line) and Pcdh9 WT (black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. 
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Overall time spent performing aggression (J) in Pcdh9 KO HOM (white bar), KO HET (gray bar) and WT (black bar) 
mice. One-Way ANOVA followed by Bonferroni, n.s. Frequency of aggression per day (K) in Pcdh9 KO HET (red line), KO 
HOM (blue line) and Pcdh9 WT (black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. Overall frequency 
of aggression (L) in Pcdh9 KO HOM (white bar), KO HET (gray bar) and WT (black bar) mice. One-Way ANOVA followed 
by Bonferroni, n.s. Time spent performing sexual activity per day (M) in Pcdh9 KO HET (red line), KO HOM (blue line) 
and Pcdh9 WT (black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. Overall time spent performing 
sexual activity (N) in Pcdh9 KO HOM (white bar), KO HET (gray bar) and WT (black bar) mice. One-Way ANOVA 
followed by Bonferroni, n.s. Frequency of sexual activity per day (O) in Pcdh9 KO HET (red line), KO HOM (blue line) 
and Pcdh9 WT (black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. Overall frequency of sexual activity 
(P) in Pcdh9 KO HOM (white bar), KO HET (gray bar) and WT (black bar) mice. One-Way ANOVA followed by 
Bonferroni, n.s. Data are expressed as mean ± SEM (n=6 per group). 
Non-social behaviours in mixed-genotype VBS colonies  
We scored environmental exploration, alone inactivity, avoidance and passive/receiving social 
contact as non-social behaviours, for both frequency and duration. In particular, we found that 
duration and frequency of environmental exploration during the daily scoring and the overall were 
not significantly different among the three groups (Fig. 3A, Two-way ANOVA RM followed by 
Bonferroni, n.s.; Fig. 3B One-way ANOVA followed by Bonferroni, n.s.; Fig. 3C, Two-way ANOVA 
RM followed by Bonferroni, n.s.; Fig. 3D One-way ANOVA followed by Bonferroni, n.s.). In 
addition, our results did not show any difference in terms of alone inactivity among the different 
genotypes, for both frequency and duration (Fig. 3E, Two-way ANOVA RM followed by Bonferroni, 
n.s.; Fig. 3F One-way ANOVA followed by Bonferroni, n.s.; Fig. 3G, Two-way ANOVA RM followed 
by Bonferroni, n.s.; Fig. 3H One-way ANOVA followed by Bonferroni, n.s.). Moreover, there were 
no differences in time spent performing avoidance behaviour, and also in frequency of avoidance, 
among Pcdh9 KO HOM, KO HET and WT (Fig. 3I, Two-way ANOVA RM followed by Bonferroni, n.s.; 
Fig. 3J One-way ANOVA followed by Bonferroni, n.s.; Fig. 3K, Two-way ANOVA RM followed by 
Bonferroni, n.s.; Fig. 3L One-way ANOVA followed by Bonferroni, n.s.). Ultimately, we did not find 
significant differences in time spent and frequency of passive/receiving social contact behaviour 
(Fig. 3M, Two-way ANOVA RM followed by Bonferroni, n.s.; Fig. 3N One-way ANOVA followed by 
Bonferroni, n.s.; Fig. 3O, Two-way ANOVA RM followed by Bonferroni, n.s.; Fig. 3P One-way 
ANOVA followed by Bonferroni, n.s.). 
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Figure 3 Duration and frequency of non-social behaviours in mixed-genotype Pcdh9 colonies. Time spent performing 
environmental exploration per day (A) in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 WT (black line) mice. 
Two-way ANOVA RM followed by Bonferroni, n.s. Overall time spent performing environmental exploration (B) in 
Pcdh9 KO HOM (white bar), KO HET (gray bar) and WT (black bar) mice. One-Way ANOVA followed by Bonferroni, n.s. 
Frequency of environmental exploration per day (C) in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 WT 
(black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. Overall frequency of environmental exploration (D) 
in Pcdh9 KO HOM (white bar), KO HET (gray bar) and WT (black bar) mice. One-Way ANOVA followed by Bonferroni, 
n.s. Time spent performing alone inactivity per day (E) in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 WT 
(black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. Overall time spent performing alone inactivity (F) 
in Pcdh9 KO HOM (white bar), KO HET (gray bar) and WT (black bar) mice. One-Way ANOVA followed by Bonferroni, 
n.s. Frequency of alone inactivity per day (G) in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 WT (black line) 
mice. Two-way ANOVA RM followed by Bonferroni, n.s. Overall frequency of alone inactivity (H) in Pcdh9 KO HOM 
(white bar), KO HET (gray bar) and WT (black bar) mice. One-Way ANOVA followed by Bonferroni, n.s. Time spent 
performing avoidance per day (I) in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 WT (black line) mice. Two-
way ANOVA RM followed by Bonferroni, n.s. Overall time spent performing avoidance (J) in Pcdh9 KO HOM (white 
bar), KO HET (gray bar) and WT (black bar) mice. One-Way ANOVA followed by Bonferroni, n.s. Frequency of 
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avoidance per day (K) in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 WT (black line) mice. Two-way ANOVA 
RM followed by Bonferroni, n.s. Overall frequency of avoidance (L) in Pcdh9 KO HOM (white bar), KO HET (gray bar) 
and WT (black bar) mice. One-Way ANOVA followed by Bonferroni, n.s. Time spent performing passive/receiving 
social contact per day (M) in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 WT (black line) mice. Two-way 
ANOVA RM followed by Bonferroni, n.s. Overall time spent performing passive/receiving social contact (N) in Pcdh9 
KO HOM (white bar), KO HET (gray bar) and WT (black bar) mice. One-Way ANOVA followed by Bonferroni, n.s. 
Frequency of passive/receiving social contact per day (O) in Pcdh9 KO HET (red line), KO HOM (blue line) and Pcdh9 
WT (black line) mice. Two-way ANOVA RM followed by Bonferroni, n.s. Overall frequency of passive/receiving social 
contact (P) in Pcdh9 KO HOM (white bar), KO HET (gray bar) and WT (black bar) mice. One-Way ANOVA followed by 
Bonferroni, n.s. Data are expressed as mean ± SEM (n=6 per group). 
Increased glutamate content in somatosensory cortex in standard-housing conditions, but not in 
VBS colony housing 
We measured GABA and glutamate content in the somatosensory cortex of mixed-genotype VBS 
colonies and Pcdh9 WT, KO HET and KO HOM mice housed in standard cages, in order to 
investigate genotype differences. 
Our results showed that no genotype differences were detected in GABA content in standard-
housed mice (Fig. 4A, One-way ANOVA followed by Bonferroni, n.s.), while there was a significant 
increase in glutamate levels in somatosensory cortex of Pcdh9 KO HOM compare to KO HET and 
WT mice (Fig. 4B, One-way ANOVA followed by Bonferroni, F=15.72, P<0.01 KO HOM vs. KO HET 
and WT). Moreover, we did not found any difference in GABA and glutamate contents in 
somatosensory cortex among the three different groups (Fig. 4C-D, One-way ANOVA followed by 
Bonferroni, n.s.). 
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Figure 4 Effect of VBS colony housing on GABA and glutamate levels in somatosensory cortex of Pcdh9 KO HOM, HET 
and WT mice. GABA (A) levels in somatosensory cortex of Pcdh9 WT (white bar), KO HET (gray bar) and KO HOM 
(black bar) mice housed in standard cages. One-Way ANOVA followed by Bonferroni, n.s. Glutamate (B) levels in 
somatosensory cortex of Pcdh9 WT (white bar), KO HET (gray bar) and KO HOM (black bar) mice housed in standard 
cages.  One-Way ANOVA followed by Bonferroni, **p<0.01 vs. WT, ##p<0.01 vs. KO HET. GABA (C) and glutamate (D) 
levels in somatosensory cortex of Pcdh9 WT (white bar), KO HET (gray bar) and KO HOM (black bar) mice housed in 
VBS colonies. One-Way ANOVA followed by Bonferroni, n.s. 
 
5.4 Discussion 
In the present study, we investigated social dynamics in mixed-genotype and mixed-sex Pcdh9 
colonies in the VBS paradigm. Our preliminary analysis showed that there were no differences in 
terms of social behaviours and non-social behaviours among the three genotypes, for both 
duration and frequency. Additional analyses (e.g., including the implementation of location data 
and increasing the number of colonies tested) are needed to further strengthen these data. 
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Moreover, no genotype differences were detected in GABA content in somatosensory cortex, for 
both standard housing condition and VBS colony housing. Interestingly, glutamate levels were 
significantly increased in Pcdh9 KO HOM mice housed in standard cages, while this increase was 
not found in HOM Pcdh9-deficient mice housed in the VBS. 
We investigated social and non-social behaviours in mixed-sex and mixed-genotype colonies, using 
a modified VBS version, with four nests in a continuously dark burrow and a large open arena, 
mimicking the natural rodent housing condition. In addition, we housed together Pcdh9 WT and 
KO HET and HOM animals, aiming to analyze genotype differences.  
In particular, our results did not show genotype differences in social exploration, huddling, 
aggression and sexual activity. Thus, there were no differences in terms of social behaviours 
duration and frequency. Moreover, also non-social behaviours, in particular environmental 
exploration, alone inactivity, avoidance and passive/receiving social contact, did not show any 
significant genotype difference. 
Interestingly, Pcdh9 has been recently identified as an interesting candidate gene associated with 
ASD (Hirabayashi & Yagi, 2014; Morishita & Yagi, 2007). In this regard, Bruining and colleagues 
demonstrated that HOM Pcdh9-deficient mice show specific deficits in long-term social 
recognition, accompanied by additional impairments in sensorimotor development reflected by 
early touch-evoked biting, rotarod performance, and sensory gating deficits (Bruining et al., 2015). 
However, the recognition deficits in Pcdh9 KO mice were not associated with alterations in 
perception, multi-trial discrimination learning, sociability, behavioral flexibility or fear memory 
(Bruining et al., 2015). In line with our results, also Bruining and colleagues did not found genotype 
differences in three-chamber test, the most used dyadic test to assess sociability in rodents.  
However, we did not investigated sociability in a standard environment or social behaviours 
among Pcdh9 colonies composed by the same genotype, thus future studies are required to better 
understand HOM Pcdh9 KO social phenotype without the presence of social stimuli. Indeed, VBS 
colonies formed by mixed-genotype and mixed-sex mice are considered highly social environment, 
hence we hypothesized that strong social stimuli might be helpful to improve probable social 
deficits.  
Social deficits are an important core symptoms of ASD and schizophrenia. The positive effect of 
the social stimuli in the mixed-genotype VBS colonies might reflect the importance of the 
behavioural therapy in patients. In accordance with our hypothesis, occupational therapists, 
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together with teachers, support autistic student participation in classrooms in order to stimulate 
sociability and increase socialization (Mills & Chapparo, 2017). Moreover, a recent study reported 
that trained parents, working together with their children, are able to improve their social skills 
(Dogan et al., 2017), suggesting the beneficial effects that social stimuli can have.  
Furthermore, social deficits, in particular social withdrawal and anhedonia, are considered 
negative symptoms of schizophrenia. These symptoms, associated with cognitive (such as 
attention and memory deficits) and positive symptoms (such as delusions and hallucinations) 
significantly impair patients’ personal and professional lives (Balhara & Verma, 2012). In particular, 
negative symptoms often lead to homelessness and are thought to be the primary driver for 
suicide in schizophrenics (Balhara & Verma, 2012). 
In addition, a number of clinical evidence support the importance of employment among 
schizophrenic patients (Carmona, Gomez-Benito, Huedo-Medina, & Rojo, 2017; Llerena, Reddy, & 
Kern, 2017; Martini et al., 2017). In particular, work is considered one of the main forms of social 
organization and few individuals with mental illnesses find work opportunities (Martini et al., 
2017). In an interesting clinical study, it has been reported that negative symptoms hinder job 
obtainment and work outcomes in people with schizophrenia, rather than cognitive and positive 
symptoms, thus an enhanced understanding of the domains of negative symptoms is vital in order 
to develop treatments that translate into better employment outcomes (Llerena et al., 2017). 
Antipsychotic pharmacotherapy has shown some success in alleviating positive symptoms, 
although treatment options for negative and cognitive symptoms remain very limited. 
Consequently, there is an urgent need to decipher the underlying causes of these symptoms and 
develop new pharmacological strategies. 
In this regard, we have previously shown the suitability of VBS to investigate social withdrawal 
features and their underlying neurobiology in a mice model of ASD (Bove et al., submitted). 
Thus, we quantified GABA and glutamate content in somatosensory cortex of Pcdh9 WT, HOM KO 
and HET KO housed in VBS colonies and in standard cages. Our results showed that there were no 
differences in GABA content among the three genotypes in both VBS colonies and standard 
housing condition. Otherwise, glutamate was significantly increased only in HOM Pcdh9-deficient 
mice housed in standard cages, while no genotype differences were found in glutamate levels 
among VBS colonies. In this regard, it has been reported that altered glutamate transmission is a 
common feature of many neuropsychiatric conditions, including schizophrenia (O'Donovan, 
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Sullivan, & McCullumsmith, 2017). Moreover, a number of neuropsychiatric diseases associated to 
schizophrenia-like symptoms are characterized by alterations in sensory processing and 
perception (Gonzalez-Maeso et al., 2008). In addition, recent evidence reported that drugs 
interacting with metabotropic glutamate receptors show potential for the treatment of 
neuropsychiatric diseases (Aghajanian & Marek, 2000; Marek, 2004; Patil et al., 2007). Thus, 
glutamate neurotransmission in somatosensory cortex area might participate to the development 
of schizophrenia-like symptoms. Interestingly, a recent evidence reported that a plant-derived 
compound was able to reduce glutamate-evoked excitotoxicity in the somatosensory cortex acting 
through the inhibition of non-NMDA glutamate receptors (Borbely et al., 2016). Thus, attenuation 
of glutamatergic tone might represent a new treatment strategy in different brain diseases, such 
as schizophrenia, autism, bipolar disorders, major depression and mental retardation (Contractor, 
Mulle, & Swanson, 2011).  
Intriguingly, the VBS, beyond its employment as a tool to assess sociability in a translational way, 
might also be used as a behavioural paradigm to further test pharmacological treatments aiming 
at restoring social dysfunctions commonly occurring in several neuropsychiatric disorders, such as 
social withdrawal.  
To the best of our knowledge, this is the first study that evaluated mixed-genotype colonies in 
VBS. In particular, we showed no differences in sociability and social withdrawal features among 
Pcdh9 WT, KO HOM and KO HET, indicating no disrupted sociability of Pcdh9-deficient mice when 
housed together with WT in the VBS. Moreover, the glutamate increase found in HOM Pcdh9-
deficient mice housed in standard cages was not retrieved in VBS colony housing, suggesting a 
beneficial effect of this highly social environment on glutamate increase induced by Pcdh9 genetic 
ablation. 
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CHAPTER 6 
General discussion 
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In the present thesis, different animal models and behavioural alterations resembling human 
depressive-like symptoms shared across neuropsychiatric diseases have been investigated. In 
addition, we evaluated the neurobiological changes underlying these symptoms, with a focus on 
the analyses of monoamine and aminoacids neurotransmission, Hypothalamic-Pituitary-Adrenal 
(HPA) axis parameters and Nerve Grow Factor (NGF) levels. Our results showed that different 
neurobiological determinants are involved in the etiology of depressive-like symptoms, depending 
on several aspects, such as comorbidity, lifestyle, social, environmental and dietary factors. 
As regarding dietary factors, the influence of Polyunsaturated Fatty Acids (PUFA) on depressive-
like states has received great attention during the last decades. In this context, modern Western 
diets, characterized by low fish consumption in favour of more baked and junk food, have become 
particularly rich in n-6 PUFA and extremely poor in n-3 PUFA. To assess the consequences of this 
unbalanced n-6/n-3 PUFA ratio, in chapter 2 and 3 we investigated the effects of n-3 PUFA 
deficiency in adult female offspring. Since several studies reported that depression is more 
prevalent in women compared to men (Gorman, 2006; Kokras et al., 2015; Marcus et al., 2005) 
and that women are more likely to experience comorbid anxiety and depression in response to 
chronic stress, we focused our attention on female animals (Takahashi et al., 2017). Although the 
reasons of this gender difference are not fully understood yet, it has been reported that women 
show different responses to sex hormones, which might ultimately influence behaviour and brain 
functions (Marrocco & McEwen, 2016). In addition, it has been reported that estrogens stimulate 
the conversion of essential fatty acids into their longer chain metabolites, such as α-linolenic acid 
conversion into docosahexanoic acid (DHA) (Burdge & Wootton, 2002; Giltay et al., 2004). DHA is a 
key n-3 PUFA involved in the Central Nervous System (CNS) development, and experimental 
evidence in animals has demonstrated that DHA deficiency during early brain development is 
deleterious and permanent (Lo Van et al., 2016; Lozada et al., 2017; Maekawa et al., 2017). In our 
experiments, we used adult female rats fed from conception with three different diets, a diet poor 
in n-3 PUFA (n-6/n-3 ratio of 20:1), a diet enriched in n-3 PUFA (n-6/n-3 ratio of 1:2) and a control 
diet (n-6/n-3 ratio of 5:1). Our results reported that chronic exposure to n-3 PUFA deficient diet 
leads to highly detrimental consequences in behavioural and neurochemical parameters related to 
depressive- and anxiety-like symptoms. From a behavioural point of view, we performed Forced 
Swimming Test (FST) and Open Field test.  In particular, in the FST, we found an increase in 
immobility and a decrease in swimming frequency in n-3 PUFA deficient females, suggesting that 
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n-3 PUFA deficiency is able to induce a depressive-like behaviour. Moreover, in the Open Field 
test, we showed an increase in time spent performing self-grooming and time spent in the 
periphery of the arena, both indexes of anxiety-like behaviour. Hence, our behavioural results 
showed that lifelong n-3 PUFA deficiency is able to elicit depressive- and anxiety-like symptoms in 
female rats. Therefore, we investigated neurochemical changes underlying these behavioural 
alterations. Firstly, we focused on monoamine systems commonly studied in depressive-like 
pathogenesis, measuring 5-HT and 5-HT metabolism, NA and DA. As regarding serotoninergic 
neurotransmission, we found a decrease in cortical 5-HT and an increase in 5-HT turnover in n-3 
PUFA deficient females. Therefore, we hypothesized that n-3 PUFA deficiency influences serotonin 
neurotransmission acting through the inflammatory pathways. Accordingly, McNamara and 
colleagues showed that n-3 PUFA deficiency was positively correlated with pro-inflammatory 
cytokine production, ultimately leading to an increase in central 5-HT turnover, while n-3 PUFA 
supplementation prevented this negative effect (McNamara et al., 2010). As regarding NA and DA, 
no differences in prefrontal cortex were detected among the different diets. Interestingly, we 
found an increase in amygdaloidal NA and 5-HT content in n-3 PUFA deficient females, suggesting 
that n-3 PUFA deficiency affects this brain area deeply related to stress, emotional and anxiety-like 
disorders. Indeed, hyperactivation of the amygdala following chronic stress is believed to be one 
of the primary mechanisms underlying the increased propensity for anxiety-like behaviours and 
pathological states (Hill et al., 2013). In accordance with our results, it has been demonstrated that 
stressors increase noradrenaline release in amygdala, leading to anxiety disorders induced by 
stress (Hakamata et al., 2017; Weidenfeld et al., 2002), and in addition, Johnson and colleagues 
showed that serotonin depletion in the basolateral amygdala led to a decrease in anxiety-like 
behaviour in social interaction and open field tests (Johnson et al., 2015). Hence, our results 
indicated that lifelong n-3 PUFA deficiency is able to evoke depressive and anxiety-like symptoms, 
affecting monoamine neurotransmissions, in particular NA, 5-HT and 5-HT turnover, not only in 
prefrontal cortex, but also in amygdala.  
Moreover, chronic stress and adverse lifestyle have been indicated as triggering and worsening 
factors for neuropsychiatric diseases development. In particular, chronic stress is considered an 
important risk factor for the development of depressive-like states (Lee & Rhee, 2017). In this 
regard, it has been widely demonstrated that the HPA axis becomes active in response to stress 
and recent studies found that higher cortisol concentrations during stressful conditions are 
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associated with high levels of anxiety and depression in children and adolescents (Herman & 
Tasker, 2016; Kallen et al., 2007). Interestingly, we found a deep alteration of the HPA axis 
pathway in n-3 PUFA deficient female rats, with a significant increase in hypothalamic NA and CRF 
and in plasmatic corticosterone. Accordingly, elevated cortisol levels and HPA axis dysregulation 
represent the most frequent alteration occurring in patients affected by major depressive disorder 
(Stetler & Miller, 2011).  
Furthermore, the central role of soluble Aβ peptide in stress response is becoming evident, 
although the exact biological mechanism leading to Aβ accumulation after stress challenges has to 
be fully elucidated yet (Morgese, Schiavone, et al., 2017). In this regard, increased CRF and 
glucocorticoid levels have been associated with high soluble Aβ levels (Catania et al., 2009; Dong & 
Csernansky, 2009; Morgese, Schiavone, et al., 2017). In addition, we have previously shown that 
Aβ central injection elicits HPA axis dysfunctions in male rats (Morgese et al., 2014).   
During the last decades, increasing evidence are pointing towards the emerging role of soluble Aβ 
in the pathophysiology of neurodegenerative illnesses, not only limited to Alzheimer’s disease. In 
addition, data from preclinical research have associated different risk factors for depression with 
increased soluble Aβ production in the brain (Catania et al., 2009; Schiavone, Tucci, et al., 2017). In 
this regard, our group has previously shown that central Aβ1-42 administration in male rats was 
able to evoke a depressive-like phenotype (Colaianna et al., 2010), characterized by increased 
immobility frequency in the FST and reduced cortical 5-HT. Thus, in this thesis, we administered 
for the first time the soluble Aβ peptide in female rats, confirming the depressive-like phenotype 
we found in males also in female animals. In particular, we found an increase in immobility and a 
decrease in swimming frequency in FST in female rats fed with the control diet, accompanied by a 
decrease in cortical 5-HT. Once the animal model of ab-induced depressive-like symptoms in 
females has been validated, we assessed the effect of n-3 PUFA enriched diet on Aβ -treated 
female rats. Interestingly, our results showed that n-3 PUFA lifelong supplementation was able to 
restore the Aβ -induce deficits in depressive-like behaviour in FST and the reduction in cortical 5-
HT, suggesting a protective role of n-3 PUFA towards the Aβ -induced depressive-like phenotype. 
Moreover, Aβ-treated females fed with n-3 PUFA enriched diet showed increased DA and NGF, 
endorsing the beneficial and potentially therapeutic effect of n-3 PUFA supplementation. In 
accordance with our results, observational studies evidenced that fish oil supplementation or 
increased n-3 PUFA blood levels are linked to reduced risk of cognitive decline and depression (P. 
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Y. Lin & Su, 2007; Vinot et al., 2011), and n-3 PUFA have been shown to ameliorate cognitive 
performances and neurodegenerative processes (Bo et al., 2017; Lauritzen et al., 2017; 
McNamara, Asch, Lindquist, & Krikorian, 2017). In addition, several studies supported the benefits 
of n-3 PUFA supplementation in the treatment of post partum depressive symptoms (Chong et al., 
2015; Sparling et al., 2017; Vaz et al., 2017).  
Interestingly, in our experiments n-3 PUFA supplementation showed differences in naïve females 
compared to Aβ treated animals, indicating a positive effect only in presence of Aβ-induced 
dysfunctions. These results endorse the hypothesis of a possible therapeutic use of n-3 PUFA 
supplementation, acting in synergy with antidepressants or even alone. 
Furthermore, we found an increase in plasmatic Aβ in n-3 PUFA deficient female rats, suggesting 
that soluble AB peptide might be involved in the pathogenesis of depressive-like symptoms and 
that, ultimately, might be used as a putative plasmatic biomarker for a number of neuropsychiatric 
diseases exhibiting depressive-like symptoms. 
Moreover, we found a decrease in cortical Nerve Grow Factor (NGF) levels in female rats fed with 
a diet poor in n-3 PUFA. Interestingly, clinical studies have detected reduced levels of NGF in 
patients with major depression when compared with healthy individual controls (Diniz et al., 2014; 
Xiong et al., 2011). In addition, treatment with certain antidepressants has increased NGF levels in 
both clinical and experimental studies (Hassanzadeh & Rahimpour, 2011; Wiener et al., 2015). 
Evidence from animal studies reported decreased levels of NGF in specific brain areas of different 
mouse models related to depression, such as anxiety disorders and stress-induced diseases (Y. W. 
Chen et al., 2015). In accordance with our results, Balogun et al. reported a decrease of NGF mRNA 
expression in C57BL/6J mice fed with low n-3 PUFA diet (Balogun & Cheema, 2014). Finally, NGF 
might contribute to the neurobiological mechanisms that give rise to depressive-like symptoms. 
Taken together, our data suggest that monoamine impairments, accompanied by NGF alterations 
and HPA axis dysfunctions might be considered as important neurobiological determinants 
contributing to the pathogenesis of depressive-like symptoms induced by n-3 PUFA deficiency and 
soluble ab administration.  
Furthermore, during last decades, a number of evidence suggested that altered function of the 
aminoacid neurotransmitter systems, especially gamma-aminobutyric acid (GABA) and glutamate 
systems, might contribute significantly to the etiopathogenesis of neuropsychiatric disorders 
(Sanacora, 2010). In this regard, we found a significant decrease in GABA and increase in 
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glutamate in both amygdala and prefrontal cortex of female rats fed with n-3 PUFA deficient diet 
compared to females fed with n-3 PUFA enriched diet. 
In accordance with our results, reduced GABA concentrations have been observed in plasma and 
cerebrospinal fluid of depressed patients (Bhagwagar & Cowen, 2008), and neuroimaging data has 
shown lowered levels of GABA in the occipital cortex of depressed subjects (Price et al., 2010). In 
addition, patients suffering from schizophrenia, depression, autism spectrum disorders (ASD) and 
bipolar disorders appear to have lowered central and peripheral GABA levels when compared to 
healthy controls (Lewis, 2014; Romeo et al., 2017). As regarding glutamatergic neurotransmission, 
it has been widely demonstrated the role of glutamate excitotoxicity in the pathogenesis of 
different mental illnesses, including schizophrenia, bipolar disorders, Alzheimer’s disease, anxiety-
related disorders and major depressive disease (Frisardi et al., 2011; Hashimoto et al., 2007; 
Ogawa et al., 2017). In addition, there are several studies suggesting that glutamate is elevated in 
plasma of depressed patients (Kendell et al., 2005). Furthermore, increasing preclinical evidence 
suggests that glutamate plays an important role in the activation of the HPA axis, by inducing the 
adrenocorticotropin hormone (Zelena et al., 2005).  
Therefore, our result indicated that GABA and glutamate tone are both involved in anxiety- and 
depressive-like symptoms induced by n-3 PUFA deficiency.  
On the other hand, recent studies showed that decreasing GABA led to decreased sociability 
(Paine et al., 2017). Thus, in order to deeply investigate depression core symptoms in a 
translational way, the social sphere need to be taken into account.  An important depressive-like 
symptom affecting the social sphere is social withdrawal. Social withdrawal, defined as lack of 
desire to have social contact, is an early symptom of a wide variety of neuropsychiatric diseases, 
including schizophrenia, ASD and major depression. In this regard, in chapter 4 and 5, we 
investigated behavioural alterations related to sociability and social withdrawal, using a 
behavioural paradigm called the Visible Burrow System (VBS). In order to fully evaluate social 
dysfunctions, a group-housed environment is needed, indeed the VBS is a semi-natural 
environment that mimic natural open spaces and burrows in order to analyze social dynamics that 
naturally occur in rodent colonies. Thus, we used the VBS to study C57BL/6J colonies as control 
strain and two different mutant lines, BTBR inbred strain and Pcdh9-deficient line. BTBR strain is a 
widely used strain for its similarities with human ASD deficits, such as repetitive behaviour, 
impaired communication and reduced social interactions (Cai et al., 2017; Yoshimura et al., 2017). 
109 
 
Pcdh9 gene KO mice have altered sensory information processing and social behaviour, 
phenotypes that are relevant across the neuropsychiatric spectrum (Hirabayashi & Yagi, 2014; 
Morishita & Yagi, 2007; Xiao, Zheng, et al., 2017). In particular, in chapter 4, we investigated social 
dynamics and studied social withdrawal features in BTBR and C57BL/6J colonies in the VBS 
paradigm. Our results showed that BTBR mice performed less social behaviours and have a 
preference for non-social behaviours compared to C57BL/6J mice in a group-housed mixed-sex 
environment. Although our results are in line with previous literature regarding BTBR strain and 
decrease of sociability (Meyza et al., 2015), this was the first study showing also an effective 
increase in non-social behaviours. In particular, our results reported a trend towards social 
withdrawal in BTBR mice, opening to a deep investigation of the underlying neurobiology that 
gives rise to this important symptom.  
Hence, our study validated the suitability of VBS as a behavioural paradigm to assess sociability 
and social withdrawal features, investigating mixed-sex group-housed dynamics in rodents. 
Interestingly, social withdrawal is also considered one of the core negative symptoms of 
schizophrenia (Seillier & Giuffrida, 2016, 2017). The negative symptoms of schizophrenia can be 
classified into primary negative symptoms, which are etiologically related to the pathophysiology 
of schizophrenia, and secondary negative symptoms, which result from other factors, such as 
positive symptoms, medication, depression and anxiety (Kirkpatrick, 2014). It has been 
demonstrated that the negative symptoms, such as blunted affect, alogia, social withdrawal, 
anhedonia and avolition, affect the patients’ quality of life more than positive symptoms and are 
more difficult to treat (Foussias & Remington, 2010; Hanson, Healey, Wolf, & Kohler, 2010). 
Consequently, there is an urgent need to unravel the underlying causes of these symptoms and 
develop new pharmacological strategies. 
In this regard, in chapter 5, we investigated VBS colonies composed of Pcdh9 HOM and HET KO 
and WT, in order to evaluate social features in Pcdh9-deficient mice. Interestingly, in this 
preliminary analysis we found no differences in terms of social behaviours and non-social 
behaviours among the three genotypes, indicating no disrupted sociability of Pcdh9-deficient mice 
when housed together with WT in the VBS. 
However, we did not investigated sociability in a standard environment or social behaviours 
among Pcdh9 colonies constituted by the same genotype, thus future studies are required to 
better understand HOM Pcdh9 KO social phenotype without the presence of social stimuli. Also, 
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the study was performed in a relatively low numbers of colonies, and will need expansion of this 
current data set. Indeed, VBS colonies formed by mixed-genotype and mixed-sex mice are 
considered highly social environment, and these strong social stimuli might be helpful improve 
putative social deficits.  
In conclusion, the VBS can be used as a tool to study behavioural dysfunctions and might be 
further used as a behavioural paradigm to test pharmacological treatments aiming at restoring 
social dysfunctions commonly occurring in several neuropsychiatric disorders, such as social 
withdrawal.  
However, VBS paradigm still has to be scored manually. This big disadvantage does not allow to 
track all the behaviour over the full period of time and thus the throughput is low. Further studies 
are currently being conducted to develop an automatic tracking system. The automatic system 
would also be helpful to investigate social networks, dominance and hierarchy within colonies. 
Furthermore, in order to investigate neurobiology behind sociability and social withdrawal, we 
analyzed GABA and glutamate content in prefrontal cortex and amygdala of C57BL/6J and BTBR 
colonies and we found a significant decrease of GABA and a significant increase of glutamate in 
both areas of BTBR mice. These results are in line with recent evidence suggesting that 
attenuation of GABA tone might result in the disruption of sociability (Paine et al., 2017). 
However, different social factors contribute to sociability dysfunctions, such as social motivation, 
social anxiety and social cognition (Kennedy & Adolphs, 2012), hence future studies will be 
conducted to assess the involvement of these different social components in the sociability 
impairment. Moreover, it has been widely demonstrated that imbalances in the excitatory and 
inhibitory synaptic transmission might be responsible of severe neuropsychiatric-related 
symptoms (Gao & Penzes, 2015; Nelson & Valakh, 2015; Sorce et al., 2010; Yizhar et al., 2011). 
Accordingly with our results, a reduction in social interactions and social preference when 
activating optogenetically cortical pyramidal neurons has been showed (Yizhar et al., 2011). In 
addition, it has been reported that lesions in the medial prefrontal cortex increased social 
behaviour in the social interaction test (Shah & Treit, 2003). In conclusion, the decrease in GABA 
and the corresponding increase in glutamate in prefrontal cortex and amygdala might be 
responsible of the decrease in social behaviour and increase in social withdrawal characteristics in 
BTBR strain. Thus, enhancement of GABA neurotransmission and consequent attenuation of 
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glutamatergic tone might be a possible therapeutic strategy to treat social withdrawal symptoms 
that primarily occur in many neuropsychiatric and neurodegenerative diseases.  
Furthermore, we measured GABA and glutamate levels in somatosensory cortex of Pcdh9 colonies 
and we found that there were no differences in GABA content among the three genotypes in both 
VBS colony and standard housing condition. These results are in line with behavioural outcomes, 
in which no genotype differences in sociability were detected. Otherwise, glutamate was 
significantly increased only in HOM Pcdh9-deficient mice housed in standard cage, while no 
genotype differences were found in glutamate levels among VBS colonies. 
In this regard, a number of neuropsychiatric diseases, such as psychosis associated to 
schizophrenia-like symptoms, are characterized by alterations in sensory processing and 
perception (Gonzalez-Maeso et al., 2008).  
Interestingly, Bruining and colleagues, using quantitative-trait locus mapping, demonstrated that 
HOM Pcdh9-deficient mice showed long-term social recognition impairments, suggesting an 
important involvement of Pcdh9 in the sensory cortex development and sensorimotor phenotypes 
(Bruining et al., 2015). In addition, recent evidence reported that drugs interacting with 
metabotropic glutamate receptors show potential for the treatment of mental diseases 
(Aghajanian & Marek, 2000; Marek, 2004; Patil et al., 2007). Thus, we hypothesized that glutamate 
neurotransmission in somatosensory cortex area participate to the development of the 
excitotoxicity reported in different neuropsychiatric symptoms. 
In conclusion, the glutamate increase found in HOM Pcdh9 KO housed in standard cages and not 
found in HOM Pcdh9 KO housed in VBS colonies points towards a putative beneficial effect of this 
highly social environment on glutamate excitotoxicity induced by Pcdh9 deletion. 
 
Overall conclusions 
In the present thesis, depressive-like symptoms shared among different neuropsychiatric disorders 
have been investigated, using animal models and behavioral paradigms. In addition, different 
neurobiological substrates underlying depressive-like symptoms have been analyzed. 
Considering the heterogeneous nature of depressive-like symptoms, we developed a multifactorial 
approach based on different neurobiological determinants, interconnected with each other. Thus, 
the influence of social, environmental and dietary factors, together with comorbidities, need to be 
considered to ultimately target the correct neurobiological substrates that give rise to different 
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depressive-like symptoms shared across several brain diseases. This transdiagnostic perspective 
opens a new scenario towards the progression of precision medicine, ultimately aiming to develop 
new effective and safe treatments for individual depressive-like symptoms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
113 
 
REFERENCES 
 
Aghajanian, G. K., & Marek, G. J. (2000). Serotonin model of schizophrenia: emerging role of glutamate 
mechanisms. Brain Res Brain Res Rev, 31(2-3), 302-312.  
Ahmed, M., & Azmat, A. (2017). Decreased brain serotonin turnover rate following administration of 
Sharbat-e-Ahmed Shah produces antidepressant and anxiolytic effect in rats. Metab Brain Dis. 
doi:10.1007/s11011-017-0065-6 
Aid, S., Vancassel, S., Poumes-Ballihaut, C., Chalon, S., Guesnet, P., & Lavialle, M. (2003). Effect of a diet-
induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J Lipid Res, 44(8), 
1545-1551. doi:10.1194/jlr.M300079-JLR200 
Alam, R., Abdolmaleky, H. M., & Zhou, J. R. (2017). Microbiome, inflammation, epigenetic alterations, and 
mental diseases. Am J Med Genet B Neuropsychiatr Genet, 174(6), 651-660. 
doi:10.1002/ajmg.b.32567 
Altemus, M. (2006). Sex differences in depression and anxiety disorders: potential biological determinants. 
Horm Behav, 50(4), 534-538. doi:10.1016/j.yhbeh.2006.06.031 
Amodeo, D. A., Jones, J. H., Sweeney, J. A., & Ragozzino, M. E. (2012). Differences in BTBR T+ tf/J and 
C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors. Behav Brain Res, 
227(1), 64-72. doi:10.1016/j.bbr.2011.10.032 
Arakawa, H., Blanchard, D. C., & Blanchard, R. J. (2007). Colony formation of C57BL/6J mice in visible 
burrow system: identification of eusocial behaviors in a background strain for genetic animal 
models of autism. Behav Brain Res, 176(1), 27-39. doi:10.1016/j.bbr.2006.07.027 
Balhara, Y. P., & Verma, R. (2012). Schizophrenia and suicide. East Asian Arch Psychiatry, 22(3), 126-133.  
Balogun, K. A., & Cheema, S. K. (2014). The expression of neurotrophins is differentially regulated by 
omega-3 polyunsaturated fatty acids at weaning and postweaning in C57BL/6 mice cerebral cortex. 
Neurochem Int, 66, 33-42. doi:10.1016/j.neuint.2014.01.007 
Bangasser, D. A., Curtis, A., Reyes, B. A., Bethea, T. T., Parastatidis, I., Ischiropoulos, H., . . . Valentino, R. J. 
(2010). Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential 
role in female vulnerability to stress-related psychopathology. Mol Psychiatry, 15(9), 877, 896-904. 
doi:10.1038/mp.2010.66 
Barrenger, S. L., Draine, J., Angell, B., & Herman, D. (2017). Reincarceration Risk Among Men with Mental 
Illnesses Leaving Prison: A Risk Environment Analysis. Community Ment Health J. 
doi:10.1007/s10597-017-0113-z 
Barton, D. A., Esler, M. D., Dawood, T., Lambert, E. A., Haikerwal, D., Brenchley, C., . . . Lambert, G. W. 
(2008). Elevated brain serotonin turnover in patients with depression: effect of genotype and 
therapy. Arch Gen Psychiatry, 65(1), 38-46. doi:10.1001/archgenpsychiatry.2007.11 
Barton, M., Filardo, E. J., Lolait, S. J., Thomas, P., Maggiolini, M., & Prossnitz, E. R. (2017). Twenty years of 
the G protein-coupled estrogen receptor GPER: Historical and personal perspectives. J Steroid 
Biochem Mol Biol. doi:10.1016/j.jsbmb.2017.03.021 
Berry, C. B., Hayes, D., Murphy, A., Wiessner, M., Rauen, T., & McBean, G. J. (2005). Differential modulation 
of the glutamate transporters GLT1, GLAST and EAAC1 by docosahexaenoic acid. Brain Res, 1037(1-
2), 123-133. doi:10.1016/j.brainres.2005.01.008 
Beydoun, M. A., Fanelli Kuczmarski, M. T., Beydoun, H. A., Hibbeln, J. R., Evans, M. K., & Zonderman, A. B. 
(2013). omega-3 fatty acid intakes are inversely related to elevated depressive symptoms among 
United States women. J Nutr, 143(11), 1743-1752. doi:10.3945/jn.113.179119 
Beydoun, M. A., Fanelli Kuczmarski, M. T., Beydoun, H. A., Rostant, O. S., Evans, M. K., & Zonderman, A. B. 
(2015). Associations of the Ratios of n-3 to n-6 Dietary Fatty Acids With Longitudinal Changes in 
Depressive Symptoms Among US Women. Am J Epidemiol, 181(9), 691-705. 
doi:10.1093/aje/kwu334 
114 
 
Bhagwagar, Z., & Cowen, P. J. (2008). 'It's not over when it's over': persistent neurobiological abnormalities 
in recovered depressed patients. Psychol Med, 38(3), 307-313.  
Blanchard, D. C., Defensor, E. B., Meyza, K. Z., Pobbe, R. L., Pearson, B. L., Bolivar, V. J., & Blanchard, R. J. 
(2012). BTBR T+tf/J mice: autism-relevant behaviors and reduced fractone-associated heparan 
sulfate. Neurosci Biobehav Rev, 36(1), 285-296. doi:10.1016/j.neubiorev.2011.06.008 
Blanchard, D. C., Spencer, R. L., Weiss, S. M., Blanchard, R. J., McEwen, B., & Sakai, R. R. (1995). Visible 
burrow system as a model of chronic social stress: behavioral and neuroendocrine correlates. 
Psychoneuroendocrinology, 20(2), 117-134.  
Blanchard, R. J., Dulloog, L., Markham, C., Nishimura, O., Nikulina Compton, J., Jun, A., . . . Blanchard, D. C. 
(2001). Sexual and aggressive interactions in a visible burrow system with provisioned burrows. 
Physiol Behav, 72(1-2), 245-254.  
Blanchard, R. J., Yudko, E., Dulloog, L., & Blanchard, D. C. (2001). Defense changes in stress nonresponsive 
subordinate males in a visible burrow system. Physiol Behav, 72(5), 635-642.  
Bo, Y., Zhang, X., Wang, Y., You, J., Cui, H., Zhu, Y., . . . Lu, Q. (2017). The n-3 Polyunsaturated Fatty Acids 
Supplementation Improved the Cognitive Function in the Chinese Elderly with Mild Cognitive 
Impairment: A Double-Blind Randomized Controlled Trial. Nutrients, 9(1). doi:10.3390/nu9010054 
Boku, S., Nakagawa, S., Toda, H., & Hishimoto, A. (2017). Neural basis of major depressive disorder: Beyond 
monoamine hypothesis. Psychiatry Clin Neurosci. doi:10.1111/pcn.12604 
Bolivar, V. J., Walters, S. R., & Phoenix, J. L. (2007). Assessing autism-like behavior in mice: variations in 
social interactions among inbred strains. Behav Brain Res, 176(1), 21-26. 
doi:10.1016/j.bbr.2006.09.007 
Borbely, S., Jocsak, G., Moldovan, K., Sedlak, E., Preininger, E., Boldizsar, I., . . . Vilagi, I. (2016). Arctigenin 
reduces neuronal responses in the somatosensory cortex via the inhibition of non-NMDA glutamate 
receptors. Neurochem Int, 97, 83-90. doi:10.1016/j.neuint.2016.03.006 
Borrow, A. P., & Cameron, N. M. (2014). Estrogenic mediation of serotonergic and neurotrophic systems: 
implications for female mood disorders. Prog Neuropsychopharmacol Biol Psychiatry, 54, 13-25. 
doi:10.1016/j.pnpbp.2014.05.009 
Brugger, S. P., & Howes, O. D. (2017). Heterogeneity and Homogeneity of Regional Brain Structure in 
Schizophrenia: A Meta-analysis. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2017.2663 
Bruining, H., Matsui, A., Oguro-Ando, A., Kahn, R. S., Van't Spijker, H. M., Akkermans, G., . . . Kas, M. J. 
(2015). Genetic Mapping in Mice Reveals the Involvement of Pcdh9 in Long-Term Social and Object 
Recognition and Sensorimotor Development. Biol Psychiatry, 78(7), 485-495. 
doi:10.1016/j.biopsych.2015.01.017 
Buffalari, D. M., & Grace, A. A. (2009). Chronic cold stress increases excitatory effects of norepinephrine on 
spontaneous and evoked activity of basolateral amygdala neurons. Int J Neuropsychopharmacol, 
12(1), 95-107. doi:10.1017/S1461145708009140 
Bulloch, A. G., Williams, J. V., Lavorato, D. H., & Patten, S. B. (2009). The relationship between major 
depression and marital disruption is bidirectional. Depress Anxiety, 26(12), 1172-1177. 
doi:10.1002/da.20618 
Burdge, G. C., & Wootton, S. A. (2002). Conversion of alpha-linolenic acid to eicosapentaenoic, 
docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr, 88(4), 411-420. 
doi:10.1079/BJN2002689 
Buwalda, B., Koolhaas, J. M., & de Boer, S. F. (2017). Trait aggressiveness does not predict social dominance 
of rats in the Visible Burrow System. Physiol Behav, 178, 134-143. 
doi:10.1016/j.physbeh.2017.01.008 
Cai, Y., Wang, L., Xiao, R., Li, X., He, X., Gao, J., . . . Fan, X. (2017). Autism-like behavior in the BTBR mouse 
model of autism is improved by propofol. Neuropharmacology, 118, 175-187. 
doi:10.1016/j.neuropharm.2017.03.021 
Calder, P. C. (2006). n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin 
Nutr, 83(6 Suppl), 1505S-1519S.  
115 
 
Carmona, V. R., Gomez-Benito, J., Huedo-Medina, T. B., & Rojo, J. E. (2017). Employment outcomes for 
people with schizophrenia spectrum disorder: A meta-analysis of randomized controlled trials. Int J 
Occup Med Environ Health, 30(3), 345-366. doi:10.13075/ijomeh.1896.01074 
Catania, C., Sotiropoulos, I., Silva, R., Onofri, C., Breen, K. C., Sousa, N., & Almeida, O. F. (2009). The 
amyloidogenic potential and behavioral correlates of stress. Mol Psychiatry, 14(1), 95-105. 
doi:10.1038/sj.mp.4002101 
Celio, M. R. (1986). Parvalbumin in most gamma-aminobutyric acid-containing neurons of the rat cerebral 
cortex. Science, 231(4741), 995-997.  
Chen, T., Li, F., & Chen, B. S. (2009). Cross-talks of sensory transcription networks in response to various 
environmental stresses. Interdiscip Sci, 1(1), 46-54. doi:10.1007/s12539-008-0018-1 
Chen, Y. W., Lin, P. Y., Tu, K. Y., Cheng, Y. S., Wu, C. K., & Tseng, P. T. (2015). Significantly lower nerve 
growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-
analysis and systematic review. Neuropsychiatr Dis Treat, 11, 925-933. doi:10.2147/NDT.S81432 
Choleris, E., Thomas, A. W., Kavaliers, M., & Prato, F. S. (2001). A detailed ethological analysis of the mouse 
open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed 
magnetic field. Neurosci Biobehav Rev, 25(3), 235-260.  
Chong, M. F., Ong, Y. L., Calder, P. C., Colega, M., Wong, J. X., Tan, C. S., . . . Group, G. S. (2015). Long-chain 
polyunsaturated fatty acid status during pregnancy and maternal mental health in pregnancy and 
the postpartum period: results from the GUSTO study. J Clin Psychiatry, 76(7), e848-856. 
doi:10.4088/JCP.14m09191 
Cohen, S., Levi-Montalcini, R., & Hamburger, V. (1954). A Nerve Growth-Stimulating Factor Isolated from 
Sarcom as 37 and 180. Proc Natl Acad Sci U S A, 40(10), 1014-1018.  
Colaianna, M., Tucci, P., Zotti, M., Morgese, M. G., Schiavone, S., Govoni, S., . . . Trabace, L. (2010). Soluble 
beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking 
depressive-related state? Br J Pharmacol, 159(8), 1704-1715. doi:10.1111/j.1476-
5381.2010.00669.x 
Colangelo, L. A., Ouyang, P., Golden, S. H., Szklo, M., Gapstur, S. M., Vaidya, D., & Liu, K. (2017). Do sex 
hormones or hormone therapy modify the relation of n-3 fatty acids with incident depressive 
symptoms in postmenopausal women? The MESA Study. Psychoneuroendocrinology, 75, 26-35. 
doi:10.1016/j.psyneuen.2016.10.003 
Contractor, A., Mulle, C., & Swanson, G. T. (2011). Kainate receptors coming of age: milestones of two 
decades of research. Trends Neurosci, 34(3), 154-163. doi:10.1016/j.tins.2010.12.002 
Cryan, J. F., Valentino, R. J., & Lucki, I. (2005). Assessing substrates underlying the behavioral effects of 
antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev, 29(4-5), 547-
569.  
Cullinan, W. E., Ziegler, D. R., & Herman, J. P. (2008). Functional role of local GABAergic influences on the 
HPA axis. Brain Struct Funct, 213(1-2), 63-72. doi:10.1007/s00429-008-0192-2 
Cummings, M. A. (2015). The neurobiology of psychopathy: recent developments and new directions in 
research and treatment. CNS Spectr, 20(3), 200-206. doi:10.1017/S1092852914000741 
D'Aquila, P. S., Collu, M., Gessa, G. L., & Serra, G. (2000). The role of dopamine in the mechanism of action 
of antidepressant drugs. Eur J Pharmacol, 405(1-3), 365-373.  
D'Souza, D., & Sadananda, M. (2017). Estrous Cycle Phase-Dependent Changes in Anxiety- and Depression-
Like Profiles in the Late Adolescent Wistar-Kyoto Rat. Ann Neurosci, 24(3), 136-145. 
doi:10.1159/000477151 
Dal Forno, G., Palermo, M. T., Donohue, J. E., Karagiozis, H., Zonderman, A. B., & Kawas, C. H. (2005). 
Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol, 57(3), 381-387. 
doi:10.1002/ana.20405 
Diaz, O. V., Guendelman, S., & Kuppermann, M. (2014). Subjective social status and depression symptoms: 
a prospective study of women with noncancerous pelvic problems. Womens Health Issues, 24(6), 
649-655. doi:10.1016/j.whi.2014.07.003 
116 
 
Diniz, B. S., Reynolds, C. F., 3rd, Begley, A., Dew, M. A., Anderson, S. J., Lotrich, F., . . . Butters, M. A. (2014). 
Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive 
impairment: a longitudinal study. J Psychiatr Res, 49, 96-101. doi:10.1016/j.jpsychires.2013.11.004 
Dogan, R. K., King, M. L., Fischetti, A. T., Lake, C. M., Mathews, T. L., & Warzak, W. J. (2017). Parent-
implemented behavioral skills training of social skills. J Appl Behav Anal, 50(4), 805-818. 
doi:10.1002/jaba.411 
Dong, H., & Csernansky, J. G. (2009). Effects of stress and stress hormones on amyloid-beta protein and 
plaque deposition. J Alzheimers Dis, 18(2), 459-469. doi:10.3233/JAD-2009-1152 
Donner, N. C., & Lowry, C. A. (2013). Sex differences in anxiety and emotional behavior. Pflugers Arch, 
465(5), 601-626. doi:10.1007/s00424-013-1271-7 
Dunn, A. J., & Berridge, C. W. (1990). Physiological and behavioral responses to corticotropin-releasing 
factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev, 
15(2), 71-100.  
Dunn, A. J., & Swiergiel, A. H. (2008). The role of corticotropin-releasing factor and noradrenaline in stress-
related responses, and the inter-relationships between the two systems. Eur J Pharmacol, 583(2-3), 
186-193. doi:10.1016/j.ejphar.2007.11.069 
Echeverria, F., Valenzuela, R., Catalina Hernandez-Rodas, M., & Valenzuela, A. (2017). Docosahexaenoic 
acid (DHA), a fundamental fatty acid for the brain: New dietary sources. Prostaglandins Leukot 
Essent Fatty Acids, 124, 1-10. doi:10.1016/j.plefa.2017.08.001 
Emendato, A., Spadaccini, R., De Santis, A., Guerrini, R., D'Errico, G., & Picone, D. (2016). Preferential 
interaction of the Alzheimer peptide Abeta-(1-42) with Omega-3-containing lipid bilayers: structure 
and interaction studies. FEBS Lett, 590(4), 582-591. doi:10.1002/1873-3468.12082 
Evans, S. J., Assari, S., Harrington, G. J., Chang, Y. W., Burant, C. F., & McInnis, M. G. (2015). Plasma linoleic 
acid partially mediates the association of bipolar disorder on self-reported mental health scales. J 
Psychiatr Res, 68, 61-67. doi:10.1016/j.jpsychires.2015.06.001 
Fedorova, I., & Salem, N., Jr. (2006). Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot Essent 
Fatty Acids, 75(4-5), 271-289. doi:10.1016/j.plefa.2006.07.006 
Feldman, S., Newman, M. E., Gur, E., & Weidenfeld, J. (1998). Role of serotonin in the amygdala in 
hypothalamo-pituitary-adrenocortical responses. Neuroreport, 9(9), 2007-2009.  
Finan, P. H., & Smith, M. T. (2013). The comorbidity of insomnia, chronic pain, and depression: dopamine as 
a putative mechanism. Sleep Med Rev, 17(3), 173-183. doi:10.1016/j.smrv.2012.03.003 
Fink, G., Sumner, B. E., McQueen, J. K., Wilson, H., & Rosie, R. (1998). Sex steroid control of mood, mental 
state and memory. Clin Exp Pharmacol Physiol, 25(10), 764-775.  
Foussias, G., & Remington, G. (2010). Negative symptoms in schizophrenia: avolition and Occam's razor. 
Schizophr Bull, 36(2), 359-369. doi:10.1093/schbul/sbn094 
Frisardi, V., Panza, F., & Farooqui, A. A. (2011). Late-life depression and Alzheimer's disease: the 
glutamatergic system inside of this mirror relationship. Brain Res Rev, 67(1-2), 344-355. 
doi:10.1016/j.brainresrev.2011.04.003 
Furlanetti, L. L., Coenen, V. A., & Dobrossy, M. D. (2016). Ventral tegmental area dopaminergic lesion-
induced depressive phenotype in the rat is reversed by deep brain stimulation of the medial 
forebrain bundle. Behav Brain Res, 299, 132-140. doi:10.1016/j.bbr.2015.11.036 
Fuzesi, T., Daviu, N., Wamsteeker Cusulin, J. I., Bonin, R. P., & Bains, J. S. (2016). Hypothalamic CRH neurons 
orchestrate complex behaviours after stress. Nat Commun, 7, 11937. doi:10.1038/ncomms11937 
Gao, R., & Penzes, P. (2015). Common mechanisms of excitatory and inhibitory imbalance in schizophrenia 
and autism spectrum disorders. Curr Mol Med, 15(2), 146-167.  
Garcia-Alloza, M., Hirst, W. D., Chen, C. P., Lasheras, B., Francis, P. T., & Ramirez, M. J. (2004). Differential 
involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in 
Alzheimer's disease. Neuropsychopharmacology, 29(2), 410-416. doi:10.1038/sj.npp.1300330 
Gertsik, L., Poland, R. E., Bresee, C., & Rapaport, M. H. (2012). Omega-3 fatty acid augmentation of 
citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol, 32(1), 
61-64. doi:10.1097/JCP.0b013e31823f3b5f 
117 
 
Gilbert, C., McCafferty, D., Le Maho, Y., Martrette, J. M., Giroud, S., Blanc, S., & Ancel, A. (2010). One for all 
and all for one: the energetic benefits of huddling in endotherms. Biol Rev Camb Philos Soc, 85(3), 
545-569. doi:10.1111/j.1469-185X.2009.00115.x 
Giltay, E. J., Gooren, L. J., Toorians, A. W., Katan, M. B., & Zock, P. L. (2004). Docosahexaenoic acid 
concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr, 
80(5), 1167-1174.  
Gonzalez-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., Lopez-Gimenez, J. F., . . . Sealfon, S. C. 
(2008). Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature, 
452(7183), 93-97. doi:10.1038/nature06612 
Goodkind, M., Eickhoff, S. B., Oathes, D. J., Jiang, Y., Chang, A., Jones-Hagata, L. B., . . . Etkin, A. (2015). 
Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry, 72(4), 
305-315. doi:10.1001/jamapsychiatry.2014.2206 
Gorman, J. M. (2006). Gender differences in depression and response to psychotropic medication. Gend 
Med, 3(2), 93-109.  
Green, M. F. (2016). Impact of cognitive and social cognitive impairment on functional outcomes in patients 
with schizophrenia. J Clin Psychiatry, 77 Suppl 2, 8-11. doi:10.4088/JCP.14074su1c.02 
Grintal, B., Champeil-Potokar, G., Lavialle, M., Vancassel, S., Breton, S., & Denis, I. (2009). Inhibition of 
astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of 
docosahexaenoic acid. Neurochem Int, 54(8), 535-543. doi:10.1016/j.neuint.2009.02.018 
Grosso, G., Galvano, F., Marventano, S., Malaguarnera, M., Bucolo, C., Drago, F., & Caraci, F. (2014). 
Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid Med Cell 
Longev, 2014, 313570. doi:10.1155/2014/313570 
Grosso, G., Micek, A., Marventano, S., Castellano, S., Mistretta, A., Pajak, A., & Galvano, F. (2016). Dietary n-
3 PUFA, fish consumption and depression: A systematic review and meta-analysis of observational 
studies. J Affect Disord, 205, 269-281. doi:10.1016/j.jad.2016.08.011 
Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., . . . Caraci, F. (2014). Role of 
omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of 
randomized clinical trials. PLoS One, 9(5), e96905. doi:10.1371/journal.pone.0096905 
Hakamata, Y., Komi, S., Moriguchi, Y., Izawa, S., Motomura, Y., Sato, E., . . . Tagaya, H. (2017). Amygdala-
centred functional connectivity affects daily cortisol concentrations: a putative link with anxiety. Sci 
Rep, 7(1), 8313. doi:10.1038/s41598-017-08918-7 
Halbreich, U., Asnis, G. M., Shindledecker, R., Zumoff, B., & Nathan, R. S. (1985). Cortisol secretion in 
endogenous depression. II. Time-related functions. Arch Gen Psychiatry, 42(9), 909-914.  
Hanson, E., Healey, K., Wolf, D., & Kohler, C. (2010). Assessment of pharmacotherapy for negative 
symptoms of schizophrenia. Curr Psychiatry Rep, 12(6), 563-571. doi:10.1007/s11920-010-0148-0 
Harauma, A., & Moriguchi, T. (2011). Dietary n-3 fatty acid deficiency in mice enhances anxiety induced by 
chronic mild stress. Lipids, 46(5), 409-416. doi:10.1007/s11745-010-3523-z 
Hashimoto, K., Malchow, B., Falkai, P., & Schmitt, A. (2013). Glutamate modulators as potential therapeutic 
drugs in schizophrenia and affective disorders. Eur Arch Psychiatry Clin Neurosci, 263(5), 367-377. 
doi:10.1007/s00406-013-0399-y 
Hashimoto, K., Sawa, A., & Iyo, M. (2007). Increased levels of glutamate in brains from patients with mood 
disorders. Biol Psychiatry, 62(11), 1310-1316. doi:10.1016/j.biopsych.2007.03.017 
Hassanzadeh, P., & Rahimpour, S. (2011). The cannabinergic system is implicated in the upregulation of 
central NGF protein by psychotropic drugs. Psychopharmacology (Berl), 215(1), 129-141. 
doi:10.1007/s00213-010-2120-4 
Heinrichs, S. C., & Koob, G. F. (2004). Corticotropin-releasing factor in brain: a role in activation, arousal, 
and affect regulation. J Pharmacol Exp Ther, 311(2), 427-440. doi:10.1124/jpet.103.052092 
Herman, J. P., Mueller, N. K., & Figueiredo, H. (2004). Role of GABA and glutamate circuitry in hypothalamo-
pituitary-adrenocortical stress integration. Ann N Y Acad Sci, 1018, 35-45. 
doi:10.1196/annals.1296.004 
118 
 
Herman, J. P., & Tamashiro, K. L. (2017). The visible burrow system: A view from across the hall. Physiol 
Behav, 178, 103-109. doi:10.1016/j.physbeh.2017.01.021 
Herman, J. P., & Tasker, J. G. (2016). Paraventricular Hypothalamic Mechanisms of Chronic Stress 
Adaptation. Front Endocrinol (Lausanne), 7, 137. doi:10.3389/fendo.2016.00137 
Hill, M. N., Kumar, S. A., Filipski, S. B., Iverson, M., Stuhr, K. L., Keith, J. M., . . . McEwen, B. S. (2013). 
Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety 
and amygdalar microstructure. Mol Psychiatry, 18(10), 1125-1135. doi:10.1038/mp.2012.90 
Hill, M. N., & Patel, S. (2013). Translational evidence for the involvement of the endocannabinoid system in 
stress-related psychiatric illnesses. Biol Mood Anxiety Disord, 3(1), 19. doi:10.1186/2045-5380-3-19 
Hirabayashi, T., & Yagi, T. (2014). Protocadherins in neurological diseases. Adv Neurobiol, 8, 293-314.  
Hopperton, K. E., Trepanier, M. O., Giuliano, V., & Bazinet, R. P. (2016). Brain omega-3 polyunsaturated 
fatty acids modulate microglia cell number and morphology in response to intracerebroventricular 
amyloid-beta 1-40 in mice. J Neuroinflammation, 13(1), 257. doi:10.1186/s12974-016-0721-5 
Hori, H., & Kunugi, H. (2013). Dopamine agonist-responsive depression. Psychogeriatrics, 13(3), 189-195. 
doi:10.1111/psyg.12014 
Hsieh, L. S., Wen, J. H., Miyares, L., Lombroso, P. J., & Bordey, A. (2017). Outbred CD1 mice are as suitable 
as inbred C57BL/6J mice in performing social tasks. Neurosci Lett, 637, 142-147. 
doi:10.1016/j.neulet.2016.11.035 
Ikemoto, A., Ohishi, M., Sato, Y., Hata, N., Misawa, Y., Fujii, Y., & Okuyama, H. (2001). Reversibility of n-3 
fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as 
another critical factor. J Lipid Res, 42(10), 1655-1663.  
Insel, T. R., & Cuthbert, B. N. (2015). Medicine. Brain disorders? Precisely. Science, 348(6234), 499-500. 
doi:10.1126/science.aab2358 
Iulita, M. F., Bistue Millon, M. B., Pentz, R., Aguilar, L. F., Do Carmo, S., Allard, S., . . . Cuello, A. C. (2017). 
Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's 
disease. Neurobiol Dis, 108, 307-323. doi:10.1016/j.nbd.2017.08.019 
Jans, L. A., Lieben, C. K., & Blokland, A. (2007). Influence of sex and estrous cycle on the effects of acute 
tryptophan depletion induced by a gelatin-based mixture in adult Wistar rats. Neuroscience, 147(2), 
304-317. doi:10.1016/j.neuroscience.2007.04.028 
Jazayeri, S., Tehrani-Doost, M., Keshavarz, S. A., Hosseini, M., Djazayery, A., Amini, H., . . . Peet, M. (2008). 
Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, 
separately and in combination, in major depressive disorder. Aust N Z J Psychiatry, 42(3), 192-198. 
doi:10.1080/00048670701827275 
Johnson, P. L., Molosh, A., Fitz, S. D., Arendt, D., Deehan, G. A., Federici, L. M., . . . Shekhar, A. (2015). 
Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and 
disrupts fear conditioning. Pharmacol Biochem Behav, 138, 174-179. 
doi:10.1016/j.pbb.2015.09.021 
Jones-Davis, D. M., Yang, M., Rider, E., Osbun, N. C., da Gente, G. J., Li, J., . . . Sherr, E. H. (2013). 
Quantitative trait loci for interhemispheric commissure development and social behaviors in the 
BTBR T(+) tf/J mouse model of autism. PLoS One, 8(4), e61829. doi:10.1371/journal.pone.0061829 
Jones, C. R., Arai, T., & Rapoport, S. I. (1997). Evidence for the involvement of docosahexaenoic acid in 
cholinergic stimulated signal transduction at the synapse. Neurochem Res, 22(6), 663-670.  
Jorm, A. F. (2001). History of depression as a risk factor for dementia: an updated review. Aust N Z J 
Psychiatry, 35(6), 776-781. doi:10.1046/j.1440-1614.2001.00967.x 
Joyce, P. R. (2007). The evolving neurobiology of depression: from synapses to neurons, circuits and loops. 
Aust N Z J Psychiatry, 41(7), 561-562. doi:10.1080/00048670701429999 
Kallen, V. L., Ferdinand, R. F., & Tulen, J. H. (2007). Early attention processes and anxiety in children. 
Percept Mot Skills, 104(1), 221-235. doi:10.2466/pms.104.1.221-235 
Kalueff, A. V., Kaluyeva, A., & Maillet, E. L. (2017). Anxiolytic-like effects of noribogaine in zebrafish. Behav 
Brain Res, 330, 63-67. doi:10.1016/j.bbr.2017.05.008 
119 
 
Kalueff, A. V., Stewart, A. M., Song, C., Berridge, K. C., Graybiel, A. M., & Fentress, J. C. (2016). Neurobiology 
of rodent self-grooming and its value for translational neuroscience. Nat Rev Neurosci, 17(1), 45-59. 
doi:10.1038/nrn.2015.8 
Kanne, S. M., & Mazurek, M. O. (2011). Aggression in children and adolescents with ASD: prevalence and 
risk factors. J Autism Dev Disord, 41(7), 926-937. doi:10.1007/s10803-010-1118-4 
Kas, M. J., Krishnan, V., Gould, T. D., Collier, D. A., Olivier, B., Lesch, K. P., . . . Castren, E. (2011). Advances in 
multidisciplinary and cross-species approaches to examine the neurobiology of psychiatric 
disorders. Eur Neuropsychopharmacol, 21(7), 532-544. doi:10.1016/j.euroneuro.2010.12.001 
Kendell, S. F., Krystal, J. H., & Sanacora, G. (2005). GABA and glutamate systems as therapeutic targets in 
depression and mood disorders. Expert Opin Ther Targets, 9(1), 153-168. 
doi:10.1517/14728222.9.1.153 
Kendler, K. S., Thornton, L. M., & Gardner, C. O. (2000). Stressful life events and previous episodes in the 
etiology of major depression in women: an evaluation of the "kindling" hypothesis. Am J Psychiatry, 
157(8), 1243-1251. doi:10.1176/appi.ajp.157.8.1243 
Kennedy, D. P., & Adolphs, R. (2012). The social brain in psychiatric and neurological disorders. Trends Cogn 
Sci, 16(11), 559-572. doi:10.1016/j.tics.2012.09.006 
Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and 
comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch 
Gen Psychiatry, 62(6), 617-627. doi:10.1001/archpsyc.62.6.617 
Kiecolt-Glaser, J. K., Belury, M. A., Porter, K., Beversdorf, D. Q., Lemeshow, S., & Glaser, R. (2007). 
Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults. Psychosom 
Med, 69(3), 217-224. doi:10.1097/PSY.0b013e3180313a45 
Kirkpatrick, B. (2014). Developing concepts in negative symptoms: primary vs secondary and apathy vs 
expression. J Clin Psychiatry, 75 Suppl 1, 3-7. doi:10.4088/JCP.13049su1c.01 
Kokras, N., Antoniou, K., Mikail, H. G., Kafetzopoulos, V., Papadopoulou-Daifoti, Z., & Dalla, C. (2015). 
Forced swim test: What about females? Neuropharmacology, 99, 408-421. 
doi:10.1016/j.neuropharm.2015.03.016 
Krishnan, V., & Nestler, E. J. (2008). The molecular neurobiology of depression. Nature, 455(7215), 894-902. 
doi:10.1038/nature07455 
Kudielka, B. M., & Kirschbaum, C. (2005). Sex differences in HPA axis responses to stress: a review. Biol 
Psychol, 69(1), 113-132. doi:10.1016/j.biopsycho.2004.11.009 
Lafourcade, M., Larrieu, T., Mato, S., Duffaud, A., Sepers, M., Matias, I., . . . Manzoni, O. J. (2011). 
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat 
Neurosci, 14(3), 345-350. doi:10.1038/nn.2736 
Lang, A. P., & de Angelis, L. (2003). Experimental anxiety and antiepileptics: the effects of valproate and 
vigabatrin in the mirrored chamber test. Methods Find Exp Clin Pharmacol, 25(4), 265-271.  
Lang, U. E., Beglinger, C., Schweinfurth, N., Walter, M., & Borgwardt, S. (2015). Nutritional aspects of 
depression. Cell Physiol Biochem, 37(3), 1029-1043. doi:10.1159/000430229 
Lanni, C., Govoni, S., Lucchelli, A., & Boselli, C. (2009). Depression and antidepressants: molecular and 
cellular aspects. Cell Mol Life Sci, 66(18), 2985-3008. doi:10.1007/s00018-009-0055-x 
Laredo, S. A., Villalon Landeros, R., & Trainor, B. C. (2014). Rapid effects of estrogens on behavior: 
environmental modulation and molecular mechanisms. Front Neuroendocrinol, 35(4), 447-458. 
doi:10.1016/j.yfrne.2014.03.005 
Larrieu, T., Hilal, M. L., Fourrier, C., De Smedt-Peyrusse, V., Sans, N., Capuron, L., & Laye, S. (2014). 
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with 
depression-related behaviour through corticosterone secretion. Transl Psychiatry, 4, e437. 
doi:10.1038/tp.2014.77 
Larrieu, T., Madore, C., Joffre, C., & Laye, S. (2012). Nutritional n-3 polyunsaturated fatty acids deficiency 
alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in 
mice. J Physiol Biochem, 68(4), 671-681. doi:10.1007/s13105-012-0179-6 
120 
 
Lauritzen, L., Sorensen, L. B., Harslof, L. B., Ritz, C., Stark, K. D., Astrup, A., . . . Damsgaard, C. T. (2017). 
Mendelian randomization shows sex-specific associations between long-chain PUFA-related 
genotypes and cognitive performance in Danish schoolchildren. Am J Clin Nutr, 106(1), 88-95. 
doi:10.3945/ajcn.117.152595 
Leach, L. S., Christensen, H., Mackinnon, A. J., Windsor, T. D., & Butterworth, P. (2008). Gender differences 
in depression and anxiety across the adult lifespan: the role of psychosocial mediators. Soc 
Psychiatry Psychiatr Epidemiol, 43(12), 983-998. doi:10.1007/s00127-008-0388-z 
Lee, S., & Rhee, D. K. (2017). Effects of ginseng on stress-related depression, anxiety, and the hypothalamic-
pituitary-adrenal axis. J Ginseng Res, 41(4), 589-594. doi:10.1016/j.jgr.2017.01.010 
Lewis, D. A. (2014). Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in 
schizophrenia. Curr Opin Neurobiol, 26, 22-26. doi:10.1016/j.conb.2013.11.003 
Li, M. M., Jiang, Z. E., Song, L. Y., Quan, Z. S., & Yu, H. L. (2017). Antidepressant and anxiolytic-like 
behavioral effects of erucamide, a bioactive fatty acid amide, involving the hypothalamus-pituitary-
adrenal axis in mice. Neurosci Lett, 640, 6-12. doi:10.1016/j.neulet.2016.12.072 
Lim, G. P., Calon, F., Morihara, T., Yang, F., Teter, B., Ubeda, O., . . . Cole, G. M. (2005). A diet enriched with 
the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse 
model. J Neurosci, 25(12), 3032-3040. doi:10.1523/JNEUROSCI.4225-04.2005 
Lin, P. Y., & Su, K. P. (2007). A meta-analytic review of double-blind, placebo-controlled trials of 
antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry, 68(7), 1056-1061.  
Lin, S. H., Chou, M. L., Chen, W. C., Lai, Y. S., Lu, K. H., Hao, C. W., & Sheen, L. Y. (2015). A medicinal herb, 
Melissa officinalis L. ameliorates depressive-like behavior of rats in the forced swimming test via 
regulating the serotonergic neurotransmitter. J Ethnopharmacol, 175, 266-272. 
doi:10.1016/j.jep.2015.09.018 
Lin, Y. T., Yu, Y. L., Hong, W. C., Yeh, T. S., Chen, T. C., & Chen, J. C. (2017). NPFFR2 Activates the HPA Axis 
and Induces Anxiogenic Effects in Rodents. Int J Mol Sci, 18(8). doi:10.3390/ijms18081810 
Liu, J. J., Galfalvy, H. C., Cooper, T. B., Oquendo, M. A., Grunebaum, M. F., Mann, J. J., & Sublette, M. E. 
(2013). Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with 
comorbid anxiety disorders. J Clin Psychiatry, 74(7), 732-738. doi:10.4088/JCP.12m07970 
Liu, Z. P., Song, C., Wang, M., He, Y., Xu, X. B., Pan, H. Q., . . . Pan, B. X. (2014). Chronic stress impairs 
GABAergic control of amygdala through suppressing the tonic GABAA receptor currents. Mol Brain, 
7, 32. doi:10.1186/1756-6606-7-32 
Llerena, K., Reddy, L. F., & Kern, R. S. (2017). The role of experiential and expressive negative symptoms on 
job obtainment and work outcome in individuals with schizophrenia. Schizophr Res. 
doi:10.1016/j.schres.2017.06.001 
Lo Van, A., Sakayori, N., Hachem, M., Belkouch, M., Picq, M., Lagarde, M., . . . Bernoud-Hubac, N. (2016). 
Mechanisms of DHA transport to the brain and potential therapy to neurodegenerative diseases. 
Biochimie, 130, 163-167. doi:10.1016/j.biochi.2016.07.011 
Lopez-Munoz, F., Bhatara, V. S., Alamo, C., & Cuenca, E. (2004). [Historical approach to reserpine discovery 
and its introduction in psychiatry]. Actas Esp Psiquiatr, 32(6), 387-395.  
Lozada, L. E., Desai, A., Kevala, K., Lee, J. W., & Kim, H. Y. (2017). Perinatal Brain Docosahexaenoic Acid 
Concentration Has a Lasting Impact on Cognition in Mice. J Nutr, 147(9), 1624-1630. 
doi:10.3945/jn.117.254607 
Lucas, M., Kirmayer, L. J., Dery, S., & Dewailly, E. (2010). Erythrocyte n-3 is inversely correlated with serious 
psychological distress among the Inuit: data from the Nunavik health survey. J Am Coll Nutr, 29(3), 
211-221.  
Lydiard, R. B. (2003). The role of GABA in anxiety disorders. J Clin Psychiatry, 64 Suppl 3, 21-27.  
Ma, S., & Morilak, D. A. (2005). Norepinephrine release in medial amygdala facilitates activation of the 
hypothalamic-pituitary-adrenal axis in response to acute immobilisation stress. J Neuroendocrinol, 
17(1), 22-28. doi:10.1111/j.1365-2826.2005.01279.x 
Maekawa, M., Watanabe, A., Iwayama, Y., Kimura, T., Hamazaki, K., Balan, S., . . . Yoshikawa, T. (2017). 
Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal 
121 
 
state of schizophrenia through epigenetic changes in nuclear receptor genes. Transl Psychiatry, 
7(9), e1229. doi:10.1038/tp.2017.182 
Maletic, V., Robinson, M., Oakes, T., Iyengar, S., Ball, S. G., & Russell, J. (2007). Neurobiology of depression: 
an integrated view of key findings. Int J Clin Pract, 61(12), 2030-2040. doi:10.1111/j.1742-
1241.2007.01602.x 
Marcus, S. M., Young, E. A., Kerber, K. B., Kornstein, S., Farabaugh, A. H., Mitchell, J., . . . Rush, A. J. (2005). 
Gender differences in depression: findings from the STAR*D study. J Affect Disord, 87(2-3), 141-
150. doi:10.1016/j.jad.2004.09.008 
Marek, G. J. (2004). Metabotropic glutamate 2/3 receptors as drug targets. Curr Opin Pharmacol, 4(1), 18-
22. doi:10.1016/j.coph.2003.10.003 
Marks, D. M., Pae, C. U., & Patkar, A. A. (2008). Triple reuptake inhibitors: the next generation of 
antidepressants. Curr Neuropharmacol, 6(4), 338-343. doi:10.2174/157015908787386078 
Marrocco, J., & McEwen, B. S. (2016). Sex in the brain: hormones and sex differences. Dialogues Clin 
Neurosci, 18(4), 373-383.  
Martini, L. C., Barbosa, J. B. N., Petreche, B., Fonseca, A. O., Santos, F. V. D., Magalhaes, L., . . . Bressan, R. A. 
(2017). Schizophrenia and work: aspects related to job acquisition in a follow-up study. Rev Bras 
Psiquiatr, 0. doi:10.1590/1516-4446-2016-2128 
Martino, M., Rocchi, G., Escelsior, A., Contini, P., Colicchio, S., de Berardis, D., . . . Fornaro, M. (2013). NGF 
serum levels variations in major depressed patients receiving duloxetine. 
Psychoneuroendocrinology, 38(9), 1824-1828. doi:10.1016/j.psyneuen.2013.02.009 
Mathew, S. J., Coplan, J. D., Schoepp, D. D., Smith, E. L., Rosenblum, L. A., & Gorman, J. M. (2001). 
Glutamate-hypothalamic-pituitary-adrenal axis interactions: implications for mood and anxiety 
disorders. CNS Spectr, 6(7), 555-556, 561-554.  
McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. 
Physiol Rev, 87(3), 873-904. doi:10.1152/physrev.00041.2006 
McEwen, B. S., Eiland, L., Hunter, R. G., & Miller, M. M. (2012). Stress and anxiety: structural plasticity and 
epigenetic regulation as a consequence of stress. Neuropharmacology, 62(1), 3-12. 
doi:10.1016/j.neuropharm.2011.07.014 
McEwen, B. S., McKittrick, C. R., Tamashiro, K. L., & Sakai, R. R. (2015). The brain on stress: Insight from 
studies using the Visible Burrow System. Physiol Behav, 146, 47-56. 
doi:10.1016/j.physbeh.2015.04.015 
McEwen, B. S., & Milner, T. A. (2017). Understanding the broad influence of sex hormones and sex 
differences in the brain. J Neurosci Res, 95(1-2), 24-39. doi:10.1002/jnr.23809 
McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., & Crawley, J. N. (2008). Autism-like 
behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav, 7(2), 152-163. doi:10.1111/j.1601-
183X.2007.00330.x 
McLean, C. P., & Anderson, E. R. (2009). Brave men and timid women? A review of the gender differences 
in fear and anxiety. Clin Psychol Rev, 29(6), 496-505. doi:10.1016/j.cpr.2009.05.003 
McNamara, R. K., Able, J. A., Rider, T., Tso, P., & Jandacek, R. (2010). Effect of chronic fluoxetine treatment 
on male and female rat erythrocyte and prefrontal cortex fatty acid composition. Prog 
Neuropsychopharmacol Biol Psychiatry, 34(7), 1317-1321. doi:10.1016/j.pnpbp.2010.07.016 
McNamara, R. K., Asch, R. H., Lindquist, D. M., & Krikorian, R. (2017). Role of polyunsaturated fatty acids in 
human brain structure and function across the lifespan: An update on neuroimaging findings. 
Prostaglandins Leukot Essent Fatty Acids. doi:10.1016/j.plefa.2017.05.001 
McNamara, R. K., & Welge, J. A. (2016). Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in 
bipolar disorder. Bipolar Disord, 18(3), 300-306. doi:10.1111/bdi.12386 
Melhorn, S. J., Elfers, C. T., Scott, K. A., & Sakai, R. R. (2017). A closer look at the subordinate population 
within the visible burrow system. Physiol Behav, 178, 110-116. doi:10.1016/j.physbeh.2017.01.039 
Meyza, K., Nikolaev, T., Kondrakiewicz, K., Blanchard, D. C., Blanchard, R. J., & Knapska, E. (2015). Neuronal 
correlates of asocial behavior in a BTBR T (+) Itpr3(tf)/J mouse model of autism. Front Behav 
Neurosci, 9, 199. doi:10.3389/fnbeh.2015.00199 
122 
 
Migliaccio, S., Davis, V. L., Gibson, M. K., Gray, T. K., & Korach, K. S. (1992). Estrogens modulate the 
responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor. 
Endocrinology, 130(5), 2617-2624. doi:10.1210/endo.130.5.1572285 
Mikkelsen, J. D., Bundzikova, J., Larsen, M. H., Hansen, H. H., & Kiss, A. (2008). GABA regulates the rat 
hypothalamic-pituitary-adrenocortical axis via different GABA-A receptor alpha-subtypes. Ann N Y 
Acad Sci, 1148, 384-392. doi:10.1196/annals.1410.044 
Mill, J., & Petronis, A. (2007). Molecular studies of major depressive disorder: the epigenetic perspective. 
Mol Psychiatry, 12(9), 799-814. doi:10.1038/sj.mp.4001992 
Mills, C., & Chapparo, C. (2017). Listening to teachers: Views on delivery of a classroom based sensory 
intervention for students with autism. Aust Occup Ther J. doi:10.1111/1440-1630.12381 
Minzenberg, M. J., Firl, A. J., Yoon, J. H., Gomes, G. C., Reinking, C., & Carter, C. S. (2010). Gamma oscillatory 
power is impaired during cognitive control independent of medication status in first-episode 
schizophrenia. Neuropsychopharmacology, 35(13), 2590-2599. doi:10.1038/npp.2010.150 
Molenhuis, R. T., de Visser, L., Bruining, H., & Kas, M. J. (2014). Enhancing the value of psychiatric mouse 
models; differential expression of developmental behavioral and cognitive profiles in four inbred 
strains of mice. Eur Neuropsychopharmacol, 24(6), 945-954. doi:10.1016/j.euroneuro.2014.01.013 
Moller, J. E., & Raahave, D. (1974). Gastric localization of endodermal sinus tumour. Acta Pathol Microbiol 
Scand A, 82(2), 179-181.  
Monteggia, L. M., Luikart, B., Barrot, M., Theobold, D., Malkovska, I., Nef, S., . . . Nestler, E. J. (2007). Brain-
derived neurotrophic factor conditional knockouts show gender differences in depression-related 
behaviors. Biol Psychiatry, 61(2), 187-197. doi:10.1016/j.biopsych.2006.03.021 
Morgese, M. G., Colaianna, M., Mhillaj, E., Zotti, M., Schiavone, S., D'Antonio, P., . . . Trabace, L. (2015). 
Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and 
interleukin-1. Front Neurosci, 9, 428. doi:10.3389/fnins.2015.00428 
Morgese, M. G., Schiavone, S., & Trabace, L. (2017). Emerging role of amyloid beta in stress response: 
Implication for depression and diabetes. Eur J Pharmacol. doi:10.1016/j.ejphar.2017.08.031 
Morgese, M. G., & Trabace, L. (2016). Maternal Malnutrition in the Etiopathogenesis of Psychiatric 
Diseases: Role of Polyunsaturated Fatty Acids. Brain Sci, 6(3). doi:10.3390/brainsci6030024 
Morgese, M. G., Tucci, P., Colaianna, M., Zotti, M., Cuomo, V., Schiavone, S., & Trabace, L. (2014). 
Modulatory activity of soluble beta amyloid on HPA axis function in rats. Curr Pharm Des, 20(15), 
2539-2546.  
Morgese, M. G., Tucci, P., Mhillaj, E., Bove, M., Schiavone, S., Trabace, L., & Cuomo, V. (2016). Lifelong 
Nutritional Omega-3 Deficiency Evokes Depressive-Like State Through Soluble Beta Amyloid. Mol 
Neurobiol. doi:10.1007/s12035-016-9809-2 
Morgese, M. G., Tucci, P., Mhillaj, E., Bove, M., Schiavone, S., Trabace, L., & Cuomo, V. (2017). Lifelong 
Nutritional Omega-3 Deficiency Evokes Depressive-Like State Through Soluble Beta Amyloid. Mol 
Neurobiol, 54(3), 2079-2089. doi:10.1007/s12035-016-9809-2 
Morishita, H., & Yagi, T. (2007). Protocadherin family: diversity, structure, and function. Curr Opin Cell Biol, 
19(5), 584-592. doi:10.1016/j.ceb.2007.09.006 
Moy, S. S., Nadler, J. J., Young, N. B., Perez, A., Holloway, L. P., Barbaro, R. P., . . . Crawley, J. N. (2007). 
Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res, 
176(1), 4-20. doi:10.1016/j.bbr.2006.07.030 
Mura, E., Lanni, C., Preda, S., Pistoia, F., Sara, M., Racchi, M., . . . Govoni, S. (2010). Beta-amyloid: a disease 
target or a synaptic regulator affecting age-related neurotransmitter changes? Curr Pharm Des, 
16(6), 672-683.  
Murakami, K., Miyake, Y., Sasaki, S., Tanaka, K., & Arakawa, M. (2010). Fish and n-3 polyunsaturated fatty 
acid intake and depressive symptoms: Ryukyus Child Health Study. Pediatrics, 126(3), e623-630. 
doi:10.1542/peds.2009-3277 
Nelson, S. B., & Valakh, V. (2015). Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum 
Disorders. Neuron, 87(4), 684-698. doi:10.1016/j.neuron.2015.07.033 
123 
 
Nemeroff, C. B. (2003). The role of GABA in the pathophysiology and treatment of anxiety disorders. 
Psychopharmacol Bull, 37(4), 133-146.  
Nemeroff, C. B., Owens, M. J., Bissette, G., Andorn, A. C., & Stanley, M. (1988). Reduced corticotropin 
releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry, 45(6), 
577-579.  
Nutt, D. J., & Malizia, A. L. (2001). New insights into the role of the GABA(A)-benzodiazepine receptor in 
psychiatric disorder. Br J Psychiatry, 179, 390-396.  
O'Donovan, S. M., Sullivan, C. R., & McCullumsmith, R. E. (2017). The role of glutamate transporters in the 
pathophysiology of neuropsychiatric disorders. NPJ Schizophr, 3(1), 32. doi:10.1038/s41537-017-
0037-1 
Ogawa, S., Koga, N., Hattori, K., Matsuo, J., Ota, M., Hori, H., . . . Kunugi, H. (2017). Plasma amino acid 
profile in major depressive disorder: Analyses in two independent case-control sample sets. J 
Psychiatr Res, 96, 23-32. doi:10.1016/j.jpsychires.2017.09.014 
Ohta, K., Kuno, S., Inoue, S., Ikeda, E., Fujinami, A., & Ohta, M. (2010). The effect of dopamine agonists: the 
expression of GDNF, NGF, and BDNF in cultured mouse astrocytes. J Neurol Sci, 291(1-2), 12-16. 
doi:10.1016/j.jns.2010.01.013 
Ohta, K., Kuno, S., Mizuta, I., Fujinami, A., Matsui, H., & Ohta, M. (2003). Effects of dopamine agonists 
bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in 
cultured mouse astrocytes. Life Sci, 73(5), 617-626.  
Owens, M. J., & Nemeroff, C. B. (1991). Physiology and pharmacology of corticotropin-releasing factor. 
Pharmacol Rev, 43(4), 425-473.  
Paila, Y. D., Ganguly, S., & Chattopadhyay, A. (2010). Metabolic depletion of sphingolipids impairs ligand 
binding and signaling of human serotonin1A receptors. Biochemistry, 49(11), 2389-2397. 
doi:10.1021/bi1001536 
Paine, T. A., Swedlow, N., & Swetschinski, L. (2017). Decreasing GABA function within the medial prefrontal 
cortex or basolateral amygdala decreases sociability. Behav Brain Res, 317, 542-552. 
doi:10.1016/j.bbr.2016.10.012 
Panagiotakos, D. B., Mamplekou, E., Pitsavos, C., Kalogeropoulos, N., Kastorini, C. M., Papageorgiou, C., . . . 
Stefanadis, C. (2010). Fatty acids intake and depressive symptomatology in a Greek sample: an 
epidemiological analysis. J Am Coll Nutr, 29(6), 586-594.  
Panza, F., Frisardi, V., Capurso, C., D'Introno, A., Colacicco, A. M., Imbimbo, B. P., . . . Solfrizzi, V. (2010). 
Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr 
Psychiatry, 18(2), 98-116. doi:10.1097/JGP.0b013e3181b0fa13 
Papadimitriou, G. (2017). The "Biopsychosocial Model": 40 years of application in Psychiatry. Psychiatriki, 
28(2), 107-110. doi:10.22365/jpsych.2017.282.107 
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., . . . Schoepp, D. D. (2007). 
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 
clinical trial. Nat Med, 13(9), 1102-1107. doi:10.1038/nm1632 
Patrick, R. P., & Ames, B. N. (2015). Vitamin D and the omega-3 fatty acids control serotonin synthesis and 
action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB 
J, 29(6), 2207-2222. doi:10.1096/fj.14-268342 
Pfohl, B., Sherman, B., Schlechte, J., & Winokur, G. (1985). Differences in plasma ACTH and cortisol between 
depressed patients and normal controls. Biol Psychiatry, 20(10), 1055-1072.  
Pinna, G., Costa, E., & Guidotti, A. (2009). SSRIs act as selective brain steroidogenic stimulants (SBSSs) at 
low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol, 9(1), 24-30. 
doi:10.1016/j.coph.2008.12.006 
Pobbe, R. L., Pearson, B. L., Defensor, E. B., Bolivar, V. J., Blanchard, D. C., & Blanchard, R. J. (2010). 
Expression of social behaviors of C57BL/6J versus BTBR inbred mouse strains in the visible burrow 
system. Behav Brain Res, 214(2), 443-449. doi:10.1016/j.bbr.2010.06.025 
Pomara, N., & Sidtis, J. (2007). Possible therapeutic implication of Abeta disturbances in depression. Int J 
Geriatr Psychiatry, 22(9), 931-932; author reply 930. doi:10.1002/gps.1763 
124 
 
Popik, P., Krawczyk, M., Golembiowska, K., Nowak, G., Janowsky, A., Skolnick, P., . . . Basile, A. S. (2006). 
Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 
102,677. Cell Mol Neurobiol, 26(4-6), 857-873. doi:10.1007/s10571-006-9012-5 
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977). Behavioral despair in mice: a primary screening test for 
antidepressants. Arch Int Pharmacodyn Ther, 229(2), 327-336.  
Pouw, L. B., Rieffe, C., Oosterveld, P., Huskens, B., & Stockmann, L. (2013). Reactive/proactive aggression 
and affective/cognitive empathy in children with ASD. Res Dev Disabil, 34(4), 1256-1266. 
doi:10.1016/j.ridd.2012.12.022 
Price, G. W., Lee, J. W., Garvey, C. A., & Gibson, N. (2010). The use of background EEG activity to determine 
stimulus timing as a means of improving rTMS efficacy in the treatment of depression: a controlled 
comparison with standard techniques. Brain Stimul, 3(3), 140-152. doi:10.1016/j.brs.2009.08.004 
Pytka, K., Podkowa, K., Rapacz, A., Podkowa, A., Zmudzka, E., Olczyk, A., . . . Filipek, B. (2016). The role of 
serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect. Pharmacol Rep, 
68(2), 263-274. doi:10.1016/j.pharep.2015.08.007 
Raadsheer, F. C., Hoogendijk, W. J., Stam, F. C., Tilders, F. J., & Swaab, D. F. (1994). Increased numbers of 
corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of 
depressed patients. Neuroendocrinology, 60(4), 436-444.  
Raadsheer, F. C., van Heerikhuize, J. J., Lucassen, P. J., Hoogendijk, W. J., Tilders, F. J., & Swaab, D. F. (1995). 
Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with 
Alzheimer's disease and depression. Am J Psychiatry, 152(9), 1372-1376. 
doi:10.1176/ajp.152.9.1372 
Ressler, K. J., & Mayberg, H. S. (2007). Targeting abnormal neural circuits in mood and anxiety disorders: 
from the laboratory to the clinic. Nat Neurosci, 10(9), 1116-1124. doi:10.1038/nn1944 
Ricceri, L., Moles, A., & Crawley, J. (2007). Behavioral phenotyping of mouse models of 
neurodevelopmental disorders: relevant social behavior patterns across the life span. Behav Brain 
Res, 176(1), 40-52. doi:10.1016/j.bbr.2006.08.024 
Rodriguez Manzanares, P. A., Isoardi, N. A., Carrer, H. F., & Molina, V. A. (2005). Previous stress facilitates 
fear memory, attenuates GABAergic inhibition, and increases synaptic plasticity in the rat 
basolateral amygdala. J Neurosci, 25(38), 8725-8734. doi:10.1523/JNEUROSCI.2260-05.2005 
Romeo, B., Choucha, W., Fossati, P., & Rotge, J. Y. (2017). Meta-analysis of central and peripheral gamma-
aminobutyric acid levels in patients with unipolar and bipolar depression. J Psychiatry Neurosci, 
42(6), 160228. doi:10.1503/jpn.160228 
Rosenthal, M. (2003). Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-
label, clinical trial with paroxetine as a positive control. J Clin Psychiatry, 64(10), 1245-1249.  
Ross, B. M. (2009). Omega-3 polyunsaturated fatty acids and anxiety disorders. Prostaglandins Leukot 
Essent Fatty Acids, 81(5-6), 309-312. doi:10.1016/j.plefa.2009.10.004 
Ryan, S., Fraser-Thomas, J., & Weiss, J. A. (2017). Patterns of sport participation for youth with autism 
spectrum disorder and intellectual disability. J Appl Res Intellect Disabil. doi:10.1111/jar.12414 
Sajdyk, T. J., & Shekhar, A. (1997). Excitatory amino acid receptors in the basolateral amygdala regulate 
anxiety responses in the social interaction test. Brain Res, 764(1-2), 262-264.  
Salaminios, G., Duffy, L., Ades, A., Araya, R., Button, K. S., Churchill, R., . . . Lewis, G. (2017). A randomised 
controlled trial assessing the severity and duration of depressive symptoms associated with a 
clinically significant response to sertraline versus placebo, in people presenting to primary care 
with depression (PANDA trial): study protocol for a randomised controlled trial. Trials, 18(1), 496. 
doi:10.1186/s13063-017-2253-4 
Sanacora, G. (2010). Cortical inhibition, gamma-aminobutyric acid, and major depression: there is plenty of 
smoke but is there fire? Biol Psychiatry, 67(5), 397-398. doi:10.1016/j.biopsych.2010.01.003 
Sanders, S. K., & Shekhar, A. (1995). Regulation of anxiety by GABAA receptors in the rat amygdala. 
Pharmacol Biochem Behav, 52(4), 701-706.  
125 
 
Schaub, R. T., Anders, D., Golz, G., Gohringer, K., & Hellweg, R. (2002). Serum nerve growth factor 
concentration and its role in the preclinical stage of dementia. Am J Psychiatry, 159(7), 1227-1229. 
doi:10.1176/appi.ajp.159.7.1227 
Schiavone, S., Mhillaj, E., Neri, M., Morgese, M. G., Tucci, P., Bove, M., . . . Cuomo, V. (2017). Early Loss of 
Blood-Brain Barrier Integrity Precedes NOX2 Elevation in the Prefrontal Cortex of an Animal Model 
of Psychosis. Mol Neurobiol, 54(3), 2031-2044. doi:10.1007/s12035-016-9791-8 
Schiavone, S., Tucci, P., Mhillaj, E., Bove, M., Trabace, L., & Morgese, M. G. (2017). Antidepressant drugs for 
beta amyloid-induced depression: A new standpoint? Prog Neuropsychopharmacol Biol Psychiatry, 
78, 114-122. doi:10.1016/j.pnpbp.2017.05.004 
Schwartz, R. D., & Yu, X. (1992). Inhibition of GABA-gated chloride channel function by arachidonic acid. 
Brain Res, 585(1-2), 405-410.  
Seillier, A., & Giuffrida, A. (2016). Disruption of social cognition in the sub-chronic PCP rat model of 
schizophrenia: Possible involvement of the endocannabinoid system. Eur Neuropsychopharmacol, 
26(2), 298-309. doi:10.1016/j.euroneuro.2015.12.009 
Seillier, A., & Giuffrida, A. (2017). Anxiety does not contribute to social withdrawal in the subchronic 
phencyclidine rat model of schizophrenia. Behav Pharmacol, 28(7), 512-520. 
doi:10.1097/FBP.0000000000000325 
Shah, A. A., & Treit, D. (2003). Excitotoxic lesions of the medial prefrontal cortex attenuate fear responses 
in the elevated-plus maze, social interaction and shock probe burying tests. Brain Res, 969(1-2), 
183-194.  
Siegel, S., & Sanacora, G. (2012). The roles of glutamate receptors across major neurological and psychiatric 
disorders. Pharmacol Biochem Behav, 100(4), 653-655. doi:10.1016/j.pbb.2011.11.002 
Silverman, J. L., Babineau, B. A., Oliver, C. F., Karras, M. N., & Crawley, J. N. (2013). Influence of stimulant-
induced hyperactivity on social approach in the BTBR mouse model of autism. Neuropharmacology, 
68, 210-222. doi:10.1016/j.neuropharm.2012.07.042 
Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010). Repetitive self-grooming behavior in the 
BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. 
Neuropsychopharmacology, 35(4), 976-989. doi:10.1038/npp.2009.201 
Simopoulos, A. P. (2009). Evolutionary aspects of the dietary omega-6:omega-3 fatty acid ratio: medical 
implications. World Rev Nutr Diet, 100, 1-21. doi:10.1159/000235706 
Simopoulos, A. P. (2011). Importance of the omega-6/omega-3 balance in health and disease: evolutionary 
aspects of diet. World Rev Nutr Diet, 102, 10-21. doi:10.1159/000327785 
Skouroliakou, M., Konstantinou, D., Koutri, K., Kakavelaki, C., Stathopoulou, M., Antoniadi, M., . . . 
Markantonis, S. (2010). A double-blind, randomized clinical trial of the effect of omega-3 fatty acids 
on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr, 64(9), 
940-947. doi:10.1038/ejcn.2010.98 
Sloan, D. M., & Kornstein, S. G. (2003). Gender differences in depression and response to antidepressant 
treatment. Psychiatr Clin North Am, 26(3), 581-594.  
Smagin, G. N., Heinrichs, S. C., & Dunn, A. J. (2001). The role of CRH in behavioral responses to stress. 
Peptides, 22(5), 713-724.  
So, N., Franks, B., Lim, S., & Curley, J. P. (2015). A Social Network Approach Reveals Associations between 
Mouse Social Dominance and Brain Gene Expression. PLoS One, 10(7), e0134509. 
doi:10.1371/journal.pone.0134509 
Soares, J., Castro, L. F., Reis-Henriques, M. A., Monteiro, N. M., & Santos, M. M. (2012). Zebrafish (Danio 
rerio) life-cycle exposure to chronic low doses of ethinylestradiol modulates p53 gene transcription 
within the gonads, but not NER pathways. Ecotoxicology, 21(5), 1513-1522. doi:10.1007/s10646-
012-0905-4 
Sogaard, R., Werge, T. M., Bertelsen, C., Lundbye, C., Madsen, K. L., Nielsen, C. H., & Lundbaek, J. A. (2006). 
GABA(A) receptor function is regulated by lipid bilayer elasticity. Biochemistry, 45(43), 13118-
13129. doi:10.1021/bi060734+ 
126 
 
Song, C., Zhang, X. Y., & Manku, M. (2009). Increased phospholipase A2 activity and inflammatory response 
but decreased nerve growth factor expression in the olfactory bulbectomized rat model of 
depression: effects of chronic ethyl-eicosapentaenoate treatment. J Neurosci, 29(1), 14-22. 
doi:10.1523/JNEUROSCI.3569-08.2009 
Sorce, S., Schiavone, S., Tucci, P., Colaianna, M., Jaquet, V., Cuomo, V., . . . Krause, K. H. (2010). The NADPH 
oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine 
responses. J Neurosci, 30(34), 11317-11325. doi:10.1523/JNEUROSCI.1491-10.2010 
Sparling, T. M., Henschke, N., Nesbitt, R. C., & Gabrysch, S. (2017). The role of diet and nutritional 
supplementation in perinatal depression: a systematic review. Matern Child Nutr, 13(1). 
doi:10.1111/mcn.12235 
Stahl, S. M. (2004). Anticonvulsants as anxiolytics, part 1: tiagabine and other anticonvulsants with actions 
on GABA. J Clin Psychiatry, 65(3), 291-292.  
Stanford, S. C. (2007). The Open Field Test: reinventing the wheel. J Psychopharmacol, 21(2), 134-135. 
doi:10.1177/0269881107073199 
Starkstein, S. E., Mizrahi, R., & Power, B. D. (2008). Depression in Alzheimer's disease: phenomenology, 
clinical correlates and treatment. Int Rev Psychiatry, 20(4), 382-388. 
doi:10.1080/09540260802094480 
Steffens, D. C., Plassman, B. L., Helms, M. J., Welsh-Bohmer, K. A., Saunders, A. M., & Breitner, J. C. (1997). 
A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's 
disease. Biol Psychiatry, 41(8), 851-856. doi:10.1016/S0006-3223(96)00247-8 
Stephens, M. A., & Wand, G. (2012). Stress and the HPA axis: role of glucocorticoids in alcohol dependence. 
Alcohol Res, 34(4), 468-483.  
Stetler, C., & Miller, G. E. (2011). Depression and hypothalamic-pituitary-adrenal activation: a quantitative 
summary of four decades of research. Psychosom Med, 73(2), 114-126. 
doi:10.1097/PSY.0b013e31820ad12b 
Sublette, M. E., Galfalvy, H. C., Hibbeln, J. R., Keilp, J. G., Malone, K. M., Oquendo, M. A., & Mann, J. J. 
(2014). Polyunsaturated fatty acid associations with dopaminergic indices in major depressive 
disorder. Int J Neuropsychopharmacol, 17(3), 383-391. doi:10.1017/S1461145713001399 
Sullivan, E. L., Riper, K. M., Lockard, R., & Valleau, J. C. (2015). Maternal high-fat diet programming of the 
neuroendocrine system and behavior. Horm Behav, 76, 153-161. doi:10.1016/j.yhbeh.2015.04.008 
Sun, X., Steffens, D. C., Au, R., Folstein, M., Summergrad, P., Yee, J., . . . Qiu, W. Q. (2008). Amyloid-
associated depression: a prodromal depression of Alzheimer disease? Arch Gen Psychiatry, 65(5), 
542-550. doi:10.1001/archpsyc.65.5.542 
Sweet, R. A., Hamilton, R. L., Butters, M. A., Mulsant, B. H., Pollock, B. G., Lewis, D. A., . . . Reynolds, C. F., 
3rd. (2004). Neuropathologic correlates of late-onset major depression. 
Neuropsychopharmacology, 29(12), 2242-2250. doi:10.1038/sj.npp.1300554 
Takahashi, A., Chung, J. R., Zhang, S., Zhang, H., Grossman, Y., Aleyasin, H., . . . Russo, S. J. (2017). 
Establishment of a repeated social defeat stress model in female mice. Sci Rep, 7(1), 12838. 
doi:10.1038/s41598-017-12811-8 
Takeuchi, T., Iwanaga, M., & Harada, E. (2003). Possible regulatory mechanism of DHA-induced anti-stress 
reaction in rats. Brain Res, 964(1), 136-143.  
Tapia-Arancibia, L., Aliaga, E., Silhol, M., & Arancibia, S. (2008). New insights into brain BDNF function in 
normal aging and Alzheimer disease. Brain Res Rev, 59(1), 201-220. 
doi:10.1016/j.brainresrev.2008.07.007 
Tecchio, F., Assenza, G., Zappasodi, F., Mariani, S., Salustri, C., & Squitti, R. (2011). Glutamate-mediated 
primary somatosensory cortex excitability correlated with circulating copper and ceruloplasmin. Int 
J Alzheimers Dis, 2011, 292593. doi:10.4061/2011/292593 
Thiels, C., Linden, M., Grieger, F., & Leonard, J. (2005). Gender differences in routine treatment of 
depressed outpatients with the selective serotonin reuptake inhibitor sertraline. Int Clin 
Psychopharmacol, 20(1), 1-7.  
127 
 
Trabace, L. (2014). Soluble beta amyloid in a continuum from physiology to pathology: searching the 
determinants of its effects and designing new pharmacological treatments. Curr Pharm Des, 20(15), 
2457.  
Trabace, L., Kendrick, K. M., Castrignano, S., Colaianna, M., De Giorgi, A., Schiavone, S., . . . Govoni, S. 
(2007). Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to 
nitric oxide. Neuroscience, 147(3), 652-663. doi:10.1016/j.neuroscience.2007.04.056 
Triaca, V., & Calissano, P. (2016). Impairment of the nerve growth factor pathway driving amyloid 
accumulation in cholinergic neurons: the incipit of the Alzheimer's disease story? Neural Regen Res, 
11(10), 1553-1556. doi:10.4103/1673-5374.193224 
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., . . . Team, S. D. S. (2006). 
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: 
implications for clinical practice. Am J Psychiatry, 163(1), 28-40. doi:10.1176/appi.ajp.163.1.28 
Tsuang, M. T., Taylor, L., & Faraone, S. V. (2004). An overview of the genetics of psychotic mood disorders. J 
Psychiatr Res, 38(1), 3-15.  
Tucci, P., Mhillaj, E., Morgese, M. G., Colaianna, M., Zotti, M., Schiavone, S., . . . Trabace, L. (2014). 
Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats. Front 
Behav Neurosci, 8, 332. doi:10.3389/fnbeh.2014.00332 
Tye, K. M., Mirzabekov, J. J., Warden, M. R., Ferenczi, E. A., Tsai, H. C., Finkelstein, J., . . . Deisseroth, K. 
(2013). Dopamine neurons modulate neural encoding and expression of depression-related 
behaviour. Nature, 493(7433), 537-541. doi:10.1038/nature11740 
Vahle-Hinz, C., Detsch, O., Siemers, M., & Kochs, E. (2007). Contributions of GABAergic and glutamatergic 
mechanisms to isoflurane-induced suppression of thalamic somatosensory information transfer. 
Exp Brain Res, 176(1), 159-172. doi:10.1007/s00221-006-0604-6 
van Elst, K., Bruining, H., Birtoli, B., Terreaux, C., Buitelaar, J. K., & Kas, M. J. (2014). Food for thought: 
dietary changes in essential fatty acid ratios and the increase in autism spectrum disorders. 
Neurosci Biobehav Rev, 45, 369-378. doi:10.1016/j.neubiorev.2014.07.004 
Varela, M. J., Acanda de la Rocha, A. M., Diaz, A., & Lopez-Gimenez, J. F. (2017). Potentiation of morphine-
induced antinociception and locomotion by citalopram is accompanied by anxiolytic-like effects. 
Pharmacol Biochem Behav. doi:10.1016/j.pbb.2017.10.003 
Varghese, F. P., & Brown, E. S. (2001). The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive 
Disorder: A Brief Primer for Primary Care Physicians. Prim Care Companion J Clin Psychiatry, 3(4), 
151-155.  
Vaz, J. D. S., Farias, D. R., Adegboye, A. R. A., Nardi, A. E., & Kac, G. (2017). Omega-3 supplementation from 
pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial. 
BMC Pregnancy Childbirth, 17(1), 180. doi:10.1186/s12884-017-1365-x 
Vinot, N., Jouin, M., Lhomme-Duchadeuil, A., Guesnet, P., Alessandri, J. M., Aujard, F., & Pifferi, F. (2011). 
Omega-3 fatty acids from fish oil lower anxiety, improve cognitive functions and reduce 
spontaneous locomotor activity in a non-human primate. PLoS One, 6(6), e20491. 
doi:10.1371/journal.pone.0020491 
Vlcek, P., Polak, J., Brunovsky, M., & Horacek, J. (2017). Role of Glutamatergic System in Obsessive-
Compulsive Disorder with Possible Therapeutic Implications. Pharmacopsychiatry. doi:10.1055/s-
0043-118665 
Walsh, R. N., & Cummins, R. A. (1976). The Open-Field Test: a critical review. Psychol Bull, 83(3), 482-504.  
Wang, T., Shah, Y. M., Matsubara, T., Zhen, Y., Tanabe, T., Nagano, T., . . . Gonzalez, F. J. (2010). Control of 
steroid 21-oic acid synthesis by peroxisome proliferator-activated receptor alpha and role of the 
hypothalamic-pituitary-adrenal axis. J Biol Chem, 285(10), 7670-7685. 
doi:10.1074/jbc.M109.090175 
Wegener, G., Bandpey, Z., Heiberg, I. L., Volke, V., Trabace, L., Rosenberg, R., & Harvey, B. H. (2004). 
Combined chronic treatment with citalopram and lithium does not modify the regional 
neurochemistry of nitric oxide in rat brain. J Physiol Pharmacol, 55(3), 575-586.  
128 
 
Weidenfeld, J., Newman, M. E., Itzik, A., Gur, E., & Feldman, S. (2002). The amygdala regulates the pituitary-
adrenocortical response and release of hypothalamic serotonin following electrical stimulation of 
the dorsal raphe nucleus in the rat. Neuroendocrinology, 76(2), 63-69. doi:64430 
Weissman, M. M., Bland, R., Joyce, P. R., Newman, S., Wells, J. E., & Wittchen, H. U. (1993). Sex differences 
in rates of depression: cross-national perspectives. J Affect Disord, 29(2-3), 77-84.  
Wiener, C. D., de Mello Ferreira, S., Pedrotti Moreira, F., Bittencourt, G., de Oliveira, J. F., Lopez Molina, M., 
. . . Oses, J. P. (2015). Serum levels of nerve growth factor (NGF) in patients with major depression 
disorder and suicide risk. J Affect Disord, 184, 245-248. doi:10.1016/j.jad.2015.05.067 
Wilson, C. A., & Koenig, J. I. (2014). Social interaction and social withdrawal in rodents as readouts for 
investigating the negative symptoms of schizophrenia. Eur Neuropsychopharmacol, 24(5), 759-773. 
doi:10.1016/j.euroneuro.2013.11.008 
Witcher, J. A., & Freeman, M. E. (1985). The proestrous surge of prolactin enhances sexual receptivity in the 
rat. Biol Reprod, 32(4), 834-839.  
Xiao, X., Chang, H., & Li, M. (2017). Molecular mechanisms underlying noncoding risk variations in 
psychiatric genetic studies. Mol Psychiatry, 22(4), 497-511. doi:10.1038/mp.2016.241 
Xiao, X., Zheng, F., Chang, H., Ma, Y., Yao, Y. G., Luo, X. J., & Li, M. (2017). The Gene Encoding Protocadherin 
9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder. Neuropsychopharmacology. 
doi:10.1038/npp.2017.241 
Xiong, P., Zeng, Y., Wan, J., Xiaohan, D. H., Tan, D., Lu, J., . . . Ma, M. (2011). The role of NGF and IL-2 serum 
level in assisting the diagnosis in first episode schizophrenia. Psychiatry Res, 189(1), 72-76. 
doi:10.1016/j.psychres.2010.12.017 
Yang, M., Abrams, D. N., Zhang, J. Y., Weber, M. D., Katz, A. M., Clarke, A. M., . . . Crawley, J. N. (2012). Low 
sociability in BTBR T+tf/J mice is independent of partner strain. Physiol Behav, 107(5), 649-662. 
doi:10.1016/j.physbeh.2011.12.025 
Yang, M., Scattoni, M. L., Zhodzishsky, V., Chen, T., Caldwell, H., Young, W. S., . . . Crawley, J. N. (2007). 
Social approach behaviors are similar on conventional versus reverse lighting cycles, and in 
replications across cohorts, in BTBR T+ tf/J, C57BL/6J, and vasopressin receptor 1B mutant mice. 
Front Behav Neurosci, 1, 1. doi:10.3389/neuro.08.001.2007 
Yizhar, O., Fenno, L. E., Prigge, M., Schneider, F., Davidson, T. J., O'Shea, D. J., . . . Deisseroth, K. (2011). 
Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature, 
477(7363), 171-178. doi:10.1038/nature10360 
Yoshimura, R. F., Tran, M. B., Hogenkamp, D. J., Ayala, N. L., Johnstone, T., Dunnigan, A. J., . . . Gee, K. W. 
(2017). Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify 
autism-like behaviors in the BTBR mouse model. Neuropharmacology, 126, 38-47. 
doi:10.1016/j.neuropharm.2017.08.029 
Young, E. A., Altemus, M., Lopez, J. F., Kocsis, J. H., Schatzberg, A. F., DeBattista, C., & Zubieta, J. K. (2004). 
HPA axis activation in major depression and response to fluoxetine: a pilot study. 
Psychoneuroendocrinology, 29(9), 1198-1204. doi:10.1016/j.psyneuen.2004.02.002 
Zelena, D., Mergl, Z., & Makara, G. B. (2005). Glutamate agonists activate the hypothalamic-pituitary-
adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg 
neurons. Brain Res, 1031(2), 185-193. doi:10.1016/j.brainres.2004.10.034 
Zetterberg, H., Mattsson, N., Shaw, L. M., & Blennow, K. (2010). Biochemical markers in Alzheimer's disease 
clinical trials. Biomark Med, 4(1), 91-98.  
Zhang, Y., Ge, J. F., Wang, F. F., Liu, F., Shi, C., & Li, N. (2017). Crassifoside H improve the depressive-like 
behavior of rats under chronic unpredictable mild stress: Possible involved mechanisms. Brain Res 
Bull, 135, 77-84. doi:10.1016/j.brainresbull.2017.09.015 
Zimmer, L., Vancassel, S., Cantagrel, S., Breton, P., Delamanche, S., Guilloteau, D., . . . Chalon, S. (2002). The 
dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. 
Am J Clin Nutr, 75(4), 662-667.  
129 
 
Zuliani, G., Galvani, M., Leitersdorf, E., Volpato, S., Cavalieri, M., & Fellin, R. (2009). The role of 
polyunsaturated fatty acids (PUFA) in the treatment of dyslipidemias. Curr Pharm Des, 15(36), 
4087-4093.  
 
130 
 
131 
 
ENGLISH SUMMARY 
Depression is one of the most common psychiatric diseases; indeed the prevalence of depressive 
symptoms has reached epidemic proportions during the last few decades. Several studies reported 
that depression is more prevalent in women compared to men. Although the reasons for this 
gender pre-dominance in depression is not understood, women show different hormonal 
responses that might ultimately influence behaviours and brain functions. 
The core symptoms of depression include depressed mood, anhedonia (reduced ability to 
experience pleasure from natural rewards), irritability, difficulties in concentrating, social 
withdrawal (withdrawal from social contact that derives from indifference or lack of desire to have 
social contact) and abnormalities in appetite and sleep, the so called “neurovegetative 
symptoms”.  
Depression has shown to be comorbid with several neuropsychiatric diseases, such as 
schizophrenia, bipolar disorders, Alzheimer’s diseases, anxiety disorders, autism spectrum 
disorders (ASD) and stress-related diseases. Moreover, depression often occurs during the 
prodromic phase of Alzheimer’s disease, schizophrenia and bipolar disorders.  
Diets, genetics and lifestyle contribute to the onset and progression of mental illnesses. Regarding 
dietary factors, Polyunsaturated Fatty Acids (PUFA) have received great attention during the last 
decades, particularly due to the trend towards a poor n-3 PUFA intake of modern Western diets. In 
this regard, in chapter 2 and 3 of the present thesis, effects of n-3 PUFA deficient and n-3 PUFA 
enriched diets on female rat offspring have been investigated. Our results reported that chronic 
exposure to n-3 PUFA deficient diet leads to highly detrimental consequences in behavioural and 
neurochemical parameters related to depressive- and anxiety-like symptoms. In particular, we 
found an increase in immobility and a decrease in swimming frequency in Forced Swimming test in 
n-3 PUFA deficient females, and, in the Open Field test, we showed an increase in time spent 
performing self-grooming and time spent in the periphery of the arena. Hence, our behavioural 
results showed that lifelong n-3 PUFA deficiency is able to elicit depressive- and anxiety-like 
symptoms in female rats. Therefore, we investigated neurochemical changes underlying these 
behavioural alterations. We found a significant decrease in cortical serotonin and Nerve Growth 
Factor in n-3 PUFA deficient females, accompanied by an increase in serotonin turnover. 
Moreover, in chapter 3, we showed that n-3 PUFA deficient diet led to hyperactivation of the HPA 
axis, in particular increase in hypothalamic noradrenaline and corticotrophin-releasing factor and 
132 
 
also increase in plasmatic corticosterone, accompanied by an increase in amygdaloidal 
noradrenaline and serotonin and an increase in glutamate and a decrease of GABA in both 
prefrontal cortex and amygdala. Ultimately, we found an increase in plasmatic soluble beta 
amyloid (Aβ) 1-42 peptide in females exposed to n-3 PUFA deficient diet.  
Interestingly, soluble Aβ1-42 peptide is receiving great importance in the development of 
depression, also since depression is highly comorbid with Alzheimer’s disease and other 
neurodegenerative illnesses. Accordingly, we have previously shown that central Aβ injection is 
able to elicit depressive-like phenotype in male rats. Thus, in chapter 2, we reproduced for the first 
time the Aβ-induced depressive-like model in female rats, evaluating behavioural and 
neurochemical outcomes. Our results confirmed the Aβ-induced depressive-like profile also in 
female rats. Moreover, the Aβ-induced depressive-like profile was reversed by n-3 PUFA 
supplementation, indicating a possible therapeutic role of n-3 PUFA in the treatment of the 
burden of depressive disorders. Taken together, our data suggest that monoamine impairments, 
accompanied by Nerve Growth Factor alterations and HPA axis dysfunctions, might be considered 
important neurobiological determinants contributing to the pathogenesis of depressive-like 
symptoms induced by n-3 PUFA deficiency and soluble Aβ administration.  
During the last decades, diagnosis in psychiatry only focused on subjective symptoms and 
observable signs. Although symptoms are an important starting point, genetics and neurobiology 
underlying these symptoms need to be deeply investigated. To achieve this purpose, animal 
models can be really helpful to longitudinally study behavioural alterations resembling human 
symptoms, and ultimately investigate the underlying neurobiology in order to unravel the 
etiopathogenesis. Therefore, in this thesis, we focused on depressive-like symptoms that occur in 
several neuropsychiatric and neurodegenerative diseases, and, using different animal paradigms 
and models, we tried to disentangle the neurobiological determinants behind these symptoms. 
Intriguingly, in order to deeply investigate depression core symptoms in a translational way, the 
social sphere need to be taken into account.  An important depressive-like symptom affecting the 
social sphere is social withdrawal. Social withdrawal, defined as lack of desire to have social 
contact, is an early symptom of a wide variety of neuropsychiatric diseases, including 
schizophrenia, Autism Spectrum Disorders (ASD) and major depression.  
In chapter 4 and 5, we investigated behavioural alterations related to sociability and social 
withdrawal, using a behavioural paradigm called the Visible Burrow System (VBS). The VBS is a 
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semi-natural environment, with burrows and an open area, useful to study social dynamics that 
naturally occur in mixed-sex rodent colonies, firstly developed by Blanchard group. In particular 
we identified and validated behavioural readouts to assess sociability and social withdrawal 
features in C57BL/6J mice colonies, used as control strain, and two mutant lines, BTBR inbred 
strain and a Pcdh9-deficient line. The BTBR strain is a widely used strain for its similarities with 
human ASD deficits, such as repetitive behaviour, impaired communication and reduced social 
interactions, while Pcdh9 gene Knockout (KO) mice are known to affect social behaviour in mice 
and may, through the core deficit in sensory processing be relevant to a wide variety of 
neuropsychiatric disorders, such as schizophrenia, major depression and ASD.  
Our results showed that BTBR mice performed less social behaviours and have a preference for 
non-social behaviours compared to C57BL/6J mice in the VBS. Thus, our results reported a trend 
towards social withdrawal in BTBR mice, opening to a deep investigation of the underlying 
neurobiology that gives rise to this important symptom. Hence, our study validated the suitability 
of VBS as a behavioural paradigm to assess sociability and social withdrawal features. Conversely, 
we found no differences in terms of social behaviours and non-social behaviours among VBS 
colonies composed of Pcdh9 Homozygous (HOM) and Heterozygous (HET) KO and Wild Type (WT) 
mice, indicating no disrupted sociability of Pcdh9-deficient mice when housed together with WT in 
the VBS. In this regard, future studies are required to better understand the HOM Pcdh9 KO social 
phenotype without the presence of social stimuli. Indeed, VBS colonies formed by mixed-genotype 
and mixed-sex mice are considered highly social environment, and these strong social stimuli 
might be helpful to improve putative social deficits. In conclusion, the VBS can be used as a tool to 
study behavioural dysfunctions and might be further used as a behavioural paradigm to test 
pharmacological treatments aiming at restoring social dysfunctions that commonly occur in 
several neuropsychiatric disorders, such as social withdrawal.  
Furthermore, in order to investigate neurobiology behind sociability and social withdrawal, in 
chapter 4, we analyzed GABA and glutamate content in prefrontal cortex and amygdala of 
C57BL/6J and BTBR colonies and we found a significant decrease of GABA and a significant 
increase of glutamate in both areas of BTBR mice.  
Intriguingly, the decrease in GABA and the corresponding increase in glutamate in prefrontal 
cortex and amygdala might be responsible for the observed decrease in social behaviour and 
increase in social withdrawal characteristics in BTBR strain. Thus, enhancement of GABA 
134 
 
neurotransmission and consequent attenuation of glutamatergic tone might be a possible 
therapeutic strategy to treat social withdrawal symptoms that primarily occur in many 
neuropsychiatric and neurodegenerative diseases.  
Moreover, in chapter 5, we measured GABA and glutamate levels in somatosensory cortex of 
Pcdh9 colonies and we found that there were no differences in GABA content among the three 
genotypes in both VBS colonies and standard housing condition. Otherwise, glutamate was 
significantly increased only in HOM Pcdh9-deficient mice housed in standard cage, while no 
genotype differences were found in glutamate levels among VBS colonies. Hence, the glutamate 
increase found in HOM Pcdh9 KO mice housed in standard cages and not found in HOM Pcdh9 KO 
mice housed in VBS colonies points towards a putative beneficial effect of this highly social 
environment on glutamate increase induced by Pcdh9 deletion. 
In conclusion, in the present thesis, we investigated the heterogeneity underlying the 
neurobiology of depressive like-symptoms, that might be shared across different neuropsychiatric 
disorders. In this way a multifactorial perspective will be developed. Hence, in order to improve 
the current pharmacological approach and further develop new safe and effective treatments, the 
influence of social, environmental and dietary factors, together with comorbidities, need to be 
considered to ultimately target the correct neurobiological substrates that give rise to different 
depressive-like symptoms shared across various brain diseases. 
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NEDERLANDSE SAMENVATTING 
Depressie is één van de vaakst voorkomende psychiatrische aandoeningen. In de afgelopen 
decennia is de prevalentie van depressieve symptomen toegenomen tot epidemische proporties. 
Daarnaast, geven verscheidene wetenschappelijke studies aan dat depressies vaker voorkomen bij 
vrouwen. Hoewel de reden voor dit verschil tussen de geslachten niet geheel duidelijk is, is wel 
bekend dat vrouwen anders reageren op geslachtshormonen die uiteindelijk hun invloed hebben 
op het gedrag en de hersenen.  
De kernsymptomen van depressie bestaan uit een sombere stemming, verlies van interesse of 
plezier, prikkelbaarheid, moeite met concentreren, sociale terugtrekking (het terugtrekken van 
sociaal contact dat voorkomt uit onverschilligheid of een gebrek aan verlangen naar sociaal 
contact) en abnormaliteiten in eetlust en slaap, de zogenaamde “neurovegetatieve symptomen”. 
Wetenschappelijk onderzoek heeft aangetoond dat depressie vaak een comorbide stoornis is bij 
verschillende neuropsychiatrische aandoeningen, zoals schizofrenie, bipolaire stoornissen, de 
ziekte van Alzheimer, angststoornissen, autisme spectrum stoornissen en stress-gerelateerde 
aandoeningen. Daarnaast uit depressie zich vaak in de prodromale fase van de ziekte van 
Alzheimer, schizofrenie en bipolaire stoornissen. 
Het dieet, de genen en de levensstijl zijn allen factoren die bijdragen aan het ontstaan en de 
progressie van mentale stoornissen. Gelet op de factoren betreffende het dieet hebben 
meervoudig onverzadigde vetzuren de laatste decennia veel aandacht ontvangen, dit komt vooral 
doordat er in Westerse diëten weinig n-3 vetzuren (ook wel omega-3 vetzuren) worden genuttigd. 
In hoofdstuk 2 en 3 van dit proefschrift worden de effecten van diëten met een tekort aan n-3 
vetzuren en rijk aan n-3 vetzuren op het nageslacht van vrouwelijke ratten bestudeerd. Onze 
resultaten geven aan dat chronische blootstelling aan diëten met een tekort aan n-3 vetzuren leidt 
tot zeer negatieve consequenties in zowel gedrags- als neurochemische parameters gerelateerd 
aan symptomen die vergelijkbaar zijn met depressie en angststoornissen. We vonden met name 
een verhoogde immobiliteit en een verlaagde zwem frequentie in de “Forced Swimming” test in n-
3 vetzuur deficiënte vrouwtjes. Daarnaast poetsen deze vrouwtjes zichzelf meer en spendeerden 
ze meer tijd in de periferie in de “Open Field” test. Deze resultaten, met betrekking tot het gedrag, 
laten zien dat een levenslange deficiëntie van n-3 vetzuren kan zorgen voor symptomen 
vergelijkbaar met depressie en angststoornissen in vrouwelijke ratten. Dit heeft ertoe geleid dat 
we de neurochemische veranderingen die ten grondslag liggen aan deze gedragsveranderingen 
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zijn gaan bestuderen. We vonden een significante verlaging van corticale Serotonine en 
zenuwgroeifactor (beter bekend als nerve growth factor of NGF) in n-3 vetzuur deficiënte 
vrouwtjes, wat gepaard ging met een verhoging van de omzetting van Serotonine. Daarnaast 
lieten we in hoofdstuk 3 zien dat het n-3 vetzuur deficiënte dieet leidde tot hyperactivatie van de 
HPA-as, voornamelijk een verhoging van hypothalamisch noradrenaline en “corticotropin-
releasing factor” en ook een verhoging in plasma corticosteron, wat samenging met verhoogd 
amygdaloidale noradrenaline en serotonine en een verhoging van glutamaat en verlaging van 
GABA in zowel de prefrontale cortex als de amygdala. Tenslotte vonden we een verhoging van 
plasma oplosbaar bèta amyloïde (Aβ)1-42 peptide in vrouwtjes die blootgesteld waren aan het dieet 
met een tekort aan n-3 vetzuren. 
Oplosbaar Aβ1-42 peptide krijgt veel aandacht in de literatuur omdat het een rol speelt in de 
ontwikkeling van depressie, maar ook omdat depressie zeer vaak co morbide is met de ziekte van 
Alzheimer en andere neuropsychiatrische aandoeningen. In deze lijn hebben we in het verleden 
laten zien dat centrale Aβ injecties kunnen zorgen voor een depressie-achtig fenotype in 
mannelijke ratten.  
In hoofdstuk 2 hebben we, voor het eerst, het Aβ-geïnduceerde depressie-achtige model in 
vrouwelijke ratten gereproduceerd, waarbij we hebben gelet op gedragsmatige en 
neurochemische uitkomsten. Onze resultaten bevestigen het Aβ-geïnduceerde depressie-achtige 
profiel ook in vrouwelijke ratten. Verder lieten we zien dat het Aβ-geïnduceerde depressie model 
kon worden tenietgedaan door supplementatie van n-3 vetzuren. Dit wijst op een mogelijk 
therapeutische rol voor n-3 vetzuren in de behandeling van depressieve stoornissen. Samen 
suggereert onze data dat mono-amine verminderingen, vergezeld door veranderingen in NGF en 
disfuncties in de HPA-as beschouwd kunnen worden als belangrijke neurobiologische factoren die 
bijdragen aan de pathogenese van depressie-achtige symptomen geïnduceerd door een tekort aan 
n-3 vetzuren en de toediening van oplosbaar Aβ. 
In de afgelopen decennia richtte de diagnose in de psychiatrie zich alleen op subjectieve 
symptomen en observeerbare verschijnselen. Hoewel symptomen een belangrijk beginpunt zijn, is 
het nodig om de onderliggende genetica en neurobiologie grondig te bestuderen. Om dit doel te 
kunnen bereiken kunnen diermodellen van grote dienst zijn om longitudinaal 
gedragsveranderingen te bestuderen die vergelijkbaar zijn met humane symptomen en uiteindelijk 
de onderliggende neurobiologie bloot te leggen die ten grondslag ligt aan het ontstaan en het 
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verloop van het ziektebeeld. Om deze reden concentreren we ons, in dit proefschrift, op 
depressie-achtige symptomen die voorkomen bij verschillende neuropsychiatrische aandoeningen 
en neurodegeneratieve ziektebeelden. Door gebruik te maken van verschillende diermodellen en 
paradigma’s proberen we de neurobiologische  factoren achter deze symptomen te ontrafelen. 
Om de kernsymptomen van depressie te kunnen doorgronden op translationele wijze, is het 
belangrijk om het sociale domein in acht te nemen. Een belangrijk symptoom van depressie 
binnen het sociale domein is sociale terugtrekking. Sociale terugtrekking kan worden gedefinieerd 
als een gebrek aan verlangen naar sociaal contact. Het uit zich al in de vroege fase van 
verscheidene neuropsychiatrische aandoeningen, waaronder schizofrenie, ASS en depressie.  
Hierop gelet bestudeerden we in hoofdstuk 4 en 5 de veranderingen in gedrag die gerelateerd zijn 
aan sociabiliteit en sociale terugtrekking, waarbij we gebruik maken van een paradigma genaamd 
het “Visible Burrow System” (VBS). Het VBS is een semi-natuurlijke omgeving, met een open arena 
en een gangensysteem, dat gebruikt kan worden om de sociale dynamiek te bestuderen die uit 
zichzelf wordt gevormd in kolonies van gemixte geslachten. Dit paradigma werd als eerste gebruikt 
en ontwikkeld door de Blanchard groep. In het bijzonder identificeerden en valideerden wij 
gedragsmatige factoren om sociabiliteit en sociale terugtrekking te bestuderen in C57BL/6J muizen 
kolonies (gebruikt als referentie) en in kolonies van twee mutant lijnen, de BTBR inteelt lijn en een 
lijn waarbij het gen Protocadherin 9 (Pcdh9) mist. De BTBR lijn wordt door velen gebruikt om zijn 
gelijkenissen met de beperkingen die te zien zijn in het humane ASS, zoals repetitief gedrag, 
verslechterde communicatie en verminderde sociale interacties. Daarnaast is recent ontdekt dat 
Pcdh9 is betrokken bij sensorische problemen zoals ook gezien in neuropsychiatrische 
aandoeningen zoals schizofrenie, depressie en ASS. Onze resultaten laten zien dat de BTBR muis 
minder sociaal gedrag laten zien en dat ze een voorkeur hebben voor niet-sociaal gedragingen in 
het VBS vergeleken met de C57BL/6J controle lijn. Hiermee laten onze resultaten een trend 
richting sociale terugtrekking zien in de BTBR lijn, wat de kans biedt om de onderliggende 
neurobiologie te onderzoeken die ten grondslag ligt aan dit centrale symptoom. Ons onderzoek 
bevestigt hiermee de geschiktheid van het VBS als een paradigma om factoren gerelateerd aan 
sociabiliteit en sociale terugtrekking te bestuderen. Daarentegen vonden we geen verschillen in 
sociaal en niet-sociaal gedrag in kolonies die bestonden uit muizen homozygoot en heterozygoot 
deficiënt voor Pcdh9 en wild type muizen (met alle genen intact). Hieruit kunnen we opmaken dat 
Pcdh9 deficiënte muizen geen verstoorde sociabiliteit laten zien in het VBS wanneer deze samen in 
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een kolonie leven met wild type muizen. Hierop gelet is het nodig om verder onderzoek te doen 
om een beter begrip te krijgen van het sociale fenotype van de homozygote Pcdh9-deficiënte muis 
zonder de aanwezigheid van sociale stimuli. Kolonies in het VBS die bestaan uit muizen van 
verschillende genotypes en geslachten kunnen namelijk worden gezien als een sociaal rijke 
omgeving en deze sterk sociale stimuli kunnen helpen bij het herstellen van de vermoedelijk 
sociale problemen. Hieruit kunnen we concluderen dat het VBS kan worden gebruikt als 
hulpmiddel om gedragsmatige problemen te bestuderen en dat het in de toekomst kan worden 
gebruikt als paradigma om farmaceutische interventies te testen gericht op het herstellen van 
sociale dysfuncties die veel voorkomend zijn in verscheidene neuropsychiatrische aandoeningen, 
zoals sociale terugtrekking. 
Om de neurobiologie achter sociabiliteit en sociale terugtrekking te bestuderen hebben we in 
hoofdstuk 4 de aanwezigheid van de neurotransmitters GABA en glutamaat in de prefrontale 
cortex en de amygdala van C57BL/6J en BTBR muizen kolonies. In de BTBR lijn vonden we een 
significante verlaging van GABA en een significante verhoging van glutamaat in zowel de 
prefrontale cortex als de amygdala. De verlaging van GABA en de corresponderende verhoging van 
de aanwezigheid van glutamaat in beiden hersengebieden zouden verantwoordelijk kunnen zijn 
voor de geobserveerde vermindering van sociaal gedrag en de toenamen van factoren gerelateerd 
aan sociale terugtrekking. Dit wekt de suggestie dat een verbetering van de GABA 
neurotransmissie en de daaruit volgende vermindering van de glutamerge concentratie een 
mogelijke strategie zou kunnen zijn om de symptomen sociale terugtrekking te kunnen 
behandelen zoals die voorkomen in vele neuropsychiatrische aandoeningen en 
neurodegeneratieve ziektebeelden. 
Daarnaast hebben we in hoofdstuk 5 GABA en glutamaat niveaus gemeten in de 
somatosensorische cortex van de Pcdh9 kolonies. Hier vonden we dat er geen verschil is in GABA 
tussen de drie genotypes, niet in de VBS kolonies en ook niet in de standaard huisvesting 
condities. Daarentegen was glutamaat significant verhoogd in de homozygote deficiënte muizen 
voor Pcdh9 in de normale omstandigheden. Terwijl geen verschil was gevonden in glutamaat 
concentraties in de VBS kolonies. Dit wekt het vermoeden op dat de sociaal rijke omgeving in de 
VBS kolonies een voordelig effect heeft op de glutamaat concentraties in de muizen die 
homozygoot deficiënt zijn voor Pcdh9. 
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Samenvattend, in dit proefschrift hebben we de heterogene onderliggende neurobiologie van 
depressie-achtige symptomen onderzocht, die voorkomen bij meerdere neuropsychiatrische 
ziektes. Hierdoor is een multifactorieel perspectief gecreëerd. Om vooruit te komen in het 
ontwikkelen van nieuwe effectieve en veilige behandelingen voor deze ziektes, moet de invloed 
van sociale, omgevings- en dieet factoren overwogen worden. Dit is nodig om uiteindelijk de juiste 
neurobiologische substraten te vinden die zorgen voor de depressieve symptomen voorkomend 
bij een variëteit aan neuropsychiatrische ziektebeelden. 
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SOMMARIO  
La depressione è una delle malattie psichiatriche più frequenti, la cui prevalenza ha raggiunto 
proporzioni epidemiche negli ultimi decenni. A questo proposito, diversi studi riportano una 
maggior incidenza di depressione nelle donne rispetto agli uomini, sebbene le ragioni di questa 
differenza di genere non siano state ancora pienamente comprese. I principali sintomi della 
depressione includono umore depresso, anedonia (ridotta capacità di provare appagamento o 
interesse per attività comunemente ritenute piacevoli), irritabilità, difficoltà di concentrazione, 
ritiro sociale e anomalie dell'appetito e del sonno, i cosiddetti "sintomi neurovegetativi”. 
Numerosi disordini mentali come la schizofrenia, i disturbi bipolari, il Morbo di Alzheimer, i 
disturbi d'ansia, i disturbi dello spettro autistico (ASD) e le malattie correlate allo stress, possono 
manifestarsi come comorbidità della malattia depressiva. Inoltre, la depressione si presenta 
spesso durante la fase prodromica del Morbo di Alzheimer, della schizofrenia e dei disturbi 
bipolari. 
Diete, fattori genetici e stile di vita contribuiscono all'insorgenza e alla progressione delle malattie 
mentali. Per quanto riguarda i fattori dietetici, gli acidi grassi polinsaturi (PUFAs) hanno ricevuto 
grande attenzione negli ultimi decenni, soprattutto a causa dell’aumentato consumo di junk food, 
tipico dei Paesi Occidentali, che ha portato ad una drammatica riduzione nell’assunzione di n-3 
PUFA e ad uno smodato aumento del consumo di n-6 PUFA. A questo proposito, nei capitoli 2 e 3 
di questa tesi, sono presentati i nostri dati riguardanti gli effetti di una dieta ricca di n-3 PUFA e di 
una dieta povera di n-3 PUFA su ratte femmine sottoposte, dal concepimento fino all’età adulta, 
alle sopracitate supplementazioni dietetiche. I nostri risultati hanno mostrato che l'esposizione 
cronica alla dieta povera di n-3 PUFA può portare ad alterazioni di parametri comportamentali e 
neurochimici, correlate a sintomi depressivo-ansiosi. In particolare, nelle ratte sottoposte alla 
dieta povera di n-3 PUFA, è stato riscontrato un aumento della frequenza dell'immobilità e una 
diminuzione della frequenza di attività nel test del nuoto forzato (FST).  In un altro set di animali 
sottoposti allo stesso trattamento, l’Open Field test ha mostrato un aumento del tempo trascorso 
facendo self-grooming e di quello speso nella periferia dell'arena. Pertanto, i nostri risultati 
comportamentali suggeriscono che la protratta carenza di n-3 PUFA è in grado di indurre sintomi 
simil-depressivi e simil-ansiogeni nelle ratte femmine. Abbiamo successivamente studiato le 
possibili alterazioni neurochimiche alla base di queste alterazioni comportamentali, identificando 
una significativa diminuzione della serotonina (5-HT) corticale e del fattore di crescita neuronale 
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(NGF) nelle ratte esposte alla dieta povera di n-3 PUFA, accompagnati da un aumento del turnover 
della serotonina. Inoltre, nel capitolo 3, abbiamo mostrato che la dieta povera in n-3 PUFA 
determina un’iperattivazione dell'asse ipotalamo-ipofisi-surrene (HPA), mediante l'aumento della 
noradrenalina e del fattore di rilascio della corticotropina (CRF) in ipotalamo e l’incremento del 
corticosterone plasmatico (accompagnati da un aumento di noradrenalina e serotonina in 
amigdala), così come da un incremento del glutammato e una diminuzione dell’ acido gamma-
aminobutirrico (GABA) sia nella corteccia prefrontale che nell'amigdala. In ultima analisi, le ratte 
femmine esposte ad una dieta povera di n-3 PUFA hanno mostrato un aumento plasmatico del 
peptide beta amiloide solubile (Aβ)1-42. 
Il peptide solubile Aβ1-42 sta recentemente assumendo grande importanza nella patogenesi della 
depressione, in quanto la depressione si presenta frequentemente come comorbidità sia della 
malattia di Alzheimer sia di altre malattie neurodegenerative. A questo proposito, il nostro gruppo 
ha precedentemente dimostrato che la somminiztrazione intracerebroventricolare (icv) di Aβ è in 
grado di evocare un fenotipo simil-depressivo in ratti adulti maschi. Nel capitolo 2 di questo lavoro 
di tesi, abbiamo riprodotto per la prima volta il modello simil-depressivo indotto dalla 
somministrazione di Aβ nelle ratte femmine, valutando parametri comportamentali e 
neurochimici. I nostri risultati hanno confermato il profilo depressivo indotto da Aβ anche nelle 
ratte femmine. Inoltre, il profilo simil-depressivo Aβ-indotto è stato revertito nelle ratte esposte 
ad una dieta ricca di n-3 PUFA, indicando un possibile effetto benefico della supplementazione di 
n-3 PUFA nel trattamento dei disturbi depressivi. In conclusione, i nostri dati suggeriscono che le 
alterazioni della trasmissione monoaminergica, accompagnate da modifiche del NGF e disfunzioni 
dell'asse HPA, possono essere considerate importanti determinanti neurobiologici che 
contribuiscono alla patogenesi dei sintomi simil-depressivi indotti dalla carenza di n-3 PUFA e dalla 
somministrazione del peptide Aβ solubile. 
Negli ultimi decenni le diagnosi dei disturbi psichiatrici sono state basate essenzialmente su 
sintomi soggettivi e su segni osservabili. Sebbene i sintomi costituiscano un importante punto di 
partenza, i fattori genetici e neurobiologici sottesi a questi sintomi devono essere approfonditi. 
Pertanto, l’impiego di modelli animali può risultare molto utile al fine di studiare 
longitudinalmente le alterazioni comportamentali traslabili ai sintomi nell’uomo e, in ultima 
analisi, indagare sulla neurobiologia sottesa per identificarne l'eziopatogenesi. 
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Pertanto, in questo lavoro di tesi, sono stati investigati i meccanismi neurobiologici alla base di 
sintomi simil-depressivi comuni a molte malattie neuropsichiatriche e neurodegenerative, 
utilizzando diversi paradigmi e modelli animali.  
Per poter analizzare in maniera approfondita e traslazionale i principali sintomi simil-depressivi, 
occorre tener conto anche della sfera sociale. Un importante sintomo simil-depressivo che 
colpisce la sfera sociale è il ritiro sociale. Il ritiro sociale, definito come la mancanza di desiderio di 
avere contatti sociali, è un sintomo precoce di un'ampia varietà di malattie neuropsichiatriche, tra 
cui la schizofrenia, l'ASD e la depressione maggiore. 
A questo proposito, nel capitolo 4 e 5, abbiamo investigato le alterazioni comportamentali relative 
alla socialità e al ritiro sociale, utilizzando un nuovo paradigma comportamentale chiamato 
“Visible Burrow System” (VBS). Il VBS è un ambiente semi-naturale, costituito da un tunnel e 
numerose tane costantemente al buio e un'arena con un normale ciclo luce/buio (12h/12h), utile 
per analizzare le dinamiche sociali che si verificano naturalmente nelle colonie di roditori. In 
particolare, abbiamo individuato alterazioni comportamentali correlabili al ritiro sociale in colonie 
di topi C57BL/6J, utilizzati come ceppo di controllo, e due linee transgeniche, i topi BTBR e i topi 
Pcdh9-Knockout (KO). I topi BTBR sono ampiamente utilizzati per le loro somiglianze con i deficit 
tipici dell’ASD, poiché presentano comportamenti stereotipati, disfunzioni nella vocalizzazione e 
ridotte interazioni sociali, mentre i Pcdh9-KO sono stati recentemente studiati come modelli simil-
schizofrenici, simil-depressivi e simil-autistici. 
I nostri risultati hanno mostrato che i topi BTBR presentano deficit nei comportamenti sociali e 
hanno una preferenza per i comportamenti non sociali rispetto ai topi C57BL/6J nel VBS, con 
caratteristiche tipiche del ritiro sociale. Al contrario, non abbiamo trovato differenze di 
socializzazione nelle colonie composte da Pcdh9 omozigoti e eterozigoti KO e Wild Type (WT), 
indicando l’assenza di deficit della sfera sociale nei topi Pcdh9 KO stabulati insieme ad i WT nel 
VBS. A questo proposito, studi futuri saranno focalizzati su una maggiore caratterizzazione del 
fenotipo sociale dei Pcdh9 KO, in assenza di stimoli sociali. Infatti, le colonie, formate da topi di 
genotipo misto e di sesso misto, sono considerate setting altamente sociali, utili a migliorare i 
deficit sociali eventualmente riscontrati. In conclusione, il nostro studio ha validato l'utilità del VBS 
come paradigma comportamentale per studiare le disfunzioni sociali e potrebbe essere 
ulteriormente impiegato per testare trattamenti farmacologici mirati al loro ripristino.  
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A questo punto, un’analisi della possibili alterazioni neurobiologiche responsabili del ritiro sociale 
si è resa necessaria. A tal fine, nel capitolo 4 di questo lavoro di tesi, abbiamo analizzato il 
contenuto di GABA e glutammato nella corteccia prefrontale e nell’ amigdala di colonie di topi 
C57BL/6J e BTBR, identificando una significativa diminuzione del GABA e un significativo aumento 
del glutammato in entrambe le aree nei topi BTBR. Abbiamo così ipotizzato che la diminuzione di 
GABA e il corrispondente aumento del glutammato nella corteccia prefrontale e nell'amigdala 
potrebbero essere responsabili della ridotta socializzazione e dell'aumento del ritiro sociale nei 
topi BTBR. Pertanto, la stimolazione della neurotrasmissione GABAergica e l’attenuazione del tono 
glutammatergico potrebbero rappresentare possibili targets terapeutici per il trattamento del 
ritiro sociale, tipico di numerose malattie neuropsichiatriche e neurodegenerative. 
Inoltre, nel capitolo 5 di questa tesi, abbiamo misurato i livelli di GABA e glutammato nella 
corteccia somato-sensoriale di colonie di topi Pcdh9 e abbiamo evidenziato l’assenza di differenze 
nel contenuto di GABA tra i tre genotipi, sia nei topi raggruppati in colonie nel VBS, che nei topi 
stabulati nelle gabbie standard. Contrariamente, i topi Pcdh9-KO omozigoti, stabulati nelle gabbie 
standard, hanno riportato un aumento di glutammato rispetto ai topi KO eterozigoti ed ai WT, 
mentre nessuna differenza di genotipo è stata riscontrata nei livelli di glutammato delle le colonie 
del VBS. Di conseguenza, l'aumento del glutammato riportato dai Pcdh9 KO omozigoti stabulati in 
gabbie standard e non riscontrato nei KO omozigoti raggruppati nelle colonie del VBS, suggerisce 
un effetto positivo di questo ambiente altamente sociale, in grado di revertire l'aumento di 
glutammato indotto dalla deficienza del gene Pcdh9. 
In conclusione, il presente lavoro di tesi è stato focalizzato sullo studio di differenti pathways 
neurobiologici in grado di provocare sintomi simil-depressivi caratteristici di molti disturbi 
neuropsichiatrici, al fine di sviluppare un approccio multifattoriale.  
Al fine di migliorare le attuali opzioni terapeutiche e sviluppare nuovi trattamenti sicuri ed efficaci, 
occorre necessariamente considerare l'influenza dei fattori sociali, ambientali e alimentari, così 
come il ruolo delle comorbidità nell’eziopatogenesi dei sintomi simil-depressivi, in maniera da 
individuare i corretti substrati neurobiologici responsabili della comparsa di tali sintomi. 
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